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ABSTRACT
The human oral cavity is a complex polymicrobial environment, home to an array
of microbes that play roles in health and disease. Oral bacteria have been shown to cause
an array of systemic diseases and are particularly concerning to type II diabetics (T2D)
with numerous predispositions that exacerbate bacterial infection. In this dissertation,
we investigated the serum of healthy subjects and T2D subjects to determine whether
we see greater translocation of oral bacteria into the bloodstream of T2D individuals.
We didn’t observe any significant enrichment of oral taxa, however we detected the
presence of an emerging pathogen, Acinetobacter baumannii that is also associated with
impaired inflammation in T2D.
While some are associated with disease, many oral taxa are important in the prevention of disease. In this dissertation we investigated the interactions between two
abundant health-associated commensal microbes, Haemophilus parainfluenzae and
Streptococcus mitis. We demonstrated that H. parainfluenzae typically exists adjacent
to Mitis group streptococci in vivo in healthy subjects. We revealed that this co-occurrence is density dependent and further influenced by H2O2 production. Additionally,
Mitis group streptococci are likely the in vivo source of NAD for H. parainfluenzae
further facilitating this co-occurrence. We also investigated H. parainfluenzae’s response to H2O2, which is composed of a redundant OxyR-controlled system. Furthermore, we showed that H2O2 likely elicits the SOS response in H. parainfluenzae which
may be a mechanism of generating genetic diversity within this species. These findings
reveal mechanisms behind why these two highly abundant taxa coexist in healthy individuals.
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CHAPTER 1: Introduction
The human oral cavity is a complex environment, home to over 600 species of
bacteria (1), most of whom are considered indigenous to this site (2). It is now well established that the oral microbiota plays a vital role in the development of many diseases. While intuitively, the oral microbiota plays a role in the development of oral
diseases, oral microbes have also been associated with a range of systemic disorders
beyond the oral cavity.
One of the best-established associations is that of cardiovascular disease. Oral
bacteria belonging to the HACEK (Haemophilus species, Aggregatibacter species,
Cardiobacterium hominis, Eikenella corrodens and Kingella species) are known
causes of infective endocarditis (IE) (3). Oral microbes, including Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis have also been detected in atherosclerotic plaques (4). Additionally, the development of oral diseases including periodontitis has been shown to be an important risk factor for cardiovascular disease (5).
The most common form of periodontal disease is gingivitis (6). Gingivitis is a reversible inflammatory disease caused by bacterial plaque that forms at the gingival margin
(7). If left untreated, gingivitis may develop into periodontitis, which is a chronic, irreversible inflammatory disease that may result in destruction of connective tissue, vascular proliferation and bone destruction (8).
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An important patient population that is affected by periodontal disease are type II
diabetics (T2D). The association between T2D and periodontitis can be considered to
occur both ways as periodontitis is regarded as a potential complication of poorly controlled diabetes and that periodontal pathogens can play a role in T2D (9). In fact diabetics have 3 times the risk of developing periodontitis compared to non-diabetics
(10). Studies have shown differences in the composition of oral bacteria in T2D subjects compared to non-diabetics, including elevated numbers of some periodontal pathogens (11,12). The abundance of some periodontal pathogens has also been shown to
worsen glycemic control. Notably, the lipopolysaccharide (LPS) of the periodontal
pathogen Porphyromonas gingivalis can stimulate inflammatory cytokines that impair
insulin activity (13).
Given the propensity of some oral bacteria to cause systemic disease, it is important to determine factors that can contribute to bacterial translocation into the
bloodstream. This is particularly important among diabetics as they have multiple predispositions that can exacerbate bacterial infection. The presence of bacteria in the
bloodstream outside of sepsis has been a contentious topic (14). While the advent of
Next generation sequencing (NGS) has improved our ability to detect bacteria that are
both unculturable and found in low abundance, the lack of appropriate controls in
early studies investigating the “human blood microbiome” has hindered our understanding of this environment (14). It is now established that at least transient bacterial
translocation occurs even after brushing teeth or mastication of food (15,16). Given
that T2D subjects exhibit symptoms including poor circulation, decreased wound heal-
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ing and diminished bacterial uptake by phagocytosis (17–19), it is important to determine whether there is a greater translocation of oral bacteria into the blood of T2D.
Similarly, given that diabetics are disproportionately affected by periodontitis, it is important to determine the effects of these conditions on bloodstream colonization.
While the abundance of certain oral bacteria has been associated with both oral
and systemic disease, the abundance and selection of commensal bacteria has been associated with health and prevention of disease (20).The oral cavity is not a unitary environment in fact, the oral cavity contains several different subsites which are composed of distinct microbial communities (7). These include dental plaque, tongue dorsum, buccal mucosa and keratinized gingiva, which are home to very distinct communities. In fact, most bacterial species in the oral cavity are found in only a single site
(21). An exception to this specificity is Haemophilus parainfluenzae, which is found
in high abundance in all these sites as well as the nasopharynx (1). While H. parainfluenzae is responsible for the majority of cases of HACEK endocarditis (3), it is more
commonly associated with a healthy oral microbiome (22). In fact, the abundance of
H. parainfluenzae has been associated with beneficial immunomodulatory and antiproliferative effects against cancerous cells (23,24). It is therefore important to understand the interactions of H. parainfluenzae within the oral cavity as this may improve
our understanding of what maintains its healthy status and potentially prevents its
translocation into distal sites where it may cause disease.
Another abundant commensal found in all sites of the oral cavity and nasopharynx are Mitis group Streptococci. The Mitis group is comprised of at least 13 Streptococcus sp. including S. mitis, S. oralis, S. peroris and S. sanguinis (25). Many of the
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species within this group are amongst the first colonizers of the human oral cavity and
facilitate both microbial-microbial and host-microbial interactions by being anchors
for biofilm formation and provide surface proteins to enable attachment and integration of other bacteria (26,27). A key example of this is S. mitis, which is regarded as a
pioneering colonizer of both the oral cavity and nasopharynx (28). S. mitis has been
shown to induce expression of human-b-defensin 2, which is a host antimicrobial peptide that can kill oral pathogens and also dampen the effects of inflammation following
coculture with oral pathogens (29,30).
S. mitis can also influence overall oral biofilm ecology. It can release extracellular
DNA, which is crucial for the development and stabilization of biofilms and it can also
produce hydrogen peroxide (H2O2), which has been shown to be an effective antimicrobial that can shape microbial community composition (27). Given the abundant
presence of Mitis group Streptococci in the same environments as H. parainfluenzae it
is prudent to investigate interactions between these two commensal taxa, especially in
the context of H2O2 response and tolerance. The goals of this dissertation are to improve our understanding of H. parainfluenzae- Streptococcus sp. interaction with a focus on understanding H. parainfluenzae’s response to H2O2.
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Summary

Type-II diabetes (T2D) affects over 10% of the United States population and is a growing disease worldwide that manifests with numerous comorbidities and defects in inflammation. This dysbiotic host response allows for infection of the host by numerous
microorganisms. In the course of T2D disease, individuals can develop chronic infections including foot ulcers and periodontitis, which lead to further complications and
opportunistic infections in multiple body sites. In this study, we investigated the serum
of healthy subjects and T2D patients with (T2DP) or without periodontitis for both microbiome signatures in addition to cytokine profiles. Surprisingly, we detected the presence of Acinetobacter baumanii in the serum of 23% of T2D/T2DP individuals tested.
In T2DP, IL-1β, TNF-α, MCP-1, IL-6, IL-8, and IFN-γ were significantly elevated in
ABC positive subjects. As an emerging pathogen, A. baumanii infection represents a
risk for impaired inflammation and the development of comorbidities in T2D subjects.

Introduction
Type-II diabetes (T2D) is a chronic inflammatory disease affecting 10.5% of the United
States population, with rising prevalence both in the United States and worldwide (“National Diabetes Statistics Report | Data & Statistics | Diabetes | CDC,” 2020; Whiting et
al., 2011). Individuals with T2D typically have numerous comorbidities, and are at
greater risk of both opportunistic and nosocomial infections, which can result in significant morbidity, including amputations, and lost quality of life (QOL) measures (Erben
et al., 2013; Ferlita et al., 2019; Kim et al., 2019; McDonald et al., 2014; Vardakas et
10

al., 2007). Thus, care must be taken to prevent and monitor the infection status of these
individuals, as the development of diabetic mucosal and skin lesions across the body
can impact the host immune and diabetic responses. Key infection prevention includes
minimizing portals of entry and colonization by numerous pathogens. One example of
such a portal of entry is the emergence of diabetic foot ulcers, which can develop diabetic foot infections (DFIs). Roughly 15% of adult T2D subjects develop foot ulcers
and ~14% of these subjects undergo amputation, with the remainder needing extensive
debridement, negative pressure treatments and other therapies including antibiotics that
result in prolonged hospitalization time, lengthy healing duration and increased treatment costs (Driver et al., 2010; Reiber et al., 1998).

In addition to DFIs, T2D subjects are ~3 times more likely to develop periodontitis
(Emrich et al., 1991; Wu et al., 2020). Periodontitis is an inflammatory oral disease
accompanied by a polymicrobial biofilm infection that can lead to tissue damage,
chronic lesions and tooth/bone loss in the oral cavity (Genco et al., 2020; Irfan et al.,
2001; Mann et al., 2020). During periodontal infection, the healthy oral microbiome,
especially in the subgingival space (along teeth below the gumline, including periodontal ligament, epithelium, alveolar bone, and connective tissues), transitions to one enriched with several opportunistic pathogens that exacerbate inflammation and host tissue damage both locally and systemically (Curtis et al., 2020; Griffen et al., 2012; Hajishengallis and Lamont, 2012; Nowicki et al., 2018; Roberts and Darveau, 2015;
Socransky et al., 1998). While protective, acute inflammation is a helpful immune response, it is characterized by rapid activation of inflammation and subsequent return to

11

homeostasis (resolution). Unresolved inflammation that fails to control the trigger leads
to chronic lesions and is a hallmark of both periodontitis and T2D.

More acute bacteremia can manifest in diseases such as endocarditis or other distal infections by oral microbes (Carrizales-Sepúlveda et al., 2018; Lockhart and Durack,
1999; Parahitiyawa et al., 2009). Various systemic diseases are in fact influenced by
microbial metabolism and host interactions. “How” and “why” immune system imbalance fails to control microbial pathogenic transition remains an active area of investigation. Increasing evidence implicates periodontal diseases, especially periodontitis in
adults, as a potential risk factor for increased morbidity and mortality from systemic
conditions including diabetes, cardiovascular diseases, adverse pregnancy outcomes,
and others (Genco et al., 2020; S.E. Kleinstein et al., 2020). This is due to two plausible
mechanisms: a direct pathway leading to migration of the bacteria to distal organs and
an indirect pathway leading to production of microbial metabolites and/or activating
inflammatory mediators that activate the immune system locally and systemically. This
is likely made possible as periodontitis presents as a chronic inflammatory condition of
the tooth-supporting structures occurring with oral microbiome dysbiosis and continuous inflammatory burden. Notably, oral microbes have also been detected (Dowd et al.,
2008; Gardner et al., 2013) and isolated from DFIs (Bowler and Davies, 1999; Citron et
al., 2007). Thus, we hypothesized that T2D patients might be at a greater risk of extraoral infection and may exhibit changes in microbiota that transiently occupy their
bloodstream. We further hypothesized that these changes would be even more apparent
in T2D patients with periodontitis (T2DP) and that these patients may carry potential
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DFI-colonizing oral species in their bloodstream. Our initial investigations toward these
hypotheses utilized samples derived from previous work on resolution of inflammation
in T2D (Freire et al., 2017) and are reported here, with unexpected results.

To investigate the possibility of oral species presence in the bloodstream, we compared
the serum V1-V3 16S microbiomes of T2D and T2DP subjects versus a healthy cohort.
While our initial microbiome observations did reveal the presence of multiple oral taxa
in human serum, it did not demonstrate that these were especially enriched in T2D or
even T2DP subjects compared to non-diabetic subjects. Unexpectedly, we detected Acinetobacter baumanii in 23% of the T2DP subjects in our study with none detected in
the healthy cohort. A. baumanii is an emerging infectious pathogen (Villar et al., 2014)
notorious for its evolving antibiotic resistances (Gootz and Marra, 2008; VázquezLópez et al., 2020), nosocomial (Ayoub Moubareck and Hammoudi Halat, 2020; Dijkshoorn et al., 2007) and bloodstream infections (Peleg et al., 2008). A. baumanii is part
of a cluster of Acinetobacter species with similar clinical manifestations known as the
AB or ABC complex (Gerner-Smidt and Tjernberg, 1993) which are highly similar via
ribotyping.

A. baumanii or ABC complex organisms present several particular risks to T2D subjects, specifically higher mortality rates for those with bacteremia (Leão et al., 2016)
and for those with higher blood glucose concentrations (Leung and Liu, 2019). A. baumanii has recently emerged as medically important because of the increasing number of
local and systemic infections produced by this organism. An inoculum of this pathogen
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in a mouse pneumonia model led to increased proinflammatory cytokines, reduced neutrophil infiltration into the lung, and increased extrapulmonary dissemination (Qiu et
al., 2009). In T2D, neutrophils present failure in early chemotaxis, but a hyper-inflammatory feedback loop emerges to compensate initial myeloid cell failure (Sarah E Kleinstein et al., 2020). Patients infected with A. baumanii after burns were 9.8 times more
likely to develop glucose intolerance and ~3x more T2D burn patients developed A.
baumanii infections (27%) than patients without T2D (8.5%) (Furniss et al., 2005). Additionally, A. baumanii has also been observed in DFIs, particularly alongside other
multidrug resistant pathogens, presenting a grave concern for T2D individuals (Castellanos et al., 2019; Henig et al., 2020). In addition to DFIs, ABC complex organisms can
also spread through the body and form infections in numerous organs (Al-Anazi and AlJasser, 2014; Peleg et al., 2008).

In this work, we first investigated whether or not we could detect signatures of oral
bacteria in a post hoc microbiome analysis of serum samples collected in a previous
study (Freire et al., 2017). Our findings indicated minor, yet significant, microbiome
compositional changes between healthy cohort, type-II diabetics (T2D) and T2D subjects with periodontitis (T2DP). We discovered that nearly 1/4 of T2DP subjects in our
study contained sequence reads identical to that of A. baumanii, which was not detected
in any healthy, no-template, or mock control samples. The specific presence of A. baumanii was confirmed by further clone library and 16S rDNA Sanger sequencing. In
addition, we assayed the host response by cytokine profiles of sera. Our findings revealed distinct differences between the healthy, T2D and T2DP groups, demonstrating
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that diabetes presents the major proinflammatory forces via cytokine analysis, and periodontal diseases synergistically increased that profile when compared to healthy controls. When stratifying A. baumanii positive T2D versus A. baumanii negative T2D
samples we observed unique cytokine profiles, suggesting a specific microbial impact
on systemic inflammation. While our methodology cannot indicate if A. baumanii was
transiently present or a subclinical colonizer of our T2DP cohort, we propose that these
data reveal a much greater risk of currently ‘uninfected’ T2D individuals for A. baumanii exposure and infection than previously understood and should justify more intensive and thorough investigation into AB complex colonization of type-II diabetics.

Results

Patient demographics

Serum samples were generated from the population described in Table 1. A total of 81
subjects were investigated in this study, 57 with type-II diabetes (T2D), of which 29 had
periodontitis (T2DP) as defined by the American Association of Diabetes (ADA)
(American Diabetes Association, 2015) and American Association of Periodontology
(AAP) (Armitage, 1999) criteria respectively. All T2D donors were poorly-controlled
diabetic subjects that had not taken antimicrobials, non-steroidal anti-inflammatory
drugs or insulin sensitizers within 3 months. Diagnostic serum glucose measures were
taken for all subjects and HbA1C was measured for diabetics to stage disease status. As
expected, poorly-controlled diabetics (HbA1c% >6.5%) showed significantly elevated
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glucose levels (p < 0.0001; Table 1). There were no significant differences in gender or
ethnicity between healthy volunteers and diabetic patients. Diabetic patients showed
elevated BMI and tended to be older than healthy controls (p< 0.05), consistent with
known disease biology. Periodontal condition was further stratified among the subjects
according to severity of irreversible tissue loss (mild, moderate, severe) and reversible
lesions called gingivitis according to American Association of Periodontology (AAP)
(Armitage, 1999) criteria. Periodontal condition was significantly worse in diabetic
compared to healthy subjects (p< 0.0001). All healthy subjects had healthy periodontal
condition compared to only 11% of diabetic patients, with 15% of diabetic subjects suffering from severe periodontitis. Current and former smokers were near uniformly part
of the T2D and T2DP groups with only 1 current smoker in the healthy group. The entire
study population had a median age range of 53 +/- 11 years and all subjects were outpatient and thus not part of an extended hospital stay cohort.

Table 1. Clinical demographics
of study subjects.
Healthy

Type 2 Dia-

Total Co-

(N=24)

betic

hort

(N=57)

(N=81)

56 ± 10.38

52.78 ±

Age (mean in

46 ±

years ± SD)

10.74

Gender (no.,

Male

14 (58%)

%)

11.40
28 (49%)

42
(51.85%)

16

p-value

0.0003

Ethnicity

Female

10 (42%)

29 (51%)

39 (48.15)

Caucasian

15 (63%)

26 (46%)

40

0.62

(49.38%)
Hispanic

2 (8%)

7 (12%)

9 (11.11%)

African-Ameri-

6 (25%)

23 (40%)

29

can

Smoking Sta-

(35.80%)

Asian

0

2 (4%)

2 (2.47%)

Other

1 (4%)

0

1 (1.23%)

Smokers

1 (4%)

5 (9%)

6 (7.41%)

0

21 (38%)

21

0.23

tus (no., %)
Former Smokers
Never Smokers

(25.93%)
23 (92%)

31 (53%)

54

0.002

(66.67%)
BMI (kg/m²;

29.58 ±

32.89 ±

31.87 ±

mean ± SD)

2.82

6.07

5.48

148.50 ±

213.04 ±

194.00 ±

35.91

78.81

74.84

83.00 ±

97.00 ±

85.33 ±

11.14

1.41

11.46

Blood Cholesterol (mg/dl;
mean ± SD)
Blood Glu-

Normal

cose (mg/dl;

(<100mg/dl)

mean ± SD)

17

0.001

<0.0001

Pre-diabetes
(100-125mg/dl)
Diabetes
(>126mg/dl)
HbA1c %

Normal (<5.7%

(mean ± SD)

HbA1c)
Pre-diabetes

104.80 ±

115.60 ±

108.90 ±

3.33

7.44

7.42

165.20 ±

202.00 ±

198.60 ±

39.70

56.45

55.86

-

5.20 ± 0.26

-

-

6.13 ± 0.21

-

-

8.07 ± 1.51

-
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6 (10.71%)

31

<0.0001

(5.7-6.4%
HbA1C)
Diabetes
(>6.4% HbA1c)
Periodontal

Healthy

Condition

(100%)

(38.27%)

(no., %)
Mild

Moderate

Severe

Gingivitis

0

0

0

0

18

15

15

(26.79%)

(18.52%)

11

11

(19.64%)

(13.58%)

12

12

(21.43%)

(14.81%)

10

10

(17.86%)

(12.35%)

-

Stable Perio-

0

2 (3.57%)

2 (2.47%)

0 (0%)

13 (23%)

13

<0.0001

dontitis
ABC Positive

Positive

(no., %)

(16.05%)
Negative

19 (76%)

29 (51%)

48
(59.26%)

Not Tested

5 (24%)

15 (26%)

20

0.07

(24.69%)
Neutrophil

76.48 ±

165.46 ±

131.90 ±

Count (mil. of

57.77

97.12

94.51

66.15 ±

117.10 ±

99.22 ±

50.13

62.99

63.28

<0.0001

cells, mean ±
SD)
Monocyte
Count (mil. of

0.002

cells, mean ±
SD)

Table 1. Study subject demographics. p-values calculated by unpaired t-tests or χ2
(two-sided p-values; italicized p<0.05 significant). SD, standard deviation; BMI, bodymass index; ABC, A. baumanii; %, percentage; mg/dl, milligrams per deciliter; kg/m²,
kilograms per square meter.
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Microbiome analysis controls for low template sequencing

Data generated here was part of a post hoc study of serum samples collected for a previous study (Freire et al., 2017) and thus not available in the larger volumes ideal for
16S microbiome dataset generation. Low template concentrations can produce microbiome signatures not derived from that in the biological samples due to amplification of
contaminating gDNA in sterile buffers and reagents (Kennedy et al., 2014; Kim et al.,
2017; Salter et al., 2014), which often manifests as aquatic species signatures, many of
which are not compatible with growth in the human host (i.e. many do not even grow at
37°C) (Kim et al., 2017). A description of no-template / reagent only control samples is
provided in the methods. Data within this study is provided as either minimally filtered
(mitochondrial, human and chloroplast aligned reads removed) or strict filtered (reads
removed based on homology with reagent-only controls) and indicated as such throughout the study. All sequence data is made available at NIH SRA Bioproject
PRJNA664044, and all scripts used for data generation, filtering, and analyses are provided in the Supplemental Information.

We were able to generate abundant data from these samples with careful consideration
paid to controls for amplification bias and background bacterial gDNA contamination
of commercial sterile reagents. First, we utilized amplification of a mock standard library of 8 bacterial and 2 fungal species (Fig. S1A-B) at 10 and 1 ng of total template,
which indicated that our library preparation protocol was suitable for species-level analysis where possible by V1-V3 sequence. Second, we utilized 13 separate no-template /
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reagent only controls, which were subjected to our sequence analysis pipeline, revealing
frequently encountered contaminating taxa. These taxa were filtered from each humanderived sample in the strict-filtered datasets only.

V1-V3 16S microbiome diversity analyses reveal minor but significant differences between diabetic and nondiabetic groups

Serum and control samples were subject to bead beater lysis and genomic DNA purification. Purified gDNA was amplified using the V1-V3 targeted 27F-519R primer pair
(Stackebrandt and Goodfellow, 1991; Turner et al., 1999). Quality trimmed reads were
subjected to DADA2 analysis (Callahan et al., 2016) and aligned to the SILVA database
(Quast et al., 2013) to determine species-level identity where possible. Rarefaction
curve analysis was performed to ensure adequate sequencing depth (Fig. S2) and resequencing of each Illumina index was performed to generate greater sequencing depth
without further template amplification. Run to run variability between next-generation
sequencing was found to be insignificant (Fig. S3). Data analysis and comparisons were
performed via QIIME2 (Bolyen et al., 2019) as detailed in the methods.

We first quantified alpha and beta diversity between the healthy, T2D and T2DP subject
groups for our strict filtered (Fig. 1) and minimally filtered data (Fig. S4). For both
datasets, species richness for T2D and T2DP groups were significantly different than
the healthy cohort which was also significantly different when compared to T2DP in
each dataset for species evenness (T2D more rich, T2DP less rich and less even). Beta
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diversity was significantly less for healthy subjects versus T2D and greater when compared to T2DP for either minimal or strict filtered datasets. Thus, we observed minor
but significant shifts in microbiome composition between subject groups.

To begin investigating which taxa contributed to this composition difference we first
looked at a phylum level display of our taxonomically assigned data (Fig. 2). Figure 2A
and 2B respectively indicate phylum level data for strict versus minimal filtered datasets. Similar trends in phyla distribution were evident for either dataset and reveal
minor phylum level changes between subject groups.

22

Figure 1.1. 16S Alpha and Beta diversity of serum microbiomes changes with subject status. Species richness is displayed based on Faith’s phylogenetic diversity (Faith,
1992) (A) and species evenness based on Pielou’s evenness index (Pielou, 1966) (B)
for healthy, type-II diabetic (T2D) and type-II diabetics with periodontitis (T2DP) samples. Significance was determined by Kruskal-Wallis analysis of variance (Kruskal and
Wallis, 1952) for each comparison indicated and Benjamini-Hochberg correction (Benjamini and Hochberg, 1995) was applied to generate adjusted q-values. All data used
was strictly filtered based on no-template control indexes. * indicates q-value < 0.002
compared to Healthy, ** indicates q-value < 0.0004 compared to Healthy and to T2D,
(C) Beta-diversity Bray Curtis distances. Pairwise PERMANOVA of each category vs
each (group size of 3, n=112) was performed in 999 permutations. *** indicates q-value
differs from ‘healthy’ < 0.001.
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Figure 1.2. Phylum level diversity changes between subject status. DADA2 analyzed data was aligned to the SILVA database for taxonomical assignment via
QIIME2 as described in methods. Data from both sequencing runs were collapsed to
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phylum level taxa and displayed for (A) strict filtered and (B) minimally filtered conditions. Asterisks on the top indicate run-run sample pairs that were positive for A.
baumanii.

MED and DADA2 analysis reveal the presence of Acinetobacter baumanii

Given our initial investigation into whether or not there were differences between T2D
and T2DP microbiota and a preliminary hypothesis that oral taxa would be enriched in
T2DP serum, we first used a minimal entropy decomposition (MED) analysis identical
to one used previously to characterize oral microbiomes (Eren et al., 2014). Oligotyped
“nodes” or representative sequences were aligned to both the Human Oral Microbiome
(HOMD) (Escapa et al., 2018) and Ribosomal Database Project (RDP) (Cole et al.,
2014) databases and species were assigned based on 98% or higher sequence identity
when comparing nodes to reference databases. We next compared species assigned data
between subject groups by linear discriminate analysis effect size measurements
(LEfSe) (Segata et al., 2011). Using MED analyzed data for healthy vs all T2D subjects
(Fig. 3) we detected significant enrichments of some oral species (S. cristatus, N. flavescens) but also some known reagent contaminants (R. picketti, A. broomeae). Surprisingly, we observed Acinetobacter baumanii significantly enriched in the T2D population as a whole. For MED analysis, reads assigned as A. baumanii were present from
0.01 to 7.3 % of total reads in 8 T2D and 5 T2DP subjects. No reads assigned to A.
baumanii were detected in any healthy subjects. DADA2 amplicon sequence variants
(ASV) are similar to MED nodes and we observed that one ASV node was a perfect
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match to the singular MED node assigned to A. baumanii based on 100% RDP alignment across its full sequence.

In our DADA2 / QIIME2 based analysis we performed taxonomical assignment for each
DADA2 amplicon sequence variant (ASV) node aligned to either the Greenegenes (DeSantis et al., 2006) (not shown) or SILVA database version 132 (Quast et al., 2013).
Phylum level taxonomic assignments of DADA2 data aligned to SILVA were used in
Figure 2. ASVs are similar to MED nodes and we observed that one ASV node was a
perfect match to the singular MED node assigned to A. baumanii based on 100% RDP
alignment across its full sequence. This ASV was assigned only to the Acinetobacter
genus despite a 100% full length match to A. baumanii sequence at the RDP database
and the NCBI non-redundant database (not shown). Based on this, we manually assigned this ASV to A. baumanii and found that reads now assigned to A. baumanii were
present from 0.01 to 9.1 % of total reads in 8 T2D and 5 T2DP subjects with no reads
assigned to A. baumanii detected in any healthy subjects. This demonstrated agreement
between both MED and DADA2-based 16S data analysis. LEfSe analysis was again
performed on healthy vs all T2D, as well as between all three subject groups and demonstrated again that A. baumanii was significantly elevated amongst all T2D samples (Fig.
S5).

We next looked at differences in microbiome compositions across subjects by plotting
Bray-Curtis distances via non-metric multidimensional scaling (NMDS) while distinguishing subject groups as well as presence or absence of A. baumanii complex (ABC)
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bacteria (Fig. 4). Broadly, T2D and T2DP samples had less overlap in composition
while healthy samples intersected either group. ABC status did not seem to form a distinct microbiome cluster, suggesting that there was no unique microbiota composition
for ABC positive subjects apart from A. baumanii sequence detection.

Figure 1.3. Healthy vs all T2D subjects reveal a potential enrichment of A. baumanii. Initial Minimal Entropy Decomposition (MED) analysis of 16S data with taxonomy assigned based on RDP database alignment to generate species level assignments was performed followed by linear discriminate analysis effect size quantification (LEfSe). This revealed enrichment of several species / genera in T2D subjects relative to healthy. DADA2 analysis of the same dataset was aligned to the SILVA database and shows similar patterns of enrichment (Fig. S5).
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Figure 1.4. Beta diversity quantification between subject groups. SILVA assigned
taxonomy of DADA2 analyzed 16S data was used to determine Bray-Curtis dissimilarity between samples for strictly filtered (A) and minimally filtered (B) data. Nonmetric multidimensional scaling and statistical analysis for each subject group was
performed in R using the vegan package as described in methods.

Validating the presence of A. baumanii in T2D subjects

The finding of ABC sequences was unexpected, as study participants were not hospitalized or under treatment for any infection(s), and we wished to confirm this result by
other techniques. This was especially needed as the V1-V3 portion of the 16S rDNA
sequence only differs between A. baumanii and A. nosocomialis by 1 nucleotide substitution. Using PCR primers for the 16S rDNA region that encompasses nearly all differentiating 16S nucleotides between Acinetobacter species we generated amplicons from
a portion of our ABC positive samples alongside negative healthy and no-template control samples (Fig. 5). PCR products were ligated into a TA vector and individual colonies were propagated and subjected to Sanger sequencing of plasmid inserts. The
1242bp sequences were then aligned to the NCBI reference RNA sequence database
(refseq_rna). Each sequence (12 clones across 5 samples) was identical and matched the
A. baumanii 16S sequence across its length. This result validated our initial 16S detection of putative A. baumanii.
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Figure 1.5. Clone library design to verify ABC complex member identity. Amplification with oMR328-329 primers produced an amplicon between 120-1306bp of the
A. baumanii 16S rDNA sequence. This allowed for Sanger sequencing of information
rich nucleotides indicated above allowing for species differentiation beyond initial V1V3 sequencing with the 27F-519R primers. The table beneath indicated the total number of individual clones sequenced per sample and which species they aligned to with
100% identity in the NCBI non-redundant database.

Host cytokine responses to T2D and T2DP vs Health

In addition to serum microbiota, we also quantified twenty different human cytokines
in serum samples across all 3 patient groups (Fig. 6). Based on relative abundance pro-
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files, we observed that proinflammatory cytokines were significantly elevated in A. baumannii positive samples highlighted in the box (ABC+). MCP-1 and IL-1β, classic proinflammatory cytokines, were increased in diabetic patients. Intriguingly, T2D ABCnegative subjects did not show increase of these markers. ABC+ subjects showed significantly higher cytokine expression levels of IL-1β, IL-6, IL-8, MCP-1, and IFN- γ
when compared to ABC-negative groups (I and V, p<0.01).
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Figure 1.6. Cytokine profile quantification reveals distinct differences between
subject groupings and A. baumanii presence. Heat map showing immune mediator
concentrations derived from serum of diabetic and healthy samples (red, highest expression; yellow, lowest expression). Hierarchical clustering was employed by Morpheus from the Broad Institute (Morpheus, https://software.broadinstitute.org/mor-
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pheus). Observations from hierarchical clustering are shown in a tree, with A. baumannii positive (ABC+) groups highlighted in the box. ABC+ groups (II, III and IV)
showed significantly different (p < 0.01) levels of IL-1β, IL-6, IL-8, MCP-1, IFN- γ
compared to ABC-negative (ABC-) groups (I and V). I) Diabetic/Healthy, II)
ABC+/ABC, III) ABC+ Diabetic/ABC- Diabetic, IV) ABC+ Diabetic/Healthy, V)
ABC- Diabetic/Healthy. Data are clustered according to comparison groups. * = pvalue <0.01 between groups via unpaired Student’s t-test.

Host cytokine responses to specific microbiota

Based on the cytokine abundance data and earlier microbiome sequencing, we were able
to determine if any specific taxa were significantly correlated with cytokine presence or
absence in T2D subjects (Fig. 7). A. baumanii was significantly correlated with elevated
amounts of IFN-α, IFN-γ, IL-12p70, IL-8, and TNF-α. ABC+ subjects presented cytokine correlations consistent with a profile of chronic inflammation. IL-8 is a chemokine
that impacts neutrophil phenotype and function, and excessive amounts of this cytokine
lead to chronic activation of phagocytes (Moore and Kunkel, 2019). Excessive production of TNF-α increases failure of resolution of inflammation on innate immune cells
by controlling a resolution receptor (Freire and Van Dyke, 2013). Here, TNF-α showed
a significant increase in ABC+ subjects, suggesting co-existence with ABC in the serum
of type-II diabetics. We also performed an identical analysis for healthy subjects and
saw several genera or species with significant correlations (Fig. S6). In healthy subjects,
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unique profiles were found, correlated with lower levels of proinflammatory cytokines
and co-clustered with ABC-negative samples.

While low template concentration microbiome profiling presents many challenges, we
were able to utilize numerous control steps to minimize the impact of contaminating
taxa. We were also able to demonstrate that not only were there significant differences
between subject groups that include taxa of likely biological origins; we also demonstrated that specific cytokines significantly correlated with the presence of distinct taxa.
Most surprisingly, we were able to detect A. baumanii and confirm its presence in serum
samples of type-II diabetics not known or currently diagnosed with any underlying infection. These data do not per se indicate active infection but could also indicate colonization or transient exposure to A. baumanii for these subjects compared to healthy
subjects.
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Figure 1.7. Host-microbial correlation resolved type-II diabetic associations with
inflammatory cytokines. HOMD/RDP assigned taxonomy of MED analyzed 16S
data for both T2D and T2DP samples and cytokine concentrations were analyzed via
Pearson correlation coefficient in R using the rcorr function. Significance was determined using the asymptotic p-values generated by rcorr with * = p-value <0.05 ** =
p-value <0.01. Data are strictly filtered with taxa present in no-template controls subtracted.
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Discussion

Issues with amplification-based 16S studies from low template concentrations are well
known (Kim et al., 2017; Pollock et al., 2018; Sinha et al., 2015). We began this study
as a post hoc analysis of existing serum samples from a previous bank of anonymized
specimens (Freire et al., 2017). As sample volumes of serum were mostly limited, we
relied on amplification of 16S rDNA, using V1-V3 region primers to improve the likelihood of identifying oral taxa (Eren et al., 2014) that we hypothesized to exist in the
diabetic with periodontitis part of our cohort. To minimize effects of amplification, we
performed multiple high-throughput sequencing runs of amplified libraries to increase
sequence depth as opposed to further amplification and using a higher capacity sequencing platform. Additionally, we also included numerous no-template controls throughout
sample preparation and purification to identify as many outside contaminants as we
could (Kennedy et al., 2014; Kim et al., 2017; Salter et al., 2014). As a further control,
we carried out amplification of mock community libraries (Fig. S1) to determine if amplification bias or infidelity affected taxonomic assignment. We also used two separate
methods for correction of Illumina-sequenced amplicon errors, DADA2 (Callahan et
al., 2016) and minimal entropy decomposition / oligotyping (MED) (Eren et al., 2015),
as well as comparing our data from multiple ribosomal databases for taxonomic assignment (Cole et al., 2014; DeSantis et al., 2006; Quast et al., 2013). In addition to Illumina
sequencing, we performed a separate amplification of 16S rDNA followed by Sanger
sequencing to independently confirm the identity of putative A. baumanii sequence
presence in a subset of our diabetic samples (Fig. 5). Thus, we have made great efforts
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to validate our findings as far as is feasible and have taken care not to over interpret data
presented here.

We initially hypothesized that oral taxa would be enriched in the bloodstream of T2DP
subjects, and potentially all T2D subjects, compared to healthy subjects. Our microbiome data revealed changes in composition between our three subject groups (Figs. 1-4,
S4-5). However, while we observed oral taxa in our samples, there was only enrichment
of few oral taxa in T2DP subjects, specifically S. cristatus and N. flavescens (Fig. 3),
which are not associated with periodontitis. Given the limited template available for
each sample, we cannot rule out that other oral taxa are not elevated in T2DP subjects,
but more rigorous testing of that hypothesis would require larger serum volumes and
using a longitudinal approach on individual subjects. By far the most surprising element
of this dataset was the detection of A. baumanii (Fig. 3, 5, S5) assigned reads unique to
13 T2DP subjects and not present in any control or healthy subject samples.

A. baumanii represents a considerable risk to T2D subjects including higher mortality
rates (Leão et al., 2016) and a higher risk of infection in burn wounds, as well as DFIs
(Castellanos et al., 2019; Furniss et al., 2005; Henig et al., 2020). To confirm our V1V3 amplicon data and to determine whether or not these were A. baumanii or another
AB complex species, we used targeted near full-length 16S rDNA primers that allowed
us to sequence the majority of differentiating nucleotides necessary for ribotyping. Sequencing individual clones of these amplicons revealed 100% matches to A. baumanii
and no clones (n=50) were A. baumanii positive from indicated control samples (Fig.
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5). This result was surprising, as none of the subjects in our T2D/P cohort were currently
under in-patient treatment or had any indication of underlying infection (apart from periodontitis). Given the methodology here, we cannot speculate on the true infection status
of these individuals, nor can we be certain if the A. baumanii present were circulating
in the bloodstream or were on the skin and mixed with the sample during a blood draw.
No matter the route of entry, we were able to determine significant cytokine profile
changes in T2DP A. baumanii positive subjects, as well as broader inflammatory
changes in cytokine profiles between T2DP, T2D and healthy subjects (Fig. 6).

Cytokine dysregulation can impact the host locally and systemically, making the subject
more prone to severe infections and increased tissue damage (Tisoncik et al., 2012).
Individuals that have T2D present an increased metabolic burden, while often comorbid
periodontal disease promotes microbial dysbiosis, with both diseases resulting in a
chronic state of inflammation. In the present study, A. baumanii was only found in the
serum of diabetics, where an increase in proinflammatory cytokines was also observed
(Figs. 6, 7). We utilized an unbiased panel of 20 human cytokines to survey specific
immune responses to T2D and T2DP compared to those of healthy individuals. While
there are complications presented by low template sizes in our samples, cytokine profiling from these same volumes were well within desired assay volumes. As mediators
of inflammation, cytokine production feeds forward a cascade of signals that can impact
tissue, organ and overall host immunometabolism. In T2D, IL-1β, TNF-α, MCP-1, IL6, IL-8, and IFN-γ were significantly elevated in ABC+ subjects and not in ABC-negative subjects. Of these proinflammatory cytokines, IL-1β, TNF-α, and IL-8 suppression
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has been investigated as therapeutic targets for clinical management of diabetes and
associated chronic lesions (Feng et al., 2018; Peiró et al., 2017). We previously observed
increased TNF-α levels in cell cultured neutrophils from T2D subjects relative to cells
derived from healthy subjects (Sarah E Kleinstein et al., 2020). Co-occurrence of bacteria in the serum and cytokines also differed among controls. In the current study, cooccurrence among cytokines was more evident in diabetic subjects (100 significant cooccurrences) versus healthy individuals (30 significant co-occurrences) (Figs. 7, S6). A
baumannii especially correlated with neutrophil inflammatory signaling cytokine IL-8,
which was not observed in healthy subjects. We have previously shown differences in
gene expression in neutrophils of T2D individuals, which are primed to mount an aberrant inflammatory response when compared to neutrophils of healthy individuals (Sarah
E Kleinstein et al., 2020), consistent with production of inflammatory cytokines observed here. In contrast, IL-17α, P-selectin, and E-selectin levels were increased in diabetics that were ABC-negative compared to ABC+ diabetics. IL-4 and IL-10 did not cooccur with A. baumanii in any of the healthy versus diabetic groups. The cytokine results provide an initial glimpse into the host response to chronic inflammatory diseases,
T2DP with and without the presence of A. baumannii, which may warrant further investigation in larger studies.

In conclusion, this study has revealed modest serum microbiome compositional changes
and significant cytokine profile changes between T2D subjects with or without periodontitis versus non-T2D individuals, revealing an impaired host response when A. bau-
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manii was present. We also present here the potential for lurking A. baumanii colonization in asymptomatic T2D subjects, possibly to a much larger extent than previously
reported. In our opinion, these data present a strong justification for further monitoring
of T2D individuals for A. baumanii colonization and support the need for a more robust
study to characterize the potentially greater spread of A. baumanii amongst individuals
with T2D.

Limitations of the Study
Limitations of this study primarily include small template volumes available for serum
samples in this post hoc study. Blood and sera microbiome studies will always be more
complex due to low bacterial template concentrations inherent to these types of sample.
While we have done our utmost efforts to validate our main findings regarding A. baumanii presence, there are likely more interesting aspects to our study cohort microbiota
that have been missed. These and other minor limitations have been indicated in the
manuscript.
Resource Availability
Lead Contact – Further information and requests for resources, data, code, and reagents
should be directed to and will be fulfilled by the Lead Contact, Dr. Matthew Ramsey
(mramsey@uri.edu).
Materials Availability
This study did not generate new unique reagents or genetic constructs.
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Data and Code Availability
All data is available at NIH – SRA Bioproject number PRJNA664044. All other code
used for data analysis has been provided in the Transparent Methods section (see
Scripts) in the Supplemental Information.
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Appendix
Supplemental Information
Transparent Methods
Subject recruitment, sampling and storage

Subject recruitment has been described previously (Freire et al., 2017). Briefly, T2D
and healthy subjects were recruited from the patient cohorts of the Center for Clinical
and Translational Research at the Forsyth Institute under Forsyth Institute Institutional
Review Board-approved protocols (Protocol #11-03 and #13-07). All subjects gave
signed informed consent prior to study evaluations. Clinical periodontal data and peripheral venous blood were collected. The diagnosis of T2D was made by the subject’s
primary care physician following American Association of Diabetes guidelines (American Diabetes Association, 2015). Information was collected on subject demographics
(age, gender, self-reported ethnicity, and self-reported smoking status), body-mass index (BMI; kg/m2), blood total cholesterol, blood glucose (point-of-care), percent hemoglobin A1C (HbA1c), and periodontal condition (Armitage, 1999). HbA1c was used
to determine the level of glycemic control for diabetic subjects. One T2D individual
lacked HbA1c measurements but fit based on all other diagnostic criteria (blood glucose
>200 mg/dl) as well as cytokine profiles in accord with other T2D individuals. Neutrophil and monocyte cell counts were determined by lab assay (described below). Individuals were excluded if they were taking insulin sensitizers, nonsteroidal anti-inflammatory drugs, or antimicrobials within 3 months of study initiation. For this microbiome
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study, a total of 81 subjects (N=24 healthy, N=57 T2D) were included for analysis, all
of whom were unrelated and over 18 years of age (range: 28-79 years of age).

Sample preparation for 16S analysis

DNA Extraction

Frozen serum from N=81 samples (N=24 healthy, N=32 T2D and N=25 T2DP) were
thawed on ice and aliquots were separated for DNA extraction. DNA was extracted
using the Epicentre MasterPure Complete DNA and RNA Purification kit (Lucigen, WI,
USA). Extraction was carried out using the manufacturer’s instructions, with modifications that enabled bead beating. Briefly, 200µL of Tissue and Cell Lysis Solution (2x),
100µL of nuclease free water and 2µL of Proteinase K were added to Lysing matrix B
(LMB) tubes (MP Biomedicals, Santa Ana, CA). Thereafter 100µL of serum was added
to the tubes and placed in a Beadbeater (Biospec) for 30 seconds, then placed on ice for
3 minutes and then repeated. Each round of DNA extractions included a no template
control, which consisted of 100µL nuclease free water instead of serum. The samples
were then incubated and extracted as described in the manufacturer’s instructions. Total
DNA was precipitated using the manufacturer’s instructions, however 300 µL of MPC
Protein Precipitation Reagent was used to accommodate the increased volume. DNA
was eluted in 50µL of nuclease free water.
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16s rDNA primers 27F (TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAGAGTTTGATYMTGGCTCAG) and 519R (GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGWATTACCGCGGCKGCTG) (Stackebrandt and Goodfellow,
1991; Turner et al., 1999) were used to amplify the V1-V3 regions of 16s rDNA in a
50 µL reaction using 2x Q5 HiFi mastermix (New England Biolabs, Ipswitch, MA)
and 23 µL of extracted DNA (35 cycles).

Illumina MiSeq Library preparation

After the first round of PCR was carried out it was cleaned with Ampure XP beads
(Beckman Coulter, Pasadena, CA) and then visualized by agarose gel electrophoresis.
Full indices and adapters were added using the Illumina Nextera Index Kit (Illumina,
San Diego, CA) by running the second round of PCR (50 ng of template DNA, 5 cycles)
in 2x Phusion HF Master Mix (New England Biolabs, Ipswitch, MA). PCR were then
cleaned with Ampure XP beads and analyzed by agarose gel electrophoresis and using
the Agilent BioAnalyzer DNA1000 chip (Agilent Technologies, Santa Clara, CA). Samples were then quantified and normalized prior to pooling using a Qubit fluorimeter
(Invitrogen, Carlsbad, CA). The final pooled library was quantified with the KAPA Biosystems Illumina Kit (KAPA Biosystems, Woburn, MA) via qPCR in a Roche LightCycler480. Samples were sequenced (2x250 bp paired-end) on an Illumina MiSeq (Illumina, San Diego, CA) at the Rhode Island Genomics and Sequencing Center (Kingston, RI).
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Mock Community Standards Preparation
In order to quantify potential bias due to low template concentrations, PCR amplification, and contamination, we performed mock library assemblies with commercially
available bacterial genomic DNA templates (Zymo Research #D6305). We amplified
2 libraries using 10 and 1 ng total starting templates in both sequencing runs for a total
of 4 mock libraries synthesized.Total DNA species composition is provided in the manufacturer’s instructions.
16S clone library resequencing

Primers were made to amplify regions of 16s rDNA that enable differentiation of the
Acinetobacter species. Primers used were
oMR328 (TAGCGGCGGACGGGTGAGTAATGCTTA) and
oMR329 (TTCCGACTTCATGGAGTCGAGTTGCAGAC). 50 µL reactions in 2x Q5
mastermix (New England Biolabs, Ipswitch, MA) were run for 35 cycles using 23 µL
of DNA extracted from serum as the template. The products were then purified using
the Qiagen PCR purification kit according to the manufacturer’s instructions. Gotaq 2x
mastermix (Promega, Madison, WI) was used to generate ‘A’ overhangs via PCR for 5
cycles using 10 µL of purified DNA as the template. 4µL of the resulting PCR products
were then used to generate clones using the TOPO TA Cloning Kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions which was modified to use 0.5µL
of TOPO vector. Clones were then transformed into NEB5α cells using the manufacturer’s instructions and plated on LB plates supplemented with 0.1mM IPTG and
40µg/mL Kanamycin. Additionally, 40µl of 40mg/mL of X-gal was spread onto each
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plate prior to plating to enable blue-white screening. The plates were incubated for 24
hours at 37°C. White colonies were inoculated into liquid cultures of LB supplemented
with 40µg/mL kanamycin. Plasmids were extracted using QIAprep Spin Miniprep kit
(Qiagen, Venlo, Netherlands). Inserts were sequenced using the M13 Forward
(GTAAAACGACGGCCAGTG)

and

M13

Reverse

(CACAGGAAACAGC-

TATGACC) primers on an Applied Biosystems 3500xl using the “BigDye” Terminator
v3.1 Cycle sequencing kit. Sequences were analyzed using NCBI BLAST (NCBI Resource Coordinators, 2018). A maximum of 10 colonies were screened for each sample
or until a sequence matched a species belonging to the Acinetobacter baumanii- calcoaceticus complex.

Cytokine Quantification

Frozen (-80°C) subject serum was brought up to room temperature and assayed using
the Invitrogen human inflammation 20-plex ProcartaPlex cytokine panel (Thermo
Fisher Scientific, Waltham, MA) on a Luminex 200 instrument (Luminex, Austin, TX)
in universal assay buffer. Assayed cytokines included: MIP-1α, IL-1β, IL-4, IP-10, IL6, IL-8, IL-10, IL-12p70, IL-13, IL-17A, IFN-γ, GM-CSF, TNF-α, MIP-1β, IFN-α,
MCP-1, P-Selectin, IL-1α, sICAM-1, and E-Selectin. Following manufacturer protocols, all samples were run on a plate with 7 standards (diluted 1:4) and a control (universal assay buffer only), with all samples, standards, and controls run in duplicate similar to our methods previously (Sarah E Kleinstein et al., 2020; Pessoa et al., 2019) .
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Quality control (QC) steps were conducted according to manufacturer recommendations
by xPONENT 4.2 software (Affymetrix eBioscience, San Diego, USA). Any standards
with <70 or >130 % recovery of beads were invalidated. Samples were required to have
a bead count of >30 beads recovered (all samples had >100 beads recovered and none
were excluded at this step). Following QC, results were reported as average pg/mL for
all measured cytokines. The lower limit of quantification (LLOQ) was determined based
on the standard curve (after QC) as the average value of the lowest validated standards.
Values at or below the LLOQ for each cytokine were reported at the LLOQ. As samples
were run in two batches (with similar LLOQs for each batch), LLOQ for the cytokines
(in pg/mL) were averaged across both runs: MIP-1α=1.79, IL-1β=5.58, IL-4=23.99, IP10= 1.17, IL-6=18.89, IL-8=2.48, IL-10=2.01, IL-12p70=11.72, IL-13=5.63, IL17A=4.63, IFN-γ=11.93, GM-CSF=14.57, TNF-α=9.66, MIP-1β=7.66, IFN-α=1.32,
MCP-1=3.73, P-Selectin=1077.15, IL-1α=0.74, sICAM-1=442.80, and E-Selectin=441.00. To compare cytokine levels between study groups, unpaired t-tests were
used with a significance threshold of p<0.05 and no assumption of consistent standard
deviation.

Minimum Entropy Decomposition analysis of sequence libraries

Poor quality reads were discarded using flexbar (Dodt et al., 2012). Reads were then
treated as single end reads and trimmed for quality and to a length of 160bp using
Trimmomatic (Bolger et al., 2014). Minimum Entropy Decomposition (MED) was performed as described in the oligotyping pipeline (Eren et al., 2015), generating a list of
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node representative sequences and their relative abundances. Taxonomic assignment of
representative sequences were generated based on aligning 16s rRNA sequences at
98.5% identity against the eHOMD database (Escapa et al., 2018) and further evaluated
using the Ribosomal Database Project (RDP) database (Cole et al., 2014). MED nodes
were assigned species level taxonomy based on >98.5% identity matches to eHOMD
and/or RDP with eHOMD designations used as 1st priority as our intial aim was to identify oral taxa. Node frequency tables now assigned taxonomy were then used in association with sample metadata for Linear Discriminate Effect Size analysis (LEfSe)
(Segata et al., 2011).
QIIME2 analysis of sequence libraries

*All Scripts at end of this document. All work was performed on the University of
Rhode Island High Performance Computing Bluewaves cluster:
https://web.uri.edu/hpc-research-computing/cluster-specifications/
Data Import
Fastq sequence data were imported using the import-fastq.sh script. Generated demux.qzv files were viewed using https://view.qiime2.org/ via the “quality viewer” function to determine location for sequence quality trimming used in the following step.
Fastq Trimming, DADA2 Analysis, Run-run Merging
A second sequencing run of the prepared Illumina libraries was performed to ensure
maximum sequencing depth without further PCR amplification of starting template. At
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the end of the “D2-merge.sh” script we then used the Rarefaction-alpha.sh script output (Fig. S2) to determine read depth (22,000) to use in downstream commands.
Initial Alpha and Beta Diversity Measurements and Run-run Comparison Testing
Merged libraries were used in the Alpha-Beta-An.sh script to determine initial phylogenetics on unfiltered data using the QIIME2 core-metrics-phylogenetic function, Alpha and Beta diversity calculations via QIIME2 alpha- or beta-group-significance
functions as well as Beta diversity difference calculation (beta-group-significance) between sequencing Run 1 vs. Run 2 (Figs. S3, S4).
Mock Community Standards Quality Control Testing
This section uses the mocklibQC1.sh and mocklibQC2.sh scripts. Taxonomy files
used are described below. The *-bar-plots.qzv file generated in the 1st script was
viewed at https://view.qiime2.org/ and the level 6 data from this plot was exported as a
.csv file which provides the reads per each taxa. This data was converted to proportion
of total reads per each taxa and converted into the Zymo_actual.tsv file. The
Zymo_expected.tsv file was generated by editing the Zymo_actual.tsv file with the
proportion for each taxa present as provided in the manufacturers reference:
https://files.zymoresearch.com/protocols/_d6305_d6306_zymobiomics_microbial_community_dna_standard.pdf
These .tsv inputs were then used in the mocklibQC2.sh script to output the visualizations seen in Figure S1.
Classifier Setup and Editing
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Initial import of the SILVA 132 classifier was performed by running the following
command:
wget https://data.qiime2.org/2019.7/common/silva-132-99-nb-classifier.qza
Classifier setup was then performed using the classifier.sh script. Upon searching the
silva-taxonomy.qzv file generated, we noted that there were no reads that matched A.
baumanii sequences at all. We used the rep-seqs.merge.qzv file output from the
D2merge.sh script saved as a FASTA file from within the QIIME2 viewer function
and performed a pairwise blast vs the full length A. baumanii 16S sequence from
NCBI:
>A.baumanii 16s
AACGCTGGCGGCAGGCTTAACACATGCAAGTCGAGCGGGGGAAGGTAGCTTGCTACCGGACCTAGCGGCGGACGGGTGAGTAATGCTTAGGAATCTGCCTATTAGTGGGGG
ACAACATCTCGAAAGGGATGCTAATACCGCATACGTCCTACGGGAGAAAGCAGGGGATCTTCGGACCTTGCGCTAATAGATGAGCCTAAGTCGGATTAGCTAGTTG
GTGGGGTAAAGGCCTACCAAGGCGACGATCTGTAGCGGGTCTGAGAGGATGATCCGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATA
TTGGACAATGGGGGGAACCCTGATCCAGCCATGCCGCGTGTGTGAAGAAGGCCTTATGGTTGTAAAGCACTTTAAGCGAGGAGGAGGCTACTTTAGTTAATACCTAGAGAT
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AGTGGACGTTACTCGCAGAATAAGCACCGGCTAACTCTGTGCCAGCAGCCGCGGTAATACAGAGGGTGCGAGCGTTAATCGGATTTACTGGGCGTAAAGCGTGC
GTAGGCGGCTTATTAAGTCGGATGTGAAATCCCCGAGCTTAACTTGGGAATTGCATTCGATACTGGTGAGCTAGAGTATGGGAGAGGATGGTAGAATTCCAGGTGTAGCG
GTGAAATGCGTAGAGATCTGGAGGAATACCGATGGCGAAGGCAGCCATCTGGCCTAATACTGACGCTGAGGTACGAAAGCATGGGGAGCAAACAGGATTAGATACCC
TGGTAGTCCATGCCGTAAACGATGTCTACTAGCCGTTGGGGCCTTTGAGGCTTTAGTGGCGCAGCTAACGCGATAAGTAGACCGCCTGGGGAGTACGGTCGCAAGACTAAA
ACTCAAATGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGCCTTGACATACTAGAAACTTTCCAGAGATGGA
TTGGTGCCTTCGGGAATCTAGATACAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTTTCCTTACTTGCCAG
CATTTCGGATGGGAACTTTAAGGATACTGCCAGTGACAAACTGGAGGAAGGCGGGGACGACGTCAAGTCATCATGGCCCTTACGGCCAGGGCTACACACGTGCTACAATGGT
CGGTACAAAGGGTTGCTACACAGCGATGTGATGCTAATCTCAAAAA-
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GCCGATCGTAGTCCGGATTGGAGTCTGCAACTCGACTCCATGAAGTCGGAATCGCTAGTAATCGC
GGATCAGAATGCCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTTTGTTGCACCAGAAGTAGCTAGCCTAACTGCAAAGAGGGCGGTTAC
CACGGTGTGGCCGATGACTGGGGTGAAGT
One ASV from the rep-seqs.merge.qzv file (e875355f3179838110485d8f5013d4a6)
returned a 100% match homology to the above A. baumanii sequence. This ASV was
just annotated as Acinetobacter in the SILVA-132-99 taxonomy. We then edited the
silva classifier taxonomy file by first exporting it using the following commands:
module load QIIME2/2019.7
qiime tools export \
--input-path silva-taxonomy.qza \
--output-path silva-taxonomy
This output the file in *.tsv format which was then opened in a text editor and
searched for the ASV node identity and then modified as indicated here:
before
e875355f3179838110485d8f5013d4a6

D_0__Bacteria;D_1__Proteobacte-

ria;D_2__Gammaproteobacteria;D_3__Pseudomonadales;D_4__Moraxellaceae;D_5__Acinetobacter

0.9999662516375396
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after
e875355f3179838110485d8f5013d4a6

D_0__Bacteria;D_1__Proteobacte-

ria;D_2__Gammaproteobacteria;D_3__Pseudomonadales;D_4__Moraxellaceae;D_5__Acinetobacter;D_6__Acinetobacter baumanii

0.9999662516375396

The edited file was then saved as taxonomy-1.tsv and imported via the following command:
qiime tools import \
--input-path /data/mramseylab/classifiers/silva-taxonomy/taxonomy-1.tsv \
--type 'FeatureData[Taxonomy]' \
--input-format TSVTaxonomyFormat \
--output-path silva-mod-taxonomy.qza
qiime metadata tabulate \
--m-input-file silva-mod-taxonomy.qza \
--o-visualization silva-mod-taxonomy.qzv
The silva-mod-taxonomy.qza file was used for the rest of our analyses.
Data Filtering
Data presented throughout the manuscript is generally described as “Minimally Filtered” or “Strict Filtered”. We 1st began with all ASV assigned data from the above
scripts and used metadata based filtering to separate out all data from control samples
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which included no-template and PCR only control indexes. This was done using the
control-filter.sh script. Data output from the script was exported so it could be viewed
and then used to subtract taxa from human-derived datasets in downstream filtering
steps. Next we applied the meta-filter.sh script to our data to extract only human derived samples for further analysis and filtering. After this we applied the minimal-filter.sh script. Outputs from this script were used in all “Minimally Filtered” described
data in the manuscript. Minimal filtering included removal of instances of taxa that appeared in only 2 samples or less, features (ASV sequences) that appeared less than 10
times across all samples and any taxa with less than 20 reads per sample.
Next we took our output files from the above control-filter.sh script and used them as
part of the input for the auto-filter.sh script to exclude these taxa from the remaining
minimally filtered data. While this removed many spurious taxa from our samples we
observed high abundance of known aquatic microbial contaminant sequences not typically human associated (ex: Sphingomonas, Ralstonia). These and other taxa were
manually excluded using the strict-filter.sh script and further removal of highly abundant Pseudomonas sequences were also removed via the nopa-filter.sh script. Data
filtered to this extent are referred to as “Strictly” filtered in the manuscript.
Re-analysis of Filtered Data
A reanalysis of filtered data was performed 1st for Alpha and Beta diversity measurements via the alpha-beta2.sh script (Fig. 1). Further description and statistical analysis of Beta diversity differences were performed in R using the vegan package via the
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metaMDS and Adonis functions primarily as demonstrated in the MMR20_ellipses_NMDS.R script below.
LEfSe Analysis Comparison
Initial LEfSe analysis was performed using ASV output abundance data directly from
the initial MED pipeline (Fig. 3). Further analysis on QIIME2 / DADA2 assigned
strictly filtered data (Fig. S5) was performed first using the lefse-noTax.sh script to
export and format data for analysis on the LEfSe Galaxy server (https://huttenhower.sph.harvard.edu/galaxy/). This script only outputs ASV node information
without taxonomic assignment. Manual taxonomic assignment was performed comparing ASV node names to the rep-seqs-merge.qza file from the D2merge.sh script.
LEfSe analysis was performed using default settings, *.svg output files were further
edited in InkScape software for clarity.

Supplemental Figures and Legends
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Figure S1.1. Mock library composition evaluation. A Zymogen mock community
library was used for sequence library construction at 10 and 1 ng in duplicate between
both sequencing runs. QIIME2 / DADA2 unfiltered data was given taxonomical assignment via SILVA and assessed via the “q2-quality-control” plugin. (A) Taxon accuracy
rate (TAR), taxon detection rate (TDR) and linear regression scores (r-squared) are plotted at each taxonomic level. (B) Expected vs observed abundance of each species in the
mock community is plotted at each taxonomic level. (C) Distance between false positive observations vs nearest expected feature. Misclassifications were unique to environmental contaminant taxa and no false negative features were observed (not shown).
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Figure S1.2. Alpha-diversity at different rarefaction levels. Total observed OTUs
(here ASVs) are plotted (A) vs sequencing depth and each sample that can accommodate
that sequencing depth is plotted in (B).
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Figure S1.3. Run to Run variability quantification. A Run vs Run Beta diversity
comparison was performed for unfiltered data by comparing unweighted Unifrac distances as described in the methods. Pairwise PERMANOVA of Run-1 vs Run-2 (group
size of 2, sample size of n=134 total indexes) was performed in 999 permutations resulting in a pseudo-F value of 0.567, p-value of 0.999 and corrected q-value of 0.999.
No significant differences were observed between each run.

Figure S1.4. 16S Alpha and Beta diversity of serum microbiomes changes with
subject status. Species richness is displayed based on Faith’s phylogenetic diversity
(Faith, 1992) (A) and species evenness based on Pielou’s evenness index (Pielou, 1966)
(B) for healthy, type-II diabetic (T2D) and type-II diabetics with periodontitis (T2DP)
samples. Each graph used minimally filtered data for analysis. Significance was deter-
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mined by Kruskal-Wallis analysis of variance (Kruskal and Wallis, 1952) for each comparison indicated and Benjamini-Hochberg correction (Benjamini and Hochberg, 1995)
was applied to generate adjusted q-values. * indicates q-value < 2e-3 vs healthy, **
indicates q-value < 0.024 vs healthy, (C) Beta-diversity Bray Curtis distances. Pairwise
PERMANOVA of each category vs each (group size of 3, n=112) was performed in 999
permutations. *** indicates q-value differs from healthy < 0.001.

Figure S1.5. LEfSe Comparisons reveal taxonomical differences between subject
groups. (A) LEfSe Cladogram plots (Segata et al., 2011) reveal general taxonomic
shifts compared to (B) specifically enriched genera or species in all diabetics vs healthy
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and (C) compared across all 3 subject groups. Data was generated from DADA2 /
QIIME2 analyzed data aligned to the SILVA database that was then filtered for contaminating taxa abundant in no-template control indexes. Pseudomonas genus / species
level results were also removed for clarity.

Figure S1.6. Cytokine correlation with specific taxa in healthy subjects.
HOMD/RDP assigned taxonomy of MED analyzed 16S data for healthy samples and
cytokine concentrations were analyzed via Pearson correlation coefficient in R using
the rcorr function. Significance was determined using the asymptotic p-values generated by rcorr with * = p-value <0.05 ** = p-value <0.01. Data are strictly filtered with
taxa present in no-template controls subtracted.
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Figure S1.7. 16S Alpha and Beta diversity of serum microbiomes changes with
subject status. Alpha diversity is displayed based on Shannon’s index (Shannon and
Weaver, 1975) (A) and species evenness based on Simpson’s evenness measure (Simpson, 1949) ) (B) for healthy, type-II diabetic (T2D) and type-II diabetics with periodontitis (T2DP) samples. Each graph used minimally filtered data for analysis. Significance
was determined by Kruskal-Wallis analysis of variance (Kruskal and Wallis, 1952) for
each comparison indicated and Benjamini-Hochberg correction (Benjamini and
Hochberg, 1995) was applied to generate adjusted q-values. * indicates q-value < 1e5, ** indicates q-value < 0.007, (C) Beta-diversity unweighted Unifrac distances. Pairwise PERMANOVA of each category vs each (group size of 3, n=112) was performed
in 999 permutations. *** indicates q-value differs from ‘healthy’ < 0.02.
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Abstract

Complex polymicrobial biofilm communities are abundant in nature particularly in the
human oral cavity where their composition and fitness can affect health. While the study
of these communities during disease is essential and prevalent, little is known about
interactions within the healthy plaque community. Here we describe interactions between two of the most abundant species in this healthy microbiome, Haemophilus
parainfluenzae and Streptococcus mitis. We discovered that H. parainfluenzae typically
exists adjacent to Mitis group streptococci in vivo which it also positively correlated
with based on microbiome data. By comparing in vitro coculture data to ex vivo microscopy, we revealed that this co-occurrence is density dependent and further influenced
by H2O2 production. We discovered that H. parainfluenzae utilizes a more redundant,
multifactorial response to H2O2 than related organisms and that this system’s integrity
enhances streptococcal fitness. Our results indicate that Mitis group streptococci are
likely the in vivo source of NAD for H. parainfluenzae and also evoke patterns of carbon
utilization in vitro for H. parainfluenzae similar to those observed in vivo. Our findings
describe mechanistic interactions between two of the most abundant and prevalent
members of healthy supragingival plaque that contribute to their in vivo survival.
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Introduction

Taxon-taxon interactions are of great importance for understanding the structure and
function of natural biofilms. Many bacteria occur in nature as part of complex polymicrobial biofilms (1). The behavior of individual species within these biofilms is elaborate and likely influenced by the spatial organization between physical and chemical
substrates (1,2) produced by distinct species (3–5). Metagenomic and metatranscriptome techniques give us an unprecedented ability to observe group composition and
behaviors, but cannot resolve which species might be influencing one another nor describe their spatial interactions. Metabolite-based interactions can influence community
composition through cross feeding or trophic interactions (6,7), complementation of
auxotrophies (8) as well as competition for nutrients and production of inhibitory substances (9–12). These types of polymicrobial associations have been shown to enhance
the resiliency, fitness, and stability of these communities (4,13,14). Maintaining stable
oral microbial communities can preserve oral health, thus there is a clear need to identify
the interactions between prominent species in host-associated polymicrobial communities and how they might shape not only constituency but physical structure.

To delve into mechanisms underlying taxon-taxon interactions we chose to study the
naturally occurring biofilm of human dental plaque. The human supragingival plaque
(SUPP) biofilm has been long studied, dating to the very 1st microscopy observations of
Antony von Leeuwenhoek in 1683 (ref. 15). Early work on both subgingival plaque and
SUPP structure was aided by the study of physical aggregation between species from
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these environments (16) generating hypotheses about direct interaction and assembly of
plaque structures. Recently, much more detailed biogeography of SUPP structure was
observed (17). One notable association was between Streptococcus and other genera at
the margins of biofilm structures. Streptococci can influence community interactions
due to their ability to rapidly consume carbohydrates, produce large amounts of acidic
fermentation products, and excrete antimicrobial substances including reactive oxygen
species. These properties can support the growth of some species while excluding others
(9,18–20). Many oral Streptococcus spp. including Mitis group members are known to
produce various anti-microbial substances, including hydrogen peroxide (H2O2) in aerobic conditions. Therefore, any bacterium adjacent to these Streptococcus spp. aerobically would need to have adapted the ability to withstand H2O2 (7,21). Alongside Streptococcus species within the Mitis group (S. mitis, S. oralis, S. australis, S. infantis, and
others), Haemophilus parainfluenzae is one of the most abundant and prevalent species
in the SUPP of healthy individuals (22–26). Whilst frequently characterized as an opportunistic pathogen and implicated in diseases including endocarditis (27), in the oral
cavity H. parainfluenzae is a commensal and is associated with beneficial immunomodulatory effects (28).

To identify mechanisms of interaction that take place within this healthy polymicrobial
biofilm we investigated interactions between two of its most abundant members, H.
parainfluenzae and S. mitis. Despite the frequent co-occurrence of these species in proximity in vivo, little is known about both the spatial relationship and metabolic mechanisms of interactions between these species. In this study, we observed that these taxa
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exist in intimate proximity in SUPP and exhibit localized density dependences that also
exist in vitro which are driven by streptococcal H2O2 production. We also discovered a
highly redundant H2O2 resistance system in H. parainfluenzae that is different from
other Haemophilus species. We then observed multiple mechanisms of H. parainfluenzae interaction including NAD auxotrophy complementation by Mitis group streptococci and the upregulation of alternative carbon and energy pathways during in vitro
coculture that are also observed in in vivo gene expression data. These results provide a
robust characterization of H. parainfluenzae’s role in the oral microbiota and reveal
ways it has evolved to exist alongside streptococci in the oral cavity and likely beyond.
This study details interactions between two prominent members of a complex natural
biofilm community and allows us to demonstrate mechanisms of interaction that likely
help drive micron-scale arrangements between these organisms.

Results

H. parainfluenzae co-occurs with S. mitis and related streptococci in human supragingival plaque

To determine which species H. parainfluenzae was most likely to interact with we used
microbiome data from 117 subjects sampled by the Human Microbiome Project (HMP).
Analysis of HMP species-assigned metagenomic data indicated that H. parainfluenzae
is an abundant and prevalent member of SUPP detected in all 117 subjects averaging
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7.6% relative abundance based on sequence reads (Fig. 1). We compared the upper
quartile (n=29) of these subjects ranked by highest H. parainfluenzae abundance to the
remainder of subjects (n=88) via LEfSe analysis (29) to determine which species were
significantly likely to co-occur with H. parainfluenzae (Fig. 1). Interestingly, this indicated that individuals enriched in H. parainfluenzae have abundant Streptococcus sp.
especially those in the Mitis group. These data were what led us to investigate H. parainfluenzae interactions with S. mitis as a Mitis group representative in order to examine
the mechanisms of taxon-taxon interactions.

Species-specific FISH demonstrates frequent H. parainfluenzae - S. mitis co-proximity

To determine whether the large-scale co-occurrence of H. parainfluenzae and S. mitis
was reflected in micrometer-scale spatial structure, we analyzed the organization of
these two taxa using fluorescence in situ hybridization (FISH) and imaging. Within the
supragingival plaque, S. mitis and related streptococci are frequent features of H.
parainfluenzae's micron-scale environment. Visualizing these species with FISH probes
showed that 92% of H. parainfluenzae cells in supragingival plaque are located within
10 μm of cells labeled with a probe that hybridizes with a group of related streptococci
including S. mitis, S. oralis, and S. infantis (Fig. 2A, Table S10, hereafter referred to as
“S. mitis”). The median distance separating a H. parainfluenzae cell from the nearest S.
mitis cell was 1.14 μm. Thus, most cells of H. parainfluenzae co-occur with S. mitis at
micrometer scales.
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In addition to proximity, images suggested a density-dependent relationship between
these two taxa, with reduced densities of H. parainfluenzae in areas with the highest
densities of S. mitis (Fig. 2C). We quantified this density effect by dividing each image
into 1024 blocks of approximately 6 micrometers on a side (Fig. 2D) and measuring the
density of S. mitis, H. parainfluenzae, and total bacteria within each block. The mean
density of H. parainfluenzae increased as the percent of a block covered by S. mitis
increased from 0 to around 20% (Fig. S1). This trend is likely due, at least in part, to
variation in the overall quantity of plaque in each block because the density of each
taxon has a positive linear relationship with the overall plaque density. As the density
of S. mitis increased above 20%, the mean H. parainfluenzae density decreased, suggesting a density-dependent inhibitory effect of S. mitis on H. parainfluenzae
growth. Given that both microbiome sequencing and microscopy imaging of in vivo supragingival plaque samples indicate significant co-occurrence and co-proximity between H. parainfluenzae and S. mitis (Fig. 1,2), it is important to determine the mechanisms that underlie these observations.

S. mitis eliminates H. parainfluenzae via production of H2O2

Culturing these two taxa together under controlled conditions in vitro revealed a dosedependent interaction: H. parainfluenzae was killed by S. mitis, but only when abundance of S. mitis was high relative to that of H. parainfluenzae. We used a colony biofilm model (30,31) in which polycarbonate membranes were inoculated with S. mitis
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and H. parainfluenzae, either separately or together, and permitted to grow for 24 hours;
cell abundance was then assessed by resuspending the cells and plating for colony
counts (see Methods). Cocultures inoculated at equal densities revealed that S. mitis
reduced H. parainfluenzae numbers (Fig. 3) nearly 100-fold below inoculum density,
indicating active killing. This effect is dose-dependent as we observed a significant reduction in the growth yield of H. parainfluenzae compared to monoculture when inoculums of S. mitis were either equivalent or 3-fold greater than H. parainfluenzae. However, when S. mitis inoculum was 10-fold lower than H. parainfluenzae, there was no
significant change in the growth yield of H. parainfluenzae compared to monoculture.

The mechanism of dose-dependent killing of H. parainfluenzae involves H2O2 production by S. mitis. The reduction of H. parainfluenzae numbers in coculture was abolished
if the cocultured strain of S. mitis lacked pyruvate oxidase (ΔspxB) and thus unable to
produce H2O2. Figure 3 demonstrates that H. parainfluenzae growth yield when cocultured with S. mitis ΔspxB is not significantly different from H. parainfluenzae monoculture at any ratio tested, indicating that S. mitis-produced H2O2 is responsible for H.
parainfluenzae inhibition. Additional coculture experiments indicate that H. parainfluenzae was unable to grow in pH neutralized supernatants of S. mitis unless they were
pre-treated with exogenous catalase (data not shown), further supporting the finding that
H2O2 production limits H. parainfluenzae growth in these conditions and that acid production is not sufficient to inhibit H. parainfluenzae. Thus, our observed density-dependent exclusion of H. parainfluenzae by S. mitis in ex-vivo samples (Fig. 2) can be
explained by H2O2 toxicity.
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Although the density-dependent killing of H. parainfluenzae by S. mitis implies an antagonistic interaction, the presence of H. parainfluenzae enhances S. mitis growth yield
in biofilm coculture (Fig. S2). This enhancement was abolished when S. mitis was cocultured with H. parainfluenzae ΔoxyR but not with other catalase or cytochrome peroxidase mutants either individual or combined (Fig. S2A). The addition of exogenous
catalase elevated S. mitis monoculture yields near to those observed in coculture without
catalase which suggests that H2O2 detoxification is primarily responsible for this enhanced yield (Fig. S2B). However, a >10-fold yield enhancement was still observed in
coculture with H. parainfluenzae supplemented with exogenous catalase indicating further interactions that benefit S. mitis fitness. The role of H2O2 decomposition in S. mitis
yield increase was further confirmed when comparing mono vs coculture of S. mitis vs
its ΔspxB mutant where the mutant demonstrated greater yield in monoculture and coculture vs the wild-type with a modest increase coculture yield (Fig. S2C) reminiscent
of the wild-type coculture with exogenous catalase.

Individual H2O2 sensitive genes do not affect the fitness of H. parainfluenzae in coculture with S. mitis

The presence of S. mitis within a few micrometers of most H. parainfluenzae cells in
natural plaque suggests that H2O2 and other inhibitory or promotive compounds excreted by S. mitis are reasonably expected to perfuse the substrate in which most H.
parainfluenzae grow (32). We investigated the growth effects of known H2O2 relevant
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gene products in H. parainfluenzae by constructing gene deletions and assessing the
fitness of the deletion strains after H2O2 exposure. Genes in H. parainfluenzae relevant
to peroxide metabolism include oxyR whose gene product is a global transcriptional
regulator responsive to H2O2. Also present is a single catalase (katA) essential for H2O2
resistance in H. influenzae (33). Additionally, H. parainfluenzae possesses a cytochrome c peroxidase (ccp), orthologs of which are important for peroxide resistance in
other Pasteurellaceae (34), Campylobacter jejuni (35), and H. influenzae (36). We also
made deletions of the peroxiredoxin (prx), peroxiredoxin-glutaredoxin (pdgX) and glucose-6-phosphate dehydrogenase (g6p) genes known to contribute to oxidative stress
protection in H. influenzae and other species (37–40).

We quantified changes in H2O2 resistance by a zone of inhibition assay (Fig. 4A), in
which an agar plate inoculated with a lawn of wild-type or deletion-strain H. parainfluenzae is exposed to a small filter saturated with H2O2 and sensitivity is measured as the
diameter of the zone of inhibition. As expected, the largest increase in sensitivity was
observed in H. parainfluenzae with deletions of the global H2O2-responsive transcriptional regulator ΔoxyR, while all other individual gene deletion mutants were less sensitive to H2O2. A ΔkatA+Δccp double mutant demonstrated a significant increase in
sensitivity compared to individual mutants, indicating a combinatorial effect of these
gene products. Surprisingly, MIC concentrations for many mutants were minor and
nearly identical (Table S1) indicating that individual contributions of these genes to
H2O2 tolerance are minimal. We next used the colony biofilm model to test the fitness
of each mutant in coculture with H2O2-producing S. mitis (Fig. 4B). OxyR was shown
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to be essential for H. parainfluenzae survival in coculture, while deletion of individual
genes typically controlled by OxyR showed no significant difference compared to
wildtype which contrasts greatly to similar mutants in H. influenzae (katA) (33) and
other species (41–43). However, the ΔkatA+Δccp mutants’ growth yield was significantly inhibited in S. mitis coculture again indicating an additive effect of these gene
products on H2O2 resistance. These data demonstrate that the mechanism of H. parainfluenzae resistance to H2O2 involves a complex multifactorial system unlike other Haemophilus spp. yet characterized.

S. mitis and other Streptococcus sp. support H. parainfluenzae growth

Like other Haemophilus sp., H. parainfluenzae is a NAD auxotroph and must obtain
NAD, nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR) from the
host or other microorganisms (44). We found that human saliva was unable to support
H. parainfluenzae growth unless NAD was added (data not shown) suggesting that adjacent microbes are the source of NAD for H. parainfluenzae in the oral cavity. As
Corynebacterium and Streptococcus are two of the most abundant genera in SUPP, we
tested if species from these genera could complement NAD auxotrophy. Spot assays on
H. parainfluenzae lawns on medium lacking NAD showed robust growth of H. parainfluenzae adjacent to S. mitis and S. sanguinis but no other taxa (Fig. 5). These data
demonstrate that H. parainfluenzae obtains NAD from these taxa when they are in close
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proximity. It is notable that the two species that significantly correlate with H. parainfluenzae in microbiome data (Fig. 1) also enhance its growth most strongly in the absence of NAD compared to other Streptococcus spp.

In vitro transcriptional responses of H. parainfluenzae to S. mitis
Transcriptome analysis of H. parainfluenzae in aerobic coculture with S. mitis indicated
a multifaceted response to oxidative stress. We observed that H. parainfluenzae significantly differentially expressed 387 genes greater than 2-fold in coculture (Tables
S2&S3), compared to monoculture. Surprisingly, the differentially expressed genes did
not include catalase; however, based on transcript abundance catalase is well expressed
under both conditions. Among genes typically involved in oxidative stress responses,
dps, which encodes an iron sequestration protein, had a 2.2-fold increase in coculture
suggesting that H. parainfluenzae is sequestering free intracellular Fe2+, to prevent oxidative damage. Surprisingly however, several other genes involved in H2O2 were repressed in coculture, including ccp, pdgX, thioredoxin (trxA), glutaredoxin (grx) and
thiol peroxidase (tsa), demonstrating the complex nature of the oxidative stress response
in this species. H. parainfluenzae stress responses were induced in coculture, likely due
to H2O2–related damage by S. mitis. We observed modest but significant upregulation
of the hfq chaperone encoding gene, universal stress protein E (uspE) and repression of
lexA. LexA is involved in the repression of genes involved in the SOS response of E.
coli (44). Hfq is known to be involved in the stress responses of many species (45).
Paralogs of the Universal stress proteins including uspE, are known to be involved in
response to DNA damage (46). Genes likely involved in DNA repair are also induced
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in coculture including those encoding DNA ligase, exodeoxyribonuclease V beta chain
and endonuclease V.

Streptococcus spp. are known to rapidly consume carbohydrates, and transcriptional
data suggest that H. parainfluenzae in coculture switches from carbohydrate consumption to alternative sources of carbon and energy. There was increased expression of
genes suggesting the breakdown of glycerophospholipids resulting in the uptake and
utilization of glycerol, including the predicted extracellular patatin-like phospholipase
(2.5-fold), lysophospholipase L2 (3.8-fold), glycerol uptake facilitator protein (5.3fold), glycerol kinase (3.4-fold), and a fatty acid degradation regulator (2.1-fold). Additionally, there was an increase in expression of fructose 1,6 bisphosphatase (2.8-fold),
indicating active gluconeogenesis, consistent with H. parainfluenzae growth on 3-carbon intermediates such as glycerol. There was also evidence of the uptake and catabolism of the sialic acid, N-acetylneuraminic acid as suggested by an increase in expression of SHS family sialic acid transporter (2-fold), sialic acid utilization regulator (3.6fold), N-acetylneuraminate lyase (2-fold), N-acetylmannosamine kinase (3.8-fold), and
N-acetylmannosamine-6-phosphate 2-epimerase (3.1-fold). Lastly, there was an increase in the expression of genes involved in the oligopeptide transport system, oppA
(3-fold), oppB (2.2-fold), oppC (2.3-fold), oppD (2.7-fold), and oppF (2.4-fold). These
data together suggest uptake of alternate carbon and energy sources in coculture. S. mitis
transcriptional responses to H. parainfluenzae are the focus of a separate study.
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In vivo transcriptional responses of H. parainfluenzae vs in vitro
We hypothesized that in vivo gene expression of H. parainfluenzae is largely influenced
by S. mitis due to their in vivo proximity (Fig. 2) and that our in vitro coculture data may
be predictive of H. parainfluenzae behavior in vivo. To quantify this, we compared in
vitro H. parainfluenzae transcriptomes to two separate in vivo metatranscriptome datasets from healthy SUPP (47,48). We aligned metatranscriptomes to the H. parainfluenzae genome generating a dataset of H. parainfluenzae transcription within the complex plaque biofilm. We then compared these samples to our in vitro monoculture and
then determined which genes differentially expressed in vivo are also expressed in in
vitro coculture.

Comparing significantly differentially expressed gene patterns shared between all 3 datasets (in vitro coculture and both in vivo metatranscriptomes) we observed that 18 genes
were mutually upregulated including genes involved in glycerol catabolism, gluconeogenesis, and pili biogenesis (Table S4). We also observed 22 genes that were mutually
downregulated including those involved in stringent response, methionine metabolism,
and fur (Table S5, Fig. 6B). In individual metatranscriptome comparisons we saw even
more genes that were significantly differentially expressed in the presence of S. mitis in
vitro. This included repression of ccp, genes involved in methionine metabolism, stringent response, metal transport genes, fur, and induction of genes involved in glycerol
catabolism, gluconeogenesis, cell stress, DNA damage/repair related pathways, and
peptide/oligopeptide transport (Tables S6-S9).
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These data suggest that aspects of H. parainfluenzae transcriptional responses in SUPP
can be recapitulated in in vitro coculture with S. mitis. One notably absent overlap between in vitro cocultures vs in vivo datasets was the upregulation of genes involved in
lactate oxidation observed in vivo. Since most Streptococcus sp. produce lactate as a
metabolic end product (18), many oral taxa have evolved the ability to utilize lactate as
a carbon source. Metatranscriptome data suggests that H. parainfluenzae catabolizes
lactate in vivo, which it did not do in coculture indicating that further carbon source
competition and crossfeeding is occurring in vivo that did not occur in vitro on complex
medium. Overall, these data indicate numerous overlaps of in vitro H. parainfluenzae
transcriptional responses to S. mitis that also occur in vivo where they exist in close
proximity.

Discussion

Our findings reveal multiple factors that can dictate the spatial organization and behavior of two abundant oral commensal bacteria in vivo. The availability and distribution
of oxygen has been hypothesized to dictate the spatial organization of bacteria within
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oral biofilm structures and in mixed communities of soil bacteria, where bacterial respiration creates a reduced environment enabling the growth of strict anaerobes in the
biofilm interior (2,17). An important facet of oxygen availability is the production of
H2O2 by some microbes, which can be an important mechanism of protection against
invading or competing species in a variety of environments from the oral cavity (21) to
the surface of the oceans (49). Also, the exchange of nutrients including electron donors
and cofactors or nutrients between taxa can determine growth and interaction between
them (8,50). Here we demonstrate that streptococcal metabolism can dictate both spatial
organization and constituency within a naturally occurring multispecies biofilm.

The production of H2O2 by early colonizing Streptococcus sp. is regarded as an important mechanism of protecting commensals from invading species and is believed to
play a role in determining species composition (21). Our in vitro findings show that S.
mitis can inhibit or kill H. parainfluenzae in a dose-dependent manner via the production of H2O2. This appears to be mirrored in our in vivo findings where streptococci
seemingly exclude H. parainfluenzae above a certain density. We assert that this density
dependent interaction between these taxa is important for driving heterogeneity and spatial organization within this complex community.

Given the close association between H. parainfluenzae and H2O2 producing streptococci
we investigated mechanisms of H2O2 resistance in H. parainfluenzae and demonstrated
that it possesses a highly redundant, multifactorial oxidative stress response that sub-
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stantially differs from other closely related species, including H. influenzae. We demonstrated that while loss of OxyR caused a significant increase in H2O2 sensitivity, loss of
catalase or other individual gene products that provide H2O2 resistance did not (Fig. 4A,
Table S1) which directly contrasts with the importance of catalase in H. influenzae,
whose deletion leads to its inability to survive high concentrations of H2O2 (refs. 33,37).
Streptococcal H2O2 production is thought to provide a competitive advantage in vivo
and presents a source of stress that coexisting bacterial species must tolerate. This ability
to deal with streptococci-produced H2O2 has been demonstrated in multiple species
(10,21,32,51). Given that H. parainfluenzae is found closely associated with S. mitis in
SUPP and co-occur together in other sites of the oral cavity (52), an intriguing hypothesis is that this redundant system is born from H. parainfluenzae’s constant proximity
to a H2O2 producer in multispecies biofilms. Evaluating the regulation of this redundant
system is under current investigation by our group. We also noted that the fitness of S.
mitis in vitro was reduced when cocultured with H. parainfluenzae strains impaired in
H2O2 resistance (Fig. S2) and that when exogenous H2O2 detoxification occurred this
fitness was restored (Fig. S2B). However, we also observed that H. parainfluenzae still
further increased S. mitis yield when H2O2 was not a factor indicating further mutual
benefit beyond H2O2 responses.

Paradoxically, H. parainfluenzae can be inhibited by, but is found adjacent to, S. mitis.
This could be due to the ability of S. mitis to complement the NAD auxotrophy of H.
parainfluenzae. We observed that abundant SUPP Corynebacterium spp. were unable
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to restore H. parainfluenzae’s growth, but some oral streptococci and S. mitis in particular could (Fig. 5) while host saliva could not. Perhaps this explains why 92% of H.
parainfluenzae cells lie within 10 µm of S. mitis in vivo (Fig 2A). It is interesting to note
that both H. parainfluenzae and S. mitis are found as commensals not just in the same
sites of the human oral cavity (52), but also in other sites in the nasopharynx (53,54).
Thus, Streptococcus sp.-produced NAD could, therefore, be an important determinant
of H. parainfluenzae’s ability to survive and colonize various sites of the human body.
While this may appear to be disadvantageous to H. parainfluenzae, it is also possible
given the ubiquitous nature of Mitis group streptococci in the oral cavity, that H. parainfluenzae evolved this auxotrophy due to the constant availability of extracellular NAD.
This is reminiscent of other cases in which auxotrophy development confers a fitness
advantage (55).

When comparing the H. parainfluenzae coculture in vitro transcriptome to in vivo SUPP
metatranscriptomes (Fig. 6) we observed similar patterns of carbon catabolism including the shift from utilization of sugars to small organic acids and alcohols while downregulating genes in the stringent response suggesting greater access to peptides. Given
their in vivo proximity, it is extremely likely that Mitis group streptococci are what induce these same H. parainfluenzae behaviors in vivo, highlighting a facet of our reductionist approach that can uniquely explain behaviors in a complex multispecies in vivo
biofilm. One notable pathway absent from our in vitro cocultures was lactate oxidation,
which has previously been shown to be critical for co-infection between organisms with
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Streptococcus spp. by cross-feeding on this fermentation product (7). In vivo, metatranscriptome data indicated that H. parainfluenzae was also upregulating lactate oxidation gene products which would be expected in the more diverse, competitive SUPP
environment compared to in vitro coculture alone.

H. parainfluenzae and S. mitis are found abundantly not just in supragingival plaque but
also in other sites of the human oral cavity (26,52). The abundance of these two taxa
has been associated with health and their reduction is associated with the development
of oral squamous cell carcinomas (24,56). Both taxa have also been shown to prevent
the adhesion and attachment of the oral pathogen Porphyromonas gingivalis (57) and
their mutual proximity has been observed at the genus level (17). Therefore, further
investigating the mechanistic interactions that take place between these two species
could provide insights into maintaining their presence and thus prevention of disease.
Overall, there is a wealth of information and techniques available to study the composition, structure, and gene expression of complex multispecies communities. However,
specific mechanisms that exist between individual members of these communities can
be hard to discern from broad observational methods. Using a reductionist approach on
two highly abundant and prevalent species in the oral cavity we determined how these
taxa can support growth of each other and dictate their micron-scale distribution within
this environment while suggesting additional mechanisms in use in the greater in vivo
community.
Materials and Methods
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Strains and Media
Strains and plasmids used in this study are listed in Table S11. Unless indicated, Streptococcus mitis was cultured using Brain Heart Infusion (BHI) broth or solid agar supplemented with Yeast extract (YE), Haemophilus parainfluenzae had additional supplementation with 15µg/ml Nicotinamide Adenine Dinucleotide (Sigma-Aldrich) and
15µg/ml Hemin (Sigma-Aldrich) - (BHI-YE-HP). Escherichia coli was grown on Luria
Broth (LB). H. parainfluenzae and S. mitis were grown at 37℃ and 5% CO2, E. coli at
37℃ in standard atmospheric conditions with liquid cultures shaken at 200 RPM. Antibiotics were used at the following concentrations: kanamycin 40µg/ml, vancomycin
5µg/ml, and spectinomycin 50µg/ml for E. coli and H. parainfluenzae. 200µg/ml spectinomycin was used for selection of H. parainfluenzae transformants.

Genomic and plasmid DNA isolation
H. parainfluenzae Genomic DNA was isolated using the DNeasy Blood & Tissue kit
(Qiagen) according to the manufacturer's instructions. Plasmid isolations were performed using QIAprep spin miniprep kits (Qiagen).

Genetic manipulation of H. parainfluenzae
Gene deletions were generated using derivatives of a suicide vector pMRKO (7) as
listed in Table S8. H. parainfluenzae was transformed via conjugation and mutants
screened via PCR and Sanger sequencing. Procedures involved in plasmid construction
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and H. parainfluenzae transformation are outlined in the supplementary methods section.

Read abundance data
MetaPhlAn (58) species-assigned metagenomic sequence data from the Human Microbiome Project (Human Microbiome Project Consortium 2012) for the “Supragingival
Plaque” oral site was 1st sorted based on predicted read abundance for Haemophilus
parainfluenzae. Using the top quartile (highest 25% of samples enriched for H. parainfluenzae) we compared these samples to the bottom 75% and performed LEfSe analysis
(29) to predict species significantly encountered at higher H. parainfluenzae abundance.
LDA of a log10 score ≥ 3 were deemed significant.

Plaque Collection, Fixation, and Storage
Supragingival plaque was collected according to a protocol approved by New England
IRB; all donors provided informed consent. Donors were instructed to refrain from practicing oral hygiene for 24 h before plaque collection. Plaque samples were collected
from 7 donors by supervised self-sampling using a toothpick to scrape the supragingival
surface of the teeth, avoiding the gingival margin. We fixed the plaque in a solution of
2% paraformaldehyde (PFA) in PBS buffer on ice for 2 to 6 h. The PFA was removed
by three washes with 10 mM Tris HCl buffer (pH 7.5). The samples were stored in a
1:1 (vol/vol) solution of 10 mM Tris HCl (pH 7.5) and 100% ethanol at –20°C.
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DNA FISH and Mounting
Aliquots of plaque were dried on UltraStick Slides (Thermo Scientific) for 10 min at
46°C. The plaque was hybridized with 2 μM of each probe in a 900 mM NaCl, 20 mM
Tris HCl (pH 7.5), 0.01% SDS, and 20% formamide hybridization buffer for 3 h in a
humid chamber at 46°C. Non-hybridized probe was removed by washing the slides in
prewarmed 215 mM NaCl, 20 mM Tris HCl (pH 7.5), and 5 mM EDTA wash buffer
for 15 min at 48°C. The slides were rocked once during the wash incubation. The slides
were rinsed in chilled deionized water and allowed to mostly air-dry before the samples
were mounted in ProLong Gold Antifade mounting medium (ThermoFisher) under a
#1.5 coverslip. The slides were dried flat in the dark.

Imaging
We imaged the hybridized plaque with an LSM 780 Confocal Microscope (Zeiss) with
a Plan-Apochromat 40x/1.4 NA objective. Each field of view was simultaneously excited by linear scanning with 405, 488, 561, and 633 nm laser lines. The emission spectra were decomposed by linear unmixing using ZEN software (Zeiss) using reference
spectra recorded from pure cultures of reference cells (Leptotrichia buccalis) hybridized
with the Eub338 probe labeled with the appropriate fluorophore as described above. To
obtain a random sample of the masses of plaque large enough to permit spatial analysis,
we scanned transects spaced every 5 μm along the coverslip at 40x magnification and
imaged every mass of plaque that was at least 70 μm in diameter and 250 μm away from
the previously imaged fields of view. For each donor, we imaged the first 20 fields of
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view that satisfied these criteria or as many fields of view as were present on the slide.
To maximize the number of bacteria captured in each image, we imaged the focal plane
closest to the surface of the slide.

Image Analysis
To allow quantitative analysis of the spatial distribution of the taxa of interest, we used
FIJI to create binarized S. mitis, H. parainfluenzae, and bacterial mass images (59) as
described in the supplementary methods section.

We evaluated the pair correlations between S. mitis and H. parainfluenzae over different
distances using a linear dipole analysis performed in Daime 2.2 (refs. 60,61). For this
analysis, the reference space in each image was restricted to the area in the binary bacterial biomass image. We used all possible dipoles with lengths ranging from 0.15 to
99.90 μm in steps of 0.45 μm.

We evaluated trends between the local densities of both taxa, by dividing each field of
view into 1024 6.64 μm by 6.64 μm blocks, discarding blocks that did not contain any
of the binary bacterial mass image, and calculating the fraction of each block that was
covered by the S. mitis and H. parainfluenzae binary images.

Mono and Coculture Assays
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Colony biofilm assays were carried out as described previously (31). Briefly, equal volumes of H. parainfluenzae and/or S. mitis were spotted either in mono or coculture on
sterile 25mm 0.2 µm polycarbonate membranes (MilliporeSigmaTM) and placed on
BHIYE HP agar plates. H. parainfluenzae was spotted at an OD600 of 1 and S. mitis at
OD600 of either 0.1, 1 or 3. The plates were then incubated for 24 hours at 37°C in 5%
CO2. The membranes were then transferred to sterile media, mixed to ensure complete
resuspension of the colony into the media; serially diluted and plated for CFU enumeration. S. mitis was enumerated by counting CFUs on BHI-YE and H. parainfluenzae on
BHI-YEHP with 5 µg/ml vancomycin.

Disk diffusion assays
Cultures of H. parainfluenzae were grown anaerobically in BHI-YEHP overnight. All
strains were then adjusted to an OD600 of 1 and 100µl was spread plated on BHIYE HP
plates and incubated aerobically for 2 hours at 37°C in 5% CO2. 5 µl of 30% H2O2 was
then added to a sterile 5mm paper disk and plates were incubated for 24 hours at 37°C
in 5% CO2. The diameters of the zones of inhibition were then measured using a caliper
in at least 3 axes.

Coculture transcriptome sample preparation
RNASeq analyses were carried out on mono and coculture samples following the colony
biofilm assays described above. Briefly, H. parainfluenzae was spotted on the polycarbonate membranes at an OD600 of 1 and S. mitis at OD600 0.1. The plates were then
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incubated for 22 hours at 37°C in 5% CO2. The membranes were then transferred onto
fresh media for 4 hours and immediately placed in RNAlater solution (AmbionTM). Experiments were carried out in biological duplicates. RNA extraction, library preparation
and sequencing were then carried out by the Microbial ‘Omics Core facility at the Broad
Institute. Sequences are submitted to the NIH SRA Gene Expression Omnibus (GEO)
database and can be found under submission GSE158845.

Transcriptome analyses
The H. parainfluenzae ATCC 33392 genome (GCA_000191405.1) was obtained from
NCBI and annotation were generated using RAST under default settings (62–64).
RNASeq reads were aligned, mapped and differentially expressed genes were analyzed
using bowtie2 (ref. 65), HTSeq (66) and DESeq2 (ref. 67) with a Unix based pipeline,
generated in this paper (available at https://github.com/dasithperera-hub/RNASeq-analysis-toolkit). This pipeline was also used to carry out a pathway analysis by mapping
DEGs to KEGG orthology (https://www.genome.jp/kegg-bin/get_htext?ko00001). This
allowed for improved annotations and the identification of potential pathways that are
involved in coculture. The same pipeline was used to analyze H. parainfluenzae gene
expression in published metatranscriptome datasets (47,48).

Complementing Nicotinamide Adenine Dinucleotide (NAD) auxotrophy of H. parainfluenzae
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Overnight cultures of H. parainfluenzae were washed 3 times in 1x Phosphate buffered
saline (PBS) and diluted to an OD600 of 0.1 and spread plated on a plate containing BHIYE supplemented with Hemin and 20units/ml catalase. 5µL of bacteria at an OD600 of
1 was added to a sterile paper disk and incubated for 48 hours. Strains used for spotting
include C. matruchotii, C. durum, S. mitis, S. sanguinis, S. cristatus, and S. gordonii.
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Figure 2.1: Read abundance data and predicted correlations between taxa in supragingival plaque. Human Microbiome Project (HMP) metagenome data of supragingival plaque was used to plot the relative abundance and prevalence of species
of interest including Haemophilus parainfluenzae (blue), several Mitis group streptococci and all remaining Streptococcus spp. (dark grey). (Top Right) The top 25% of
subjects based on H. parainfluenzae abundance were compared to the remainder via
LEfSe analysis. Shown are species enriched in this comparison above an LDA score ≤
-3.0.
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Figure 2.2. H. parainfluenzae distribution is related to the density of S. mitis in
vivo (A) Histogram of the distance to the nearest S. mitis cell, measured edge-to-edge,
from each of the 37,591 H. parainfluenzae cells in 41 fields of view. (B) Pair correlations between H. parainfluenzae and S. mitis cells. The lighter lines represent the
bounds of the 95% confidence interval for the correlation values. The dashed line represents the null hypothesis: the pair correlation equals one. n = 41 fields of view. (C)
Plaque with sparsely distributed H. parainfluenzae (cyan). (D) Plaque with high abundances of both S. mitis (magenta) and H. parainfluenzae. (i) Most H. parainfluenzae
cells are within a few microns of the nearest S. mitis cell. Generally, H. parainfluenzae
are randomly distributed with respect to S. mitis. (ii) H. parainfluenzae avoids the
highest densities of S. mitis. Scale bars indicate 10 µm.
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Figure 2.3: H. parainfluenzae growth is inhibited by Streptococcus mitis produced
H2O2 in a dose dependent manner. H. parainfluenzae (Hp) CFU counts in mono and
coculture with wildtype (Sm) or a pyruvate oxidase mutant (𝛥spxB) of S. mitis. Hp had
an initial inoculum using 10µL at an OD600 of 1, which corresponds to 4.65x106
CFU/ml. Wildtype (Sm) and S. mitis 𝛥spxB with initial inoculums using 10µL at an
OD600 of either 0.1, 1 or 3 which corresponds to an average of 2.45x105, 1.55x106 or
3.45x106 CFU/ml. Data are mean CFU counts with error bars indicating standard deviation for n≥3. *denotes p< 0.001 using a Student's t-test compared to monoculture.
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Figure 2.4: H. parainfluenzae resistance to H2O2 relies on the contribution of multiple genes. We assessed the sensitivity of wildtype H. parainfluenzae (WT) to H2O2
or coculture yield with S. mitis vs mutants lacking oxyR, catalase (katA), cytochrome c
peroxidase (ccp), peroxiredoxin (prx), glutaredoxin-peroxiredoxin (pdgX), DNA-binding protein from starved cells (dps) and glucose-6-phosphate dehydrogenase (g6p).
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(A) Zones of inhibition by 30% H2O2 exposure (areas of no visible H. parainfluenzae
growth) were measured after 24 hours and fold change calculated compared to
wildtype. Data are the mean fold change relative to WT; error bars indicate standard
deviation for n≥3. All strains were significantly different from WT, while 𝛥katA-𝛥ccp
was significantly different from 𝛥katA (padj < 0.05), based on t-test with Bonferroni
correction. (B) WT and mutant H. parainfluenzae CFU following 24h coculture with
S. mitis. H. parainfluenzae inocula were 4.65 x106 CFU/ml. S. mitis inoculum was
2.45x105 CFU/ml. Data are represented as mean CFU, error bars indicate standard deviation for n≥3. *denotes p< 0.05 by Student's t-test compared to monoculture.
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Figure 2.5: Streptococcus-produced Nicotinamide Adenine Dinucleotide (NAD)
supports H. parainfluenzae growth. Cultures of S. mitis, S. sanguinis, S. gordonii, S.
cristatus, Corynebacterium matruchotii and C. durum were grown overnight, normalized based on optical density, and spotted onto paper discs over lawns of H. parainfluenzae spread on solid agar medium lacking NAD. Plates were incubated for 48h before observation. Rings near the disc indicate H. parainfluenzae growth. NAD was
added a positive control (NAD+).
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Figure 2.6: Comparison of coculture gene expression with meta-transcriptome
datasets. Mono vs coculture RNASeq results (in vitro) for H. parainfluenzae indicated 387 significantly differentially expressed genes (DEG) above 2-fold. By comparing in vitro monoculture to in vivo metatranscriptome reads from Benítez-Páez
2014 (Meta 1) and Jorth 2014 (Meta 2) we were able to generate two sets of in vivospecific DEGs to determine differences in (A) significantly upregulated or (B) significantly downregulated genes shared between in vitro coculture and in vivo conditions.
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Appendix
Table S2.1: Minimum inhibitory concentrations in BHI-YE HP for H2O2
Strain
Wildtype
DkatA
Dccp
DoxyR

MIC (µM)
834
834
834
104

Table S2.2: H. parainfluenzae genes induced in in vitro coculture
Fold
ID
change
37.19 fig|6666666.571729.peg.656
12.14 fig|6666666.571729.peg.1162
10.87 fig|6666666.571729.peg.747
9.92 fig|6666666.571729.peg.1163
9.42 fig|6666666.571729.peg.1164
6.52 fig|6666666.571729.peg.744
6.35 fig|6666666.571729.peg.265
5.65 fig|6666666.571729.peg.102
5.56 fig|6666666.571729.peg.173
5.37 fig|6666666.571729.peg.1645
5.36 fig|6666666.571729.peg.40
5.34 fig|6666666.571729.peg.593
5.3
5.13
5.08
4.85

fig|6666666.571729.peg.60
fig|6666666.571729.peg.32
fig|6666666.571729.peg.105
fig|6666666.571729.peg.1165

Description
hypothetical protein
4-alpha-glucanotransferase (amylomaltase)
(EC 2.4.1.25);Ontology_term
Type IV pilin PilA
1%2C4-alpha-glucan (glycogen) branching enzyme%2C GH-13-type (EC 2.4.1.18);Ontology_term
Limit dextrin alpha-1%2C6-maltotetraose-hydrolase (EC 3.2.1.196);Ontology_term
Leader peptidase (Prepilin peptidase) (EC
3.4.23.43) / N-methyltransferase (EC 2.1.1.);Ontology_term
Vitamin B12 ABC transporter%2C ATP-binding protein BtuD
GALNS arylsulfatase regulator (Fe-S oxidoreductase)
Putative ABC transporter of substrate X%2C
permease subunit I
DNA ligase
Hydroxymethylpyrimidine ABC transporter%2C transmembrane component
hypothetical protein
Glycerol uptake facilitator protein
Type IV pilus biogenesis protein PilM
Sodium-Choline Symporter
Glucose-1-phosphate adenylyltransferase (EC
2.7.7.27);Ontology_term
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4.81 fig|6666666.571729.peg.592
4.72 fig|6666666.571729.peg.1288
4.67 fig|6666666.571729.peg.595
4.67 fig|6666666.571729.peg.174
4.65 fig|6666666.571729.peg.254
4.63 fig|6666666.571729.peg.1235
4.6 fig|6666666.571729.peg.131
4.58 fig|6666666.571729.peg.690
4.54 fig|6666666.571729.peg.95

4.5 fig|6666666.571729.peg.274
4.47 fig|6666666.571729.peg.101
4.47 fig|6666666.571729.peg.25
4.41 fig|6666666.571729.peg.1865
4.4 fig|6666666.571729.peg.649
4.16 fig|6666666.571729.peg.501
4.14 fig|6666666.571729.peg.930
4.09 fig|6666666.571729.peg.596
3.99
3.99
3.97
3.92

fig|6666666.571729.peg.502
fig|6666666.571729.peg.323
fig|6666666.571729.peg.257
fig|6666666.571729.peg.849

3.88 fig|6666666.571729.peg.252
3.84 fig|6666666.571729.peg.249
3.82 fig|6666666.571729.peg.435
3.8 fig|6666666.571729.peg.792
3.76 fig|6666666.571729.peg.969
3.75 fig|6666666.571729.peg.1138

hypothetical protein
Type III restriction-modification system methylation subunit (EC 2.1.1.72);Ontology_term
FIG00847847: hypothetical protein
Putative ABC transporter of substrate X%2C
permease subunit II
hypothetical protein
Oligopeptide/dipeptide ABC transporter%2C
permease protein / Oligopeptide/dipeptide
ABC transporter%2C ATP-binding protein
Site-specific tyrosine recombinase XerC
hypothetical protein
Phosphoribosylformylglycinamidine synthase%2C synthetase subunit (EC 6.3.5.3) /
Phosphoribosylformylglycinamidine synthase%2C glutamine amidotransferase subunit
(EC 6.3.5.3);Ontology_term
hypothetical protein
small multidrug resistance family (SMR) protein
AAA+ ATPase superfamily protein
YifB/ComM%2C associated with DNA recombination
Dihydrofolate reductase (EC 1.5.1.3);Ontology_term
hypothetical protein
hypothetical protein
hypothetical protein
Efflux ABC transporter%2C ATP-binding protein
hypothetical protein
DNA transformation protein TfoX
Tryptophanase (EC 4.1.99.1);Ontology_term
Guanylate kinase (EC 2.7.4.8);Ontology_term
hypothetical protein
Lysophospholipase L2 (EC 3.1.1.5);Ontology_term
Biofilm PGA synthesis deacetylase PgaB (EC
3.-)
N-acetylmannosamine kinase (EC
2.7.1.60);Ontology_term
Trehalose operon transcriptional repressor
Dihydrolipoamide succinyltransferase component (E2) of 2-oxoglutarate dehydrogenase
complex (EC 2.3.1.61);Ontology_term
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3.66 fig|6666666.571729.peg.648
3.6 fig|6666666.571729.peg.793
3.54 fig|6666666.571729.peg.172
3.54 fig|6666666.571729.peg.1075
3.52 fig|6666666.571729.peg.402
3.51 fig|6666666.571729.peg.470
3.48 fig|6666666.571729.peg.689
3.48 fig|6666666.571729.peg.1189
3.44 fig|6666666.571729.peg.171
3.43 fig|6666666.571729.peg.1122
3.43 fig|6666666.571729.peg.1247
3.38 fig|6666666.571729.peg.61
3.38 fig|6666666.571729.peg.17
3.37 fig|6666666.571729.peg.544
3.35 fig|6666666.571729.peg.403
3.32 fig|6666666.571729.peg.1681
3.3 fig|6666666.571729.peg.134
3.29 fig|6666666.571729.peg.2
3.27 fig|6666666.571729.peg.1011
3.24 fig|6666666.571729.peg.1141
3.23 fig|6666666.571729.peg.896
3.22 fig|6666666.571729.peg.161
3.2 fig|6666666.571729.peg.475
3.19 fig|6666666.571729.peg.1639
3.19 fig|6666666.571729.peg.1191
3.16 fig|6666666.571729.peg.778
3.14 fig|6666666.571729.peg.791
3.13 fig|6666666.571729.peg.629
3.08 fig|6666666.571729.peg.525
3.07 fig|6666666.571729.peg.597

Mobile element protein
Sialic acid utilization regulator%2C RpiR family
Putative ABC transporter of substrate X%2C
ATP-binding subunit
Uncharacterized integral membrane protein
GSU2901
3'(2')%2C5'-bisphosphate nucleotidase (EC
3.1.3.7);Ontology_term
hypothetical protein
hypothetical protein
Zn-ribbon-containing%2C possibly nucleicacid-binding protein
Protein SlyX
Phage integrase
Iron(III) ABC transporter%2C ATP-binding
protein
Glycerol kinase (EC 2.7.1.30);Ontology_term
Oligopeptide ABC transporter%2C substratebinding protein OppA (TC 3.A.1.5.1)
dTDP-glucose 4%2C6-dehydratase (EC
4.2.1.46);Ontology_term
hypothetical protein
hypothetical protein
Shikimate 5-dehydrogenase I alpha (EC
1.1.1.25);Ontology_term
Methionine ABC transporter ATP-binding protein
CRISPR-associated endonuclease Cas9
Succinyl-CoA ligase [ADP-forming] alpha
chain (EC 6.2.1.5);Ontology_term
5'-deoxynucleotidase YfbR (EC 3.1.3.89);Ontology_term
hypothetical protein
Transcriptional regulator%2C AsnC family
Transcriptional factor MdcH
Cysteine desulfurase (EC 2.8.1.7) > sulfur
transfer pathway protein CsdA;Ontology_term
Cytochrome c552 precursor (EC 1.7.2.2);Ontology_term
N-acetylmannosamine-6-phosphate 2-epimerase (EC 5.1.3.9);Ontology_term
NADP-specific glutamate dehydrogenase (EC
1.4.1.4);Ontology_term
D-glycerate transporter (predicted)
hypothetical protein
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3.06 fig|6666666.571729.peg.20
3.05 fig|6666666.571729.peg.748
3.04 fig|6666666.571729.peg.1260
3.03 fig|6666666.571729.peg.1137
3.03 fig|6666666.571729.peg.21
3.03 fig|6666666.571729.peg.1113
3 fig|6666666.571729.peg.560
3 fig|6666666.571729.peg.1814
2.99 fig|6666666.571729.peg.1192
2.99 fig|6666666.571729.peg.1477
2.98 fig|6666666.571729.peg.176
2.95 fig|6666666.571729.peg.1246
2.95 fig|6666666.571729.peg.1927
2.95 fig|6666666.571729.peg.929
2.93 fig|6666666.571729.peg.106
2.91 fig|6666666.571729.peg.965
2.91 fig|6666666.571729.peg.100

2.89 fig|6666666.571729.peg.1147
2.89 fig|6666666.571729.peg.1234
2.89 fig|6666666.571729.peg.511
2.88 fig|6666666.571729.peg.1502
2.87 fig|6666666.571729.peg.1325
2.85 fig|6666666.571729.peg.1287
2.85 fig|6666666.571729.peg.436
2.84 fig|6666666.571729.peg.242
2.75 fig|6666666.571729.peg.3
2.74 fig|6666666.571729.peg.1446

Oligopeptide ABC transporter%2C ATP-binding protein OppD (TC 3.A.1.5.1)
1%2C6-anhydro-N-acetylmuramyl-L-alanine
amidase
hypothetical protein
2-oxoglutarate dehydrogenase E1 component
(EC 1.2.4.2);Ontology_term
Oligopeptide ABC transporter%2C ATP-binding protein OppF (TC 3.A.1.5.1)
Uncharacterized DUF218 membrane proteinn
PM0506
hypothetical protein
Alanyl-tRNA synthetase (EC 6.1.1.7);Ontology_term
Micrococcal nuclease (thermonuclease) homologs
Uncharacterized protein MSMEG_6412
Sodium-dependent anion transporter family
ABC transporter%2C substrate-binding protein
(cluster 8%2C B12/iron complex)
Carbonic anhydrase%2C alpha class (EC
4.2.1.1);Ontology_term
hypothetical protein
Predicted permeases
Permease of the drug/metabolite transporter
(DMT) superfamily
5'-nucleotidase (EC 3.1.3.5)%3B 2'%2C3'-cyclic-nucleotide 2'-phosphodiesterase (EC
3.1.4.16)%3B Putative UDP-sugar hydrolase
(EC 3.6.1.45);Ontology_term
UPF0115 protein YfcN
Putative glutathione transporter%2C permease
component
DNA uptake protein and related DNA-binding
proteins
Ferric iron ABC transporter%2C iron-binding
protein
Ribulosamine/erythrulosamine 3-kinase potentially involved in protein deglycation
Type III restriction-modification system restriction subunit (EC 3.1.21.5);Ontology_term
Biofilm PGA outer membrane secretin PgaA
Fructose-1%2C6-bisphosphatase%2C GlpX
type (EC 3.1.3.11);Ontology_term
Methionine ABC transporter permease protein
Allophanate hydrolase 2 subunit 2 (EC
3.5.1.54);Ontology_term
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2.74
2.73
2.7
2.69

fig|6666666.571729.peg.1273
fig|6666666.571729.peg.158
fig|6666666.571729.peg.256
fig|6666666.571729.peg.1038

2.68 fig|6666666.571729.peg.720
2.67 fig|6666666.571729.peg.130
2.67
2.66
2.66
2.65

fig|6666666.571729.peg.261
fig|6666666.571729.peg.775
fig|6666666.571729.peg.258
fig|6666666.571729.peg.434

2.65 fig|6666666.571729.peg.1258
2.65 fig|6666666.571729.peg.1017
2.63 fig|6666666.571729.peg.1719
2.62 fig|6666666.571729.peg.1720
2.62 fig|6666666.571729.peg.33
2.61 fig|6666666.571729.peg.433
2.61 fig|6666666.571729.peg.19
2.6 fig|6666666.571729.peg.259
2.59 fig|6666666.571729.peg.1916
2.59 fig|6666666.571729.peg.1083
2.59 fig|6666666.571729.peg.148
2.59 fig|6666666.571729.peg.583
2.59 fig|6666666.571729.peg.1315
2.58 fig|6666666.571729.peg.1775
2.57 fig|6666666.571729.peg.1774
2.56 fig|6666666.571729.peg.1657
2.55 fig|6666666.571729.peg.159
2.55 fig|6666666.571729.peg.104
2.55 fig|6666666.571729.peg.1595
2.55 fig|6666666.571729.peg.1078

Universal stress protein E
Endonuclease V (EC 3.2.2.17);Ontology_term
hypothetical protein
Tripeptide aminopeptidase (EC 3.4.11.4);Ontology_term
hypothetical protein
Histone acetyltransferase HPA2 and related
acetyltransferases
hypothetical protein
NrfD protein
Tyrosine-specific transport protein
Biofilm PGA synthesis N-glycosyltransferase
PgaC (EC 2.4.-.-);Ontology_term
hypothetical protein
Cell division inhibitor Slr1223 (YfcH in
EC)%2C contains epimerase/dehydratase and
DUF1731 domains
Aldose 1-epimerase (EC 5.1.3.3);Ontology_term
Galactokinase (EC 2.7.1.6);Ontology_term
Multimodular transpeptidase-transglycosylase
(EC 2.4.1.129) (EC 3.4.-.-);Ontology_term
AagD
Oligopeptide ABC transporter%2C permease
protein OppC (TC 3.A.1.5.1)
hypothetical protein
Glycosyl transferase
Peptide transport system ATP-binding protein
sapF (TC 3.A.1.5.5)
Nitrate/nitrite response regulator protein NarP
FIGfam138462: Acyl-CoA synthetase%2C
AMP-(fatty) acid ligase
hypothetical protein
Ribosome LSU-associated GTP-binding protein HflX
RNA-binding protein Hfq
VgrG protein
hypothetical protein
Choline-sulfatase (EC 3.1.6.6);Ontology_term
Ribonucleotide reductase of class III (anaerobic)%2C activating protein (EC 1.97.1.4);Ontology_term
Aspartokinase (EC 2.7.2.4);Ontology_term
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2.54 fig|6666666.571729.peg.1085
2.54
2.53
2.51
2.5

fig|6666666.571729.peg.1678
fig|6666666.571729.peg.322
fig|6666666.571729.peg.160
fig|6666666.571729.peg.18

2.49 fig|6666666.571729.peg.1406
2.49 fig|6666666.571729.peg.855

2.49 fig|6666666.571729.peg.842
2.48 fig|6666666.571729.peg.23
2.48 fig|6666666.571729.peg.1726
2.46 fig|6666666.571729.peg.1380
2.45 fig|6666666.571729.peg.1243
2.45 fig|6666666.571729.peg.1786
2.45 fig|6666666.571729.peg.1877
2.43 fig|6666666.571729.peg.1
2.42 fig|6666666.571729.peg.1447
2.42 fig|6666666.571729.peg.84
2.41 fig|6666666.571729.peg.933
2.41 fig|6666666.571729.peg.41
2.41 fig|6666666.571729.peg.1359
2.4 fig|6666666.571729.peg.1236
2.4 fig|6666666.571729.peg.400
2.4 fig|6666666.571729.peg.658
2.39 fig|6666666.571729.peg.1391
2.39 fig|6666666.571729.peg.1223
2.37 fig|6666666.571729.peg.1233

ABC transporter%2C permease protein 2
(cluster 5%2C nickel/peptides/opines)
hypothetical protein
Patatin-like phospholipase
hypothetical protein
Oligopeptide ABC transporter%2C permease
protein OppB (TC 3.A.1.5.1)
Lysine exporter LysO
Glutamine synthetase adenylyl-L-tyrosine
phosphorylase (EC 2.7.7.89) / Glutamate-ammonia-ligase adenylyltransferase (EC
2.7.7.42);Ontology_term
hypothetical protein
GTP-binding protein EngB
Galactose/methyl galactoside ABC transporter%2C permease protein MglC (EC
3.6.3.17);Ontology_term
Phosphoenolpyruvate carboxylase (EC
4.1.1.31);Ontology_term
TonB-dependent receptor%3B Outer membrane receptor for ferrienterochelin and colicins
tRNA(Ile)-lysidine synthetase (EC
6.3.4.19);Ontology_term
hypothetical protein
D-glycero-beta-D-manno-heptose-1%2C7bisphosphate 7-phosphatase (EC 3.1.3.82);Ontology_term
Allophanate hydrolase 2 subunit 1 (EC
3.5.1.54);Ontology_term
Aspartate--ammonia ligase (EC 6.3.1.1);Ontology_term
hypothetical protein
Hydroxymethylpyrimidine ABC transporter%2C ATPase component
Putative high-affinity iron permease
Oligopeptide ABC transporter%2C ATP-binding protein OppF (TC 3.A.1.5.1)
6-phosphogluconolactonase (EC 3.1.1.31)%2C
eukaryotic type;Ontology_term
Ribosome-associated inhibitor A
ATPase component NikO of energizing module of nickel ECF transporter
Exodeoxyribonuclease V beta chain (EC
3.1.11.5);Ontology_term
ABC transporter%2C substrate-binding protein
(cluster 5%2C nickel/peptides/opines)
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2.37 fig|6666666.571729.peg.1455
2.36 fig|6666666.571729.peg.7
2.36 fig|6666666.571729.peg.1475
2.36 fig|6666666.571729.peg.600
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fig|6666666.571729.peg.1003
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2.26 fig|6666666.571729.peg.1402
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2.24 fig|6666666.571729.peg.423
2.23 fig|6666666.571729.peg.284
2.23 fig|6666666.571729.peg.683
2.21 fig|6666666.571729.peg.794

NADP-dependent malic enzyme (EC
1.1.1.40);Ontology_term
hypothetical protein
Aerobic respiration control sensor protein
ArcB (EC 2.7.13.3);Ontology_term
3-oxoacyl-[acyl-carrier-protein] synthase III
(EC 2.3.1.41);Ontology_term
Predicted hydroxymethylpyrimidine transporter CytX
Uncharacterized protein YfgD%2C not an arsenate reductase
Phosphoribosylamine--glycine ligase (EC
6.3.4.13);Ontology_term
Galactose/methyl galactoside ABC transporter%2C substrate-binding protein MglB
(EC 3.6.3.17);Ontology_term
Succinyl-CoA ligase [ADP-forming] beta
chain (EC 6.2.1.5);Ontology_term
hypothetical protein
Rod shape-determining protein RodA
D-alanyl-D-alanine carboxypeptidase (EC
3.4.16.4);Ontology_term
Galactose operon repressor%2C GalR-LacI
family of transcriptional regulators
Putative DNA-binding protein in cluster with
Type I restriction-modification system
hypothetical protein
Ribonuclease G
hypothetical protein
Anaerobic respiratory reductase chaperone
23S rRNA (uracil(1939)-C(5))-methyltransferase (EC 2.1.1.190);Ontology_term
Hydrogenase-4 component B
Cystathionine beta-lyase (EC 4.4.1.8);Ontology_term
Vitamin B12 ABC transporter%2C permease
protein BtuC
Glycosyltransferase
Hydrogenase-4 component C
deoxyribose-phosphate aldolase( EC:4.1.2.4
);Ontology_term
Shikimate 5-dehydrogenase I gamma (EC
1.1.1.25);Ontology_term
Aerobic respiration control response regulator
ArcA
N-acetylneuraminate lyase (EC 4.1.3.3);Ontology_term
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2.21 fig|6666666.571729.peg.653
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fig|6666666.571729.peg.913
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fig|6666666.571729.peg.1631
fig|6666666.571729.peg.1901
fig|6666666.571729.peg.693
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2.07
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fig|6666666.571729.peg.696
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fig|6666666.571729.peg.1369
fig|6666666.571729.peg.763

2.06 fig|6666666.571729.peg.1976
2.06 fig|6666666.571729.peg.697

Phosphoserine phosphatase (EC 3.1.3.3);Ontology_term
FIG021862: membrane protein%2C exporter
Chloride channel protein EriC
Pentapeptide repeat family protein
T6SS component Hcp
ABC-type antimicrobial peptide transport system%2C permease component
Possible ABC transporter%2C periplasmic
substrate X binding protein precursor
ImpA
NrfC protein
DNA protection during starvation protein
Peptide ABC transporter%2C ATP-binding
protein SapD
Hypothetical protein VC0266 (sugar utilization
related?)
IMP cyclohydrolase (EC 3.5.4.10) / Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3);Ontology_term
Uncharacterized protein EC-HemY in Proteobacteria (unrelated to HemY-type PPO in
GramPositives)
putative 5'(3')-deoxyribonucleotidase
hypothetical protein
beta-galactosidase (EC 3.2.1.23);Ontology_term
tRNA 5-methylaminomethyl-2-thiouridine
synthesis sulfur carrier protein TusA
Inner membrane protein YedI
AAA ATPase%2C central region
Outer membrane protein P2 precursor
hypothetical protein
Oxygen-insensitive NAD(P)H nitroreductase
(EC 1.-.-.-) / Dihydropteridine reductase (EC
1.5.1.34);Ontology_term
Na+/H+ antiporter NhaB
Putative metabolite transport protein YjhB
pseudoazurin
Phosphatidate cytidylyltransferase (EC
2.7.7.41);Ontology_term
UDP-2%2C3-diacylglucosamine diphosphatase (EC 3.6.1.54);Ontology_term
Transcriptional regulator for fatty acid degradation FadR%2C GntR family
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2.05 fig|6666666.571729.peg.1209
2.05 fig|6666666.571729.peg.1372
2.05 fig|6666666.571729.peg.382
2.05 fig|6666666.571729.peg.729
2.02 fig|6666666.571729.peg.266
2.02
2.02
2.01
2

fig|6666666.571729.peg.1919
fig|6666666.571729.peg.1721
fig|6666666.571729.peg.279
fig|6666666.571729.peg.1979

tRNA pseudouridine(65) synthase (EC
5.4.99.26);Ontology_term
ABC-type Fe3+-hydroxamate transport system%2C periplasmic component
LSU rRNA pseudouridine(746) synthase (EC
5.4.99.29) @ tRNA pseudouridine(32) synthase (EC 5.4.99.28);Ontology_term
Septum-associated rare lipoprotein A
thiamine-phosphate pyrophosphorylase(
EC:2.5.1.3 );Ontology_term
FIG00696423: hypothetical protein
Galactokinase (EC 2.7.1.6);Ontology_term
Ribonuclease BN
hypothetical protein

Table S2.3: H. parainfluenzae genes repressed in in vitro coculture
Fold
ID
change
-7.49 fig|6666666.571729.peg.7
56
-5.51 fig|6666666.571729.peg.8
82
-5.45 fig|6666666.571729.peg.9
04
-5.39 fig|6666666.571729.peg.6
66
-4.62 fig|6666666.571729.peg.6
80
-4.56 fig|6666666.571729.peg.1
296
-4.45 fig|6666666.571729.peg.1
754
-4.37 fig|6666666.571729.peg.1
825
-4.36 fig|6666666.571729.peg.9
03
-4.23 fig|6666666.571729.peg.1
340
-4.22 fig|6666666.571729.peg.6
65
-4.09 fig|6666666.571729.peg.9
06

Description
FIG00697202: hypothetical protein
Monothiol glutaredoxin GrxD
hypothetical protein
UPF0394 inner membrane protein YeeE
LSU ribosomal protein L36p @ LSU ribosomal
protein L36p%2C zinc-independent
Exodeoxyribonuclease VII small subunit (EC
3.1.11.6);Ontology_term
Dihydroneopterin triphosphate pyrophosphohydrolase type 2
Lipid-A-disaccharide synthase (EC
2.4.1.182);Ontology_term
O-acetylhomoserine sulfhydrylase (EC 2.5.1.49)
@ O-succinylhomoserine sulfhydrylase (EC
2.5.1.48);Ontology_term
Transcription elongation factor GreA
UPF0033 protein YeeD
hypothetical protein
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-4.03 fig|6666666.571729.peg.1
728
-3.98 fig|6666666.571729.peg.1
700
-3.97 fig|6666666.571729.peg.1
108
-3.92 fig|6666666.571729.peg.1
751
-3.76 fig|6666666.571729.peg.8
81
-3.66 fig|6666666.571729.peg.1
884
-3.57 fig|6666666.571729.peg.1
770
-3.56 fig|6666666.571729.peg.1
516
-3.43 fig|6666666.571729.peg.2
41
-3.41 fig|6666666.571729.peg.1
305
-3.4 fig|6666666.571729.peg.1
644
-3.36 fig|6666666.571729.peg.1
897
-3.32 fig|6666666.571729.peg.8
38
-3.31 fig|6666666.571729.peg.3
38
-3.26 fig|6666666.571729.peg.1
769
-3.25 fig|6666666.571729.peg.4
5
-3.21 fig|6666666.571729.peg.1
819
-3.16 fig|6666666.571729.peg.2
04
-3.11 fig|6666666.571729.peg.1
338
-3.07 fig|6666666.571729.peg.1
743
-3.03 fig|6666666.571729.peg.3
60
-2.94 fig|6666666.571729.peg.1
051
-2.94 fig|6666666.571729.peg.6
32
-2.92 fig|6666666.571729.peg.3
57
-2.91 fig|6666666.571729.peg.1
892

Protein IscX%2C believed to be involved in assembly of Fe-S clusters
Cytochrome c551 peroxidase (EC 1.11.1.5);Ontology_term
hypothetical protein
Crossover junction endodeoxyribonuclease RuvC
(EC 3.1.22.4);Ontology_term
Beta-propeller domains of methanol dehydrogenase type
Nucleoid-associated protein YaaK
Phage integrase
Thiol peroxidase%2C Tpx-type (EC
1.11.1.15);Ontology_term
Cell division protein ZapB
Threonyl-tRNA synthetase (EC 6.1.1.3);Ontology_term
D-sedoheptulose 7-phosphate isomerase (EC
5.3.1.28);Ontology_term
Putative glutamine amidotransferase YafJ
Uracil permease @ Uracil:proton symporter UraA
Hybrid peroxiredoxin hyPrx5 (EC 1.11.1.15);Ontology_term
hypothetical protein
DNA primase DnaG
Heat shock protein 10 kDa family chaperone
GroES
Xanthine-guanine phosphoribosyltransferase (EC
2.4.2.22);Ontology_term
23S rRNA (uridine(2552)-2'-O)-methyltransferase (EC 2.1.1.166);Ontology_term
Tol-Pal system-associated acyl-CoA thioesterase
LSU ribosomal protein L22p (L17e)
Modulator of drug activity B
Twin-arginine translocation protein TatB
LSU ribosomal protein L23p (L23Ae)
LSU ribosomal protein L31p @ LSU ribosomal
protein L31p%2C zinc-dependent
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-2.9 fig|6666666.571729.peg.1
464
-2.89 fig|6666666.571729.peg.1
214
-2.88 fig|6666666.571729.peg.1
849
-2.88 fig|6666666.571729.peg.3
64
-2.88 fig|6666666.571729.peg.4
7
-2.88 fig|6666666.571729.peg.1
463
-2.87 fig|6666666.571729.peg.1
809
-2.86 fig|6666666.571729.peg.1
409
-2.86 fig|6666666.571729.peg.1
733
-2.82 fig|6666666.571729.peg.1
242
-2.81 fig|6666666.571729.peg.1
643
-2.81 fig|6666666.571729.peg.1
729
-2.78 fig|6666666.571729.peg.9
49
-2.77 fig|6666666.571729.peg.7
17
-2.76 fig|6666666.571729.peg.1
87
-2.76 fig|6666666.571729.peg.1
740
-2.76 fig|6666666.571729.peg.3
55
-2.74 fig|6666666.571729.peg.1
710
-2.72 fig|6666666.571729.peg.6
9
-2.71 fig|6666666.571729.peg.1
509
-2.7 fig|6666666.571729.peg.1
123
-2.7 fig|6666666.571729.peg.7
74
-2.69 fig|6666666.571729.peg.1
602
-2.69 fig|6666666.571729.peg.3
58

GTP cyclohydrolase II (EC 3.5.4.25);Ontology_term
3-hydroxyacyl-[acyl-carrier-protein] dehydratase%2C FabA form (EC 4.2.1.59) @ Trans-2-decenoyl-[acyl-carrier-protein] isomerase (EC
5.3.3.14);Ontology_term
tRNA (guanine(46)-N(7))-methyltransferase (EC
2.1.1.33);Ontology_term
SSU ribosomal protein S17p (S11e)
N(6)-L-threonylcarbamoyladenine synthase (EC
2.3.1.234);Ontology_term
Phosphatidylglycerophosphatase B (EC
3.1.3.27);Ontology_term
Copper(I) chaperone CopZ
Outer membrane stress sensor protease
DegQ%2C serine protease
Iron-sulfur cluster assembly iron binding protein
IscA
Iron(III) ABC transporter%2C solute-binding
protein
Arginine ABC transporter%2C ATP-binding protein ArtP
Ferredoxin%2C 2Fe-2S
Flavodoxin 1
Uncharacterized protease YegQ
Sigma factor RpoE negative regulatory protein
RseB precursor
TolA protein
LSU ribosomal protein L3p (L3e)
Acid stress protein IbaG
hypothetical protein
DNA polymerase III psi subunit (EC 2.7.7.7);Ontology_term
Pyruvate kinase (EC 2.7.1.40);Ontology_term
Cytochrome c-type heme lyase subunit nrfE%2C
nitrite reductase complex assembly
FIG024746: hypothetical protein
LSU ribosomal protein L2p (L8e)
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730
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80
-2.67 fig|6666666.571729.peg.1
482
-2.65 fig|6666666.571729.peg.3
59
-2.65 fig|6666666.571729.peg.6
30
-2.64 fig|6666666.571729.peg.2
003
-2.63 fig|6666666.571729.peg.7
3
-2.61 fig|6666666.571729.peg.3
53
-2.59 fig|6666666.571729.peg.3
54
-2.59 fig|6666666.571729.peg.1
858
-2.58 fig|6666666.571729.peg.1
168
-2.58 fig|6666666.571729.peg.1
641
-2.57 fig|6666666.571729.peg.9
48
-2.57 fig|6666666.571729.peg.1
013
-2.57 fig|6666666.571729.peg.1
169
-2.55 fig|6666666.571729.peg.1
542
-2.55 fig|6666666.571729.peg.9
89
-2.55 fig|6666666.571729.peg.1
731
-2.52 fig|6666666.571729.peg.1
750
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65
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485
-2.49 fig|6666666.571729.peg.1
692
-2.48 fig|6666666.571729.peg.3
61
-2.47 fig|6666666.571729.peg.1
846

Chaperone protein HscA
hypothetical protein
hypothetical protein
SSU ribosomal protein S19p (S15e)
Porphobilinogen synthase (EC 4.2.1.24);Ontology_term
Frataxin homolog CyaY%2C facilitates Fe-S
cluster assembly%2C interacts with IscS
Purine nucleoside phosphorylase (EC
2.4.2.1);Ontology_term
hypothetical protein
SSU ribosomal protein S10p (S20e)
Glutathionylspermidine synthase (EC 6.3.1.8) /
Glutathionylspermidine amidohydrolase (EC
3.5.1.78);Ontology_term
6%2C7-dimethyl-8-ribityllumazine synthase (EC
2.5.1.78);Ontology_term
Arginine ABC transporter%2C permease protein
ArtQ
Ferric uptake regulation protein FUR
LSU ribosomal protein L25p
Transcription termination protein NusB
HesA/MoeB/ThiF family protein > sulfur transfer
pathway protein CsdL
Iron compound ABC transporter%2C permease
protein
Uncharacterized protein YbfG
Holliday junction ATP-dependent DNA helicase
RuvA (EC 3.6.4.12);Ontology_term
FIG01269488: protein%2C clustered with ribosomal protein L32p
Transcriptional activator MetR
T6SS lysozyme-like component TssE
SSU ribosomal protein S3p (S3e)
Transcriptional regulator%2C AcrR family
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-2.46 fig|6666666.571729.peg.3
56
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768
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59
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40
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16
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64
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26
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30
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39
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737
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7
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36
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012
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245
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297
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917
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316
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566
-2.3 fig|6666666.571729.peg.1
573
-2.3 fig|6666666.571729.peg.9
05

LSU ribosomal protein L4p (L1e)
hypothetical protein
hypothetical protein
Iron(III) dicitrate transport system%2C periplasmic iron-binding protein FecB (TC 3.A.1.14.1)
tRNA pseudouridine(13) synthase (EC
5.4.99.27);Ontology_term
Alanine transaminase (EC 2.6.1.2);Ontology_term
LSU ribosomal protein L27p
Membrane protein involved in the export of Oantigen and teichoic acid
Molybdopterin-guanine dinucleotide biosynthesis
protein MobB
LSU ribosomal protein L31p @ LSU ribosomal
protein L31p%2C zinc-independent
Threonine dehydratase biosynthetic (EC
4.3.1.19);Ontology_term
33 kDa chaperonin HslO
Uracil phosphoribosyltransferase (EC
2.4.2.9);Ontology_term
Glutamyl-tRNA synthetase (EC 6.1.1.17);Ontology_term
tRNA (cytidine(32)/uridine(32)-2'-O)-methyltransferase (EC 2.1.1.200);Ontology_term
L-cystine ABC transporter%2C substrate-binding
protein TcyA
Nucleoside-diphosphate-sugar epimerases
DedA protein
Molybdate-binding domain of ModE
(2E%2C6E)-farnesyl diphosphate synthase (EC
2.5.1.10);Ontology_term
Lipooligosaccharide biosynthesis protein lex-1
(EC 2.-.-.-);Ontology_term
Stringent starvation protein B
UPF0307 protein YjgA
N-succinyl-L%2CL-diaminopimelate desuccinylase (EC 3.5.1.18);Ontology_term
Chaperone protein DnaK

137

-2.3 fig|6666666.571729.peg.1
603
-2.29 fig|6666666.571729.peg.1
742
-2.28 fig|6666666.571729.peg.1
732
-2.28 fig|6666666.571729.peg.7
55
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7
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67
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35
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42
-2.18 fig|6666666.571729.peg.1
493
-2.17 fig|6666666.571729.peg.1
486

FIG023677: hypothetical protein
Tol-Pal system protein TolQ
Chaperone protein HscB
Autonomous glycyl radical cofactor
hypothetical protein
Excinuclease ABC subunit A
Efflux ABC transporter%2C permease/ATP-binding protein
Site-specific recombinase
Peptide chain release factor 1
Hypothetical metal-binding enzyme%2C YcbL
homolog
Nitric-oxide reductase (EC 1.7.99.7)%2C quinoldependent;Ontology_term
FAD:protein FMN transferase (EC 2.7.1.180) @
FAD:protein FMN transferase (EC
2.7.1.180)%2C NqrBC-associated;Ontology_term
DNA polymerase III chi subunit (EC 2.7.7.7);Ontology_term
Putative phosphatase YigL%2C haloacid dehalogenase-like phosphatase family
Signal recognition particle protein Ffh
3-hydroxyacyl-[acyl-carrier-protein] dehydratase%2C FabZ form (EC 4.2.1.59);Ontology_term
Methionine repressor MetJ
GTP-binding protein TypA/BipA
Apolipoprotein N-acyltransferase / Copper homeostasis protein CutE
FIG002060: uncharacterized protein YggL
LSU ribosomal protein L33p @ LSU ribosomal
protein L33p%2C zinc-independent
Ketol-acid reductoisomerase (NADP(+)) (EC
1.1.1.86);Ontology_term
Uridine kinase (EC 2.7.1.48);Ontology_term
Site-specific recombinase
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44
-2.05 fig|6666666.571729.peg.1
341
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6

SSU ribosomal protein S9p (S16e)
tmRNA-binding protein SmpB
Copper-translocating P-type ATPase (EC
3.6.3.4);Ontology_term
Thioredoxin
Transcription accessory protein (S1 RNA-binding
domain)
LSU ribosomal protein L5p (L11e)
LemA family protein
LSU ribosomal protein L16p (L10e)
hypothetical protein
Tol biopolymer transport system%2C TolR protein
Soluble lytic murein transglycosylase (EC
4.2.2.n1)
LSU ribosomal protein L20p
LSU ribosomal protein L21p
Ribonucleotide reductase of class Ia (aerobic)%2C alpha subunit (EC 1.17.4.1);Ontology_term
Phospholipid ABC transporter ATP-binding protein MlaF
Phosphatidylserine decarboxylase (EC
4.1.1.65);Ontology_term
tRNA-5-carboxymethylaminomethyl-2thiouridine(34) synthesis protein MnmG
Translation initiation factor 3
LSU ribosomal protein L9p
Heat shock protein 60 kDa family chaperone
GroEL
Transcription termination protein NusA
histone H1
D-alanyl-D-alanine carboxypeptidase (EC
3.4.16.4);Ontology_term
SSU ribosomal protein S21p
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-2.03 fig|6666666.571729.peg.1
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63
-2.01 fig|6666666.571729.peg.4
96
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494
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Ribonucleotide reductase of class III (anaerobic)%2C large subunit (EC 1.17.4.2);Ontology_term
LSU ribosomal protein L29p (L35e)
2-haloalkanoic acid dehalogenase (EC
3.8.1.2);Ontology_term
Deoxycytidine triphosphate deaminase (EC
3.5.4.13);Ontology_term
DNA topoisomerase IV subunit B (EC
5.99.1.3);Ontology_term
Thiol:disulfide interchange protein DsbC
SOS-response repressor and protease LexA (EC
3.4.21.88);Ontology_term

Table S2.4: H. parainfluenzae genes induced in in vitro coculture and both in vivo metatranscriptomes
id

Description

fig|6666666.571729.peg.60
fig|6666666.571729.peg.32
fig|6666666.571729.peg.40

Glycerol uptake facilitator protein
Type IV pilus biogenesis protein PilM
Hydroxymethylpyrimidine ABC transporter transmembrane component
fig|6666666.571729.peg.629 NADP-specific glutamate dehydrogenase (EC 1.4.1.4);Ontology_term
fig|6666666.571729.peg.1372 ABC-type Fe3+-hydroxamate transport system periplasmic
component
fig|6666666.571729.peg.1681 hypothetical protein
fig|6666666.571729.peg.25
AAA+ ATPase superfamily protein YifB/ComM associated with DNA recombination
fig|6666666.571729.peg.687 Phosphoribosylamine--glycine ligase (EC 6.3.4.13);Ontology_term
fig|6666666.571729.peg.119 Chloride channel protein EriC
fig|6666666.571729.peg.95
Phosphoribosylformylglycinamidine synthase synthetase
subunit (EC 6.3.5.3) / Phosphoribosylformylglycinamidine
synthase glutamine amidotransferase subunit (EC
6.3.5.3);Ontology_term
fig|6666666.571729.peg.1446 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54);Ontology_term
fig|6666666.571729.peg.522 23S rRNA (uracil(1939)-C(5))-methyltransferase (EC
2.1.1.190);Ontology_term
fig|6666666.571729.peg.173 Putative ABC transporter of substrate X permease subunit I
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fig|6666666.571729.peg.242

Fructose-16-bisphosphatase GlpX type (EC 3.1.3.11);Ontology_term
fig|6666666.571729.peg.502 hypothetical protein
fig|6666666.571729.peg.866 beta-galactosidase (EC 3.2.1.23);Ontology_term
fig|6666666.571729.peg.1078 Aspartokinase (EC 2.7.2.4);Ontology_term
fig|6666666.571729.peg.61
Glycerol kinase (EC 2.7.1.30);Ontology_term
Table S2.5: H. parainfluenzae genes repressed in in vitro coculture and both in vivo metatranscriptomes
id
fig|6666666.571729.peg.903
fig|6666666.571729.peg.905

Description
O-acetylhomoserine sulfhydrylase (EC 2.5.1.49) @ O-succinylhomoserine sulfhydrylase (EC 2.5.1.48);Ontology_term
Chaperone protein DnaK

fig|6666666.571729.peg.1409 Outer membrane stress sensor protease DegQ serine protease
fig|6666666.571729.peg.1340 Transcription elongation factor GreA
fig|6666666.571729.peg.1811 Methionine repressor MetJ
fig|6666666.571729.peg.1850 FIG002060: uncharacterized protein YggL
fig|6666666.571729.peg.980
fig|6666666.571729.peg.430

hypothetical protein
33 kDa chaperonin HslO

fig|6666666.571729.peg.904
fig|6666666.571729.peg.906

hypothetical protein
hypothetical protein

fig|6666666.571729.peg.69
fig|6666666.571729.peg.496

hypothetical protein
2-haloalkanoic acid dehalogenase (EC 3.8.1.2);Ontology_term
L-cystine ABC transporter substrate-binding protein TcyA
Purine nucleoside phosphorylase (EC 2.4.2.1);Ontology_term
Stringent starvation protein B
Glutathionylspermidine synthase (EC 6.3.1.8) / Glutathionylspermidine amidohydrolase (EC 3.5.1.78);Ontology_term
Nucleoid-associated protein YaaK
Phosphatidylserine decarboxylase (EC 4.1.1.65);Ontology_term
Threonine dehydratase biosynthetic (EC 4.3.1.19);Ontology_term
LSU ribosomal protein L25p

fig|6666666.571729.peg.57
fig|6666666.571729.peg.73
fig|6666666.571729.peg.1316
fig|6666666.571729.peg.1858
fig|6666666.571729.peg.1884
fig|6666666.571729.peg.1861
fig|6666666.571729.peg.226
fig|6666666.571729.peg.1013

fig|6666666.571729.peg.948 Ferric uptake regulation protein FUR
fig|6666666.571729.peg.1305 Threonyl-tRNA synthetase (EC 6.1.1.3);Ontology_term
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Table S2.6: H. parainfluenzae genes upregulated in in vitro coculture and in vivo metatranscriptome Benítez-Páez et al., (2014)
id
fig|6666666.571729.peg.60
fig|6666666.571729.peg.32
fig|6666666.571729.peg.40

Description
Glycerol uptake facilitator protein
Type IV pilus biogenesis protein PilM
Hydroxymethylpyrimidine ABC transporter transmembrane component
fig|6666666.571729.peg.629 NADP-specific glutamate dehydrogenase (EC 1.4.1.4);Ontology_term
fig|6666666.571729.peg.1372 ABC-type Fe3+-hydroxamate transport system periplasmic
component
fig|6666666.571729.peg.1681 hypothetical protein
fig|6666666.571729.peg.25
AAA+ ATPase superfamily protein YifB/ComM associated with DNA recombination
fig|6666666.571729.peg.687 Phosphoribosylamine--glycine ligase (EC 6.3.4.13);Ontology_term
fig|6666666.571729.peg.119 Chloride channel protein EriC
fig|6666666.571729.peg.95
Phosphoribosylformylglycinamidine synthase synthetase
subunit (EC 6.3.5.3) / Phosphoribosylformylglycinamidine
synthase glutamine amidotransferase subunit (EC
6.3.5.3);Ontology_term
fig|6666666.571729.peg.1446 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54);Ontology_term
fig|6666666.571729.peg.522 23S rRNA (uracil(1939)-C(5))-methyltransferase (EC
2.1.1.190);Ontology_term
fig|6666666.571729.peg.173 Putative ABC transporter of substrate X permease subunit I
fig|6666666.571729.peg.686

IMP cyclohydrolase (EC 3.5.4.10) / Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC
2.1.2.3);Ontology_term
fig|6666666.571729.peg.896 5'-deoxynucleotidase YfbR (EC 3.1.3.89);Ontology_term
fig|6666666.571729.peg.242 Fructose-16-bisphosphatase GlpX type (EC 3.1.3.11);Ontology_term
fig|6666666.571729.peg.502 hypothetical protein
fig|6666666.571729.peg.866 beta-galactosidase (EC 3.2.1.23);Ontology_term
fig|6666666.571729.peg.3
Methionine ABC transporter permease protein
fig|6666666.571729.peg.792 N-acetylmannosamine kinase (EC 2.7.1.60);Ontology_term
fig|6666666.571729.peg.1078 Aspartokinase (EC 2.7.2.4);Ontology_term
fig|6666666.571729.peg.61
Glycerol kinase (EC 2.7.1.30);Ontology_term

Table S2.7: H. parainfluenzae genes downregulated in in vitro coculture and in vivo metatranscriptome Benítez-Páez et al., (2014)
id
Description
fig|6666666.571729.peg.1245 Molybdate-binding domain of ModE
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fig|6666666.571729.peg.903
fig|6666666.571729.peg.1768
fig|6666666.571729.peg.905
fig|6666666.571729.peg.1409
fig|6666666.571729.peg.1340
fig|6666666.571729.peg.1811
fig|6666666.571729.peg.1700
fig|6666666.571729.peg.1850
fig|6666666.571729.peg.980
fig|6666666.571729.peg.430
fig|6666666.571729.peg.904
fig|6666666.571729.peg.906
fig|6666666.571729.peg.665
fig|6666666.571729.peg.1242
fig|6666666.571729.peg.1809
fig|6666666.571729.peg.1012
fig|6666666.571729.peg.1818
fig|6666666.571729.peg.67
fig|6666666.571729.peg.69
fig|6666666.571729.peg.496
fig|6666666.571729.peg.57
fig|6666666.571729.peg.73
fig|6666666.571729.peg.782
fig|6666666.571729.peg.1316
fig|6666666.571729.peg.1858
fig|6666666.571729.peg.46
fig|6666666.571729.peg.1797
fig|6666666.571729.peg.1731
fig|6666666.571729.peg.1884
fig|6666666.571729.peg.717
fig|6666666.571729.peg.838
fig|6666666.571729.peg.1299
fig|6666666.571729.peg.1730
fig|6666666.571729.peg.1861

O-acetylhomoserine sulfhydrylase (EC 2.5.1.49) @ O-succinylhomoserine sulfhydrylase (EC 2.5.1.48);Ontology_term
hypothetical protein
Chaperone protein DnaK
Outer membrane stress sensor protease DegQ serine protease
Transcription elongation factor GreA
Methionine repressor MetJ
Cytochrome c551 peroxidase (EC 1.11.1.5);Ontology_term
FIG002060: uncharacterized protein YggL
hypothetical protein
33 kDa chaperonin HslO
hypothetical protein
hypothetical protein
UPF0033 protein YeeD
Iron(III) ABC transporter solute-binding protein
Copper(I) chaperone CopZ
DedA protein
Heat shock protein 60 kDa family chaperone GroEL
hypothetical protein
hypothetical protein
2-haloalkanoic acid dehalogenase (EC 3.8.1.2);Ontology_term
L-cystine ABC transporter substrate-binding protein TcyA
Purine nucleoside phosphorylase (EC 2.4.2.1);Ontology_term
LSU ribosomal protein L33p @ LSU ribosomal protein
L33p zinc-independent
Stringent starvation protein B
Glutathionylspermidine synthase (EC 6.3.1.8) / Glutathionylspermidine amidohydrolase (EC 3.5.1.78);Ontology_term
SSU ribosomal protein S21p
Soluble lytic murein transglycosylase (EC 4.2.2.n1)
Uncharacterized protein YbfG
Nucleoid-associated protein YaaK
Uncharacterized protease YegQ
Uracil permease @ Uracil:proton symporter UraA
LSU ribosomal protein L20p
Chaperone protein HscA
Phosphatidylserine decarboxylase (EC 4.1.1.65);Ontology_term

143

fig|6666666.571729.peg.1800 Glutamyl-tRNA synthetase (EC 6.1.1.17);Ontology_term
fig|6666666.571729.peg.226 Threonine dehydratase biosynthetic (EC 4.3.1.19);Ontology_term
fig|6666666.571729.peg.1013 LSU ribosomal protein L25p
fig|6666666.571729.peg.948 Ferric uptake regulation protein FUR
fig|6666666.571729.peg.1305 Threonyl-tRNA synthetase (EC 6.1.1.3);Ontology_term

Table S2.8: H. parainfluenzae genes induced in in vitro coculture and in vivo metatranscriptome Jorth et al., (2014)
id
Description
fig|6666666.571729.peg.1083 Peptide transport system ATP-binding protein sapF (TC
3.A.1.5.5)
fig|6666666.571729.peg.747 Type IV pilin PilA
fig|6666666.571729.peg.656 hypothetical protein
fig|6666666.571729.peg.1288 Type III restriction-modification system methylation subunit (EC 2.1.1.72);Ontology_term
fig|6666666.571729.peg.40
Hydroxymethylpyrimidine ABC transporter transmembrane component
fig|6666666.571729.peg.1084 Peptide ABC transporter ATP-binding protein SapD
fig|6666666.571729.peg.1446 Allophanate hydrolase 2 subunit 2 (EC 3.5.1.54);Ontology_term
fig|6666666.571729.peg.25
AAA+ ATPase superfamily protein YifB/ComM associated with DNA recombination
fig|6666666.571729.peg.254 hypothetical protein
fig|6666666.571729.peg.1645 DNA ligase
fig|6666666.571729.peg.583 FIGfam138462: Acyl-CoA synthetase AMP-(fatty) acid
ligase
fig|6666666.571729.peg.160 hypothetical protein
fig|6666666.571729.peg.1223 Exodeoxyribonuclease V beta chain (EC 3.1.11.5);Ontology_term
fig|6666666.571729.peg.629 NADP-specific glutamate dehydrogenase (EC 1.4.1.4);Ontology_term
fig|6666666.571729.peg.32
Type IV pilus biogenesis protein PilM
fig|6666666.571729.peg.60
Glycerol uptake facilitator protein
fig|6666666.571729.peg.1192 Micrococcal nuclease (thermonuclease) homologs
fig|6666666.571729.peg.95
Phosphoribosylformylglycinamidine synthase synthetase
subunit (EC 6.3.5.3) / Phosphoribosylformylglycinamidine
synthase glutamine amidotransferase subunit (EC
6.3.5.3);Ontology_term
fig|6666666.571729.peg.279 Ribonuclease BN
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fig|6666666.571729.peg.687
fig|6666666.571729.peg.1141
fig|6666666.571729.peg.242
fig|6666666.571729.peg.102
fig|6666666.571729.peg.382
fig|6666666.571729.peg.649
fig|6666666.571729.peg.1287
fig|6666666.571729.peg.1163
fig|6666666.571729.peg.1475
fig|6666666.571729.peg.595
fig|6666666.571729.peg.18
fig|6666666.571729.peg.403
fig|6666666.571729.peg.61
fig|6666666.571729.peg.592
fig|6666666.571729.peg.322
fig|6666666.571729.peg.593
fig|6666666.571729.peg.648
fig|6666666.571729.peg.597
fig|6666666.571729.peg.173
fig|6666666.571729.peg.172
fig|6666666.571729.peg.1147
fig|6666666.571729.peg.475
fig|6666666.571729.peg.1258
fig|6666666.571729.peg.522
fig|6666666.571729.peg.119
fig|6666666.571729.peg.1122
fig|6666666.571729.peg.1372
fig|6666666.571729.peg.134
fig|6666666.571729.peg.1681
fig|6666666.571729.peg.252
fig|6666666.571729.peg.693
fig|6666666.571729.peg.249

Phosphoribosylamine--glycine ligase (EC 6.3.4.13);Ontology_term
Succinyl-CoA ligase [ADP-forming] alpha chain (EC
6.2.1.5);Ontology_term
Fructose-16-bisphosphatase GlpX type (EC 3.1.3.11);Ontology_term
GALNS arylsulfatase regulator (Fe-S oxidoreductase)
LSU rRNA pseudouridine(746) synthase (EC 5.4.99.29) @
tRNA pseudouridine(32) synthase (EC 5.4.99.28);Ontology_term
hypothetical protein
Type III restriction-modification system restriction subunit
(EC 3.1.21.5);Ontology_term
14-alpha-glucan (glycogen) branching enzyme GH-13-type
(EC 2.4.1.18);Ontology_term
Aerobic respiration control sensor protein ArcB (EC
2.7.13.3);Ontology_term
FIG00847847: hypothetical protein
Oligopeptide ABC transporter permease protein OppB (TC
3.A.1.5.1)
hypothetical protein
Glycerol kinase (EC 2.7.1.30);Ontology_term
hypothetical protein
Patatin-like phospholipase
hypothetical protein
Mobile element protein
hypothetical protein
Putative ABC transporter of substrate X permease subunit I
Putative ABC transporter of substrate X ATP-binding subunit
UPF0115 protein YfcN
Transcriptional regulator AsnC family
hypothetical protein
23S rRNA (uracil(1939)-C(5))-methyltransferase (EC
2.1.1.190);Ontology_term
Chloride channel protein EriC
Phage integrase
ABC-type Fe3+-hydroxamate transport system periplasmic
component
Shikimate 5-dehydrogenase I alpha (EC 1.1.1.25);Ontology_term
hypothetical protein
hypothetical protein
hypothetical protein
Lysophospholipase L2 (EC 3.1.1.5);Ontology_term
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fig|6666666.571729.peg.1636 Putative DNA-binding protein in cluster with Type I restriction-modification system
fig|6666666.571729.peg.501 hypothetical protein
fig|6666666.571729.peg.323 DNA transformation protein TfoX
fig|6666666.571729.peg.1477 Uncharacterized protein MSMEG_6412
fig|6666666.571729.peg.969 Trehalose operon transcriptional repressor
fig|6666666.571729.peg.1916 Glycosyl transferase
fig|6666666.571729.peg.423 deoxyribose-phosphate aldolase( EC:4.1.2.4 );Ontology_term
fig|6666666.571729.peg.161 hypothetical protein
fig|6666666.571729.peg.1209 tRNA pseudouridine(65) synthase (EC 5.4.99.26);Ontology_term
fig|6666666.571729.peg.720 hypothetical protein
fig|6666666.571729.peg.730 Rod shape-determining protein RodA
fig|6666666.571729.peg.502 hypothetical protein
fig|6666666.571729.peg.855 Glutamine synthetase adenylyl-L-tyrosine phosphorylase
(EC 2.7.7.89) / Glutamate-ammonia-ligase adenylyltransferase (EC 2.7.7.42);Ontology_term
fig|6666666.571729.peg.1078 Aspartokinase (EC 2.7.2.4);Ontology_term
fig|6666666.571729.peg.470 hypothetical protein
fig|6666666.571729.peg.525 D-glycerate transporter (predicted)
fig|6666666.571729.peg.1189 Zn-ribbon-containing possibly nucleic-acid-binding protein
fig|6666666.571729.peg.1786 tRNA(Ile)-lysidine synthetase (EC 6.3.4.19);Ontology_term
fig|6666666.571729.peg.866 beta-galactosidase (EC 3.2.1.23);Ontology_term
fig|6666666.571729.peg.960 Inner membrane protein YedI
fig|6666666.571729.peg.1017 Cell division inhibitor Slr1223 (YfcH in EC) contains epimerase/dehydratase and DUF1731 domains
fig|6666666.571729.peg.578 FIG021862: membrane protein exporter
fig|6666666.571729.peg.1011 CRISPR-associated endonuclease Cas9
fig|6666666.571729.peg.176 Sodium-dependent anion transporter family
fig|6666666.571729.peg.1248 Vitamin B12 ABC transporter permease protein BtuC
fig|6666666.571729.peg.19
Oligopeptide ABC transporter permease protein OppC (TC
3.A.1.5.1)
fig|6666666.571729.peg.689 hypothetical protein
fig|6666666.571729.peg.1260 hypothetical protein
fig|6666666.571729.peg.258 Tyrosine-specific transport protein
fig|6666666.571729.peg.148 Nitrate/nitrite response regulator protein NarP
fig|6666666.571729.peg.21
Oligopeptide ABC transporter ATP-binding protein OppF
(TC 3.A.1.5.1)
fig|6666666.571729.peg.1140 Succinyl-CoA ligase [ADP-forming] beta chain (EC
6.2.1.5);Ontology_term
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fig|6666666.571729.peg.1235 Oligopeptide/dipeptide ABC transporter permease protein /
Oligopeptide/dipeptide ABC transporter ATP-binding protein
fig|6666666.571729.peg.1631 AAA ATPase central region
fig|6666666.571729.peg.763 Phosphatidate cytidylyltransferase (EC 2.7.7.41);Ontology_term
fig|6666666.571729.peg.653 Phosphoserine phosphatase (EC 3.1.3.3);Ontology_term
fig|6666666.571729.peg.1236 Oligopeptide ABC transporter ATP-binding protein OppF
(TC 3.A.1.5.1)
fig|6666666.571729.peg.104 Choline-sulfatase (EC 3.1.6.6);Ontology_term
fig|6666666.571729.peg.965 Permease of the drug/metabolite transporter (DMT) superfamily

Table S2.9: H. parainfluenzae genes repressedin in vitro coculture and in vivo metatranscriptome Jorth et al., (2014)
id
fig|6666666.571729.peg.1646
fig|6666666.571729.peg.905
fig|6666666.571729.peg.1013
fig|6666666.571729.peg.1850
fig|6666666.571729.peg.1409
fig|6666666.571729.peg.1884
fig|6666666.571729.peg.73
fig|6666666.571729.peg.948
fig|6666666.571729.peg.1793
fig|6666666.571729.peg.903
fig|6666666.571729.peg.338
fig|6666666.571729.peg.1737
fig|6666666.571729.peg.906
fig|6666666.571729.peg.1340
fig|6666666.571729.peg.353
fig|6666666.571729.peg.1811
fig|6666666.571729.peg.1482
fig|6666666.571729.peg.1733

Description
Thioredoxin
Chaperone protein DnaK
LSU ribosomal protein L25p
FIG002060: uncharacterized protein YggL
Outer membrane stress sensor protease DegQ serine protease
Nucleoid-associated protein YaaK
Purine nucleoside phosphorylase (EC 2.4.2.1);Ontology_term
Ferric uptake regulation protein FUR
Membrane protein involved in the export of O-antigen and
teichoic acid
O-acetylhomoserine sulfhydrylase (EC 2.5.1.49) @ O-succinylhomoserine sulfhydrylase (EC 2.5.1.48);Ontology_term
Hybrid peroxiredoxin hyPrx5 (EC 1.11.1.15);Ontology_term
tRNA (cytidine(32)/uridine(32)-2'-O)-methyltransferase
(EC 2.1.1.200);Ontology_term
hypothetical protein
Transcription elongation factor GreA
hypothetical protein
Methionine repressor MetJ
hypothetical protein
Iron-sulfur cluster assembly iron binding protein IscA
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fig|6666666.571729.peg.1858 Glutathionylspermidine synthase (EC 6.3.1.8) / Glutathionylspermidine amidohydrolase (EC 3.5.1.78);Ontology_term
fig|6666666.571729.peg.142 Ketol-acid reductoisomerase (NADP(+)) (EC 1.1.1.86);Ontology_term
fig|6666666.571729.peg.1108 hypothetical protein
fig|6666666.571729.peg.1168 67-dimethyl-8-ribityllumazine synthase (EC 2.5.1.78);Ontology_term
fig|6666666.571729.peg.764 Alanine transaminase (EC 2.6.1.2);Ontology_term
fig|6666666.571729.peg.57
L-cystine ABC transporter substrate-binding protein TcyA
fig|6666666.571729.peg.430 33 kDa chaperonin HslO
fig|6666666.571729.peg.904 hypothetical protein
fig|6666666.571729.peg.1728 Protein IscX believed to be involved in assembly of Fe-S
clusters
fig|6666666.571729.peg.1929 SOS-response repressor and protease LexA (EC
3.4.21.88);Ontology_term
fig|6666666.571729.peg.1316 Stringent starvation protein B
fig|6666666.571729.peg.666 UPF0394 inner membrane protein YeeE
fig|6666666.571729.peg.632 Twin-arginine translocation protein TatB
fig|6666666.571729.peg.1123 Pyruvate kinase (EC 2.7.1.40);Ontology_term
fig|6666666.571729.peg.1464 GTP cyclohydrolase II (EC 3.5.4.25);Ontology_term
fig|6666666.571729.peg.1214 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabA
form (EC 4.2.1.59) @ Trans-2-decenoyl-[acyl-carrier-protein] isomerase (EC 5.3.3.14);Ontology_term
fig|6666666.571729.peg.226 Threonine dehydratase biosynthetic (EC 4.3.1.19);Ontology_term
fig|6666666.571729.peg.841 Nitric-oxide reductase (EC 1.7.99.7) quinol-dependent;Ontology_term
fig|6666666.571729.peg.1861 Phosphatidylserine decarboxylase (EC 4.1.1.65);Ontology_term
fig|6666666.571729.peg.980 hypothetical protein
fig|6666666.571729.peg.1303 Translation initiation factor 3
fig|6666666.571729.peg.871 DNA polymerase III chi subunit (EC 2.7.7.7);Ontology_term
fig|6666666.571729.peg.359 SSU ribosomal protein S19p (S15e)
fig|6666666.571729.peg.1643 Arginine ABC transporter ATP-binding protein ArtP
fig|6666666.571729.peg.1741 Tol biopolymer transport system TolR protein
fig|6666666.571729.peg.1338 23S rRNA (uridine(2552)-2'-O)-methyltransferase (EC
2.1.1.166);Ontology_term
fig|6666666.571729.peg.1516 Thiol peroxidase Tpx-type (EC 1.11.1.15);Ontology_term
fig|6666666.571729.peg.1644 D-sedoheptulose 7-phosphate isomerase (EC 5.3.1.28);Ontology_term
fig|6666666.571729.peg.1587 Ribonucleotide reductase of class III (anaerobic) large subunit (EC 1.17.4.2);Ontology_term
fig|6666666.571729.peg.69
hypothetical protein
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fig|6666666.571729.peg.1305 Threonyl-tRNA synthetase (EC 6.1.1.3);Ontology_term
fig|6666666.571729.peg.989 Iron compound ABC transporter permease protein
fig|6666666.571729.peg.1341 D-alanyl-D-alanine carboxypeptidase (EC 3.4.16.4);Ontology_term
fig|6666666.571729.peg.1096 Thiol:disulfide interchange protein DsbC
fig|6666666.571729.peg.949 Flavodoxin 1
fig|6666666.571729.peg.1494 Deoxycytidine triphosphate deaminase (EC 3.5.4.13);Ontology_term
fig|6666666.571729.peg.358 LSU ribosomal protein L2p (L8e)
fig|6666666.571729.peg.1602 FIG024746: hypothetical protein
fig|6666666.571729.peg.1729 Ferredoxin 2Fe-2S
fig|6666666.571729.peg.496 2-haloalkanoic acid dehalogenase (EC 3.8.1.2);Ontology_term
fig|6666666.571729.peg.1566 UPF0307 protein YjgA

Figure S2.1: Total bacteria and H. parainfluenzae density relative to S. mitis. Bar heights
represent the mean densities of (A) Eub338-labeled bacteria and (B) H. parainfluenzae with
respect to the mean S. mitis densities for 16,205 blocks of 6.64 μm by 6.64 μm, from 41 fields
of view. The number of blocks for each range of S. mitis densities is shown in S1A. The error
bars represent ± 1 standard error.
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Figure S2.2: H. parainfluenzae H O detoxification aids S. mitis growth. (A) S. mitis CFU
2

2

when cocultured with H. parainfluenzae WT and indicated H O resistance gene deletion mu2

2

tants. Data are mean CFU, error bars indicate standard deviation for n=3. *denotes p< 0.001
by Student's t-test compared to monoculture CFU. (B) S. mitis CFU in mono and coculture
with the addition of 20U/ml of exogenous catalase following incubation for 24 hours. (C)
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CFU counts of S. mitis (Sm) and the pyruvate oxidase mutant of S. mitis (𝛥spxB) in mono and
coculture with wildtype H. parainfluenzae (Hp). Hp had an initial inoculum of 4.65 x 10

6

CFU/ml. Wildtype (Sm) and S. mitis 𝛥spxB with initial inoculums of 2.45x10 , 1.55x10 or
5

6

3.45x10 CFU/ml. Data are mean CFU and error bars indicate standard deviation for n≥3. *de6

notes p< 0.05 by Student's t-test compared to monoculture.

A
B

Figure S2.3: H. parainfluenzae transcriptional response to S. mitis. (A) Pathways induced
in H. parainfluenzae when cocultured with S. mitis based on number of genes that have > 2fold increase in expression. (B) Pathways repressed when H. parainfluenzae is cocultured with
S. mitis based on a 2-fold decrease in coculture.
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Table S2.10: DNA FISH probes
Probe

Fluorophore

Target Taxon

Probe Sequence 5’-3’

Reference

Eub338

Dual At655

Bacteria (domain)

GCTGCCTCCCGTAGGAGT

Amann et al. 1990

Pas111

Dual Dy615

Pasteurallaceae (family)

TCCCAAGCATTACTCACC

Valm et al. 2011

Str405

RRX

Streptococcus (genus)

TAGCCGTCCCTTTCTGGT

Paster et al. 1998

Smit651

Dual Dy415

S. mitis

CCCCTCTTGCACTCAA

Wilbert et al. 2020

Hpar441

Dual Dy490

H. parainfluenzae

ACTAAATGCCTTCCTCGCTAC

this paper

Table S2.11: Strains used in this study
Plasmids

Identifier

Host

pDP863K

MR0203

NEB5-ɑ

pDP865K

MR0259

NEB5-ɑ

pDP801K

MR0275

NEB5-ɑ

pDP111K

MR0307

NEB5-ɑ

pDP821K

MR0314

NEB5-ɑ

pEAKO
pKC865
K

MR0254

NEB5-ɑ

MR0323

NEB5-ɑ

pDP863C

MR0339

NEB5-ɑ

Details
pMRKO (1) derivative used for the deletion of the
katA gene in H.parainfluenzae via allelic exchange
pMRKO derivative used for the deletion of the oxyR
gene in H.parainfluenzae via allelic exchange
A pMRKO derivative used for the deletion of the
ccp gene in H.parainfluenzae via allelic exchange
A pMRKO derivative used for the deletion of the
g6p gene in H.parainfluenzae via allelic exchange
A pMRKO derivative used for the deletion of the
pdgx gene in H.parainfluenzae via allelic exchange
pMRKO containing a sacB cassette used in generating clean deletion vectors
A pEAKO derivative used for the deletion of the prx
gene in H.parainfluenzae via clean deletion
A pEAKO derivative used for the deletion of the
katA gene in H.parainfluenzae via markerless deletion.
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Species
E. coli
E. coli
Haemophilus
parainfluenzae
Haemophilus
parainfluenzae
Haemophilus
parainfluenzae
Haemophilus
parainfluenzae
Haemophilus
parainfluenzae
Haemophilus
parainfluenzae
Haemophilus
parainfluenzae
Haemophilus
parainfluenzae
Haemophilus
parainfluenzae

Identifier
MR0142

Strain
NEB5-ɑ
MFD-pir

Details
Cloning strain (New England Biolabs)
Donor strain (2), Diaminopimelic acid auxotroph.

MR0160

ATCC
33392

Haemophilus parainfluenzae ATCC 33392TM

MR0205

ΔkatA

KatA deletion of H. parainfluenzae made via allelic
exchange with a kanamycin resistance gene.

ΔoxyR

OxyR deletion of H. parainfluenzae made via allelic
exchange with a kanamycin resistance gene.

Δccp

Cytochrome C Peroxidase deletion of H. parainfluenzae made via allelic exchange with a kanamycin
resistance gene.

Δg6p

Glucose-6 phosphate dehydrogenase deletion of H.
parainfluenzae made via allelic exchange with a
kanamycin resistance gene.

Δpdgx

Peroxiredoxin/Glutaredoxin deletion of H. parainfluenzae made via allelic exchange with a kanamycin resistance gene.

S. mitis
S. mitis

MR0181
MR0289

MR0266

MR0277

MR0312

MR0316

MR0341

Δprx

MR0406

ΔccpkatA

MR0359

ΔprxkatA
ATCC
49456
ΔspxB

Peroxiredoxin deletion of H. parainfluenzae made
via markerless deletion using sucrose counterselection.
Catalase and Cytochrome C peroxidase double deletion, constructed using the markerless deletion of the
catalase gene in the Δccp strain of H. parainfluenzae.
Peroxiredoxin and Catalase double deletion, constructed using the markerless deletion of the catalase
gene in the Δprx strain of H. parainfluenzae.
Streptococcus mitis ATCC 49456TM
Pyruvate oxidase deletion of S. mitis (3)
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Gene deletion in H. parainfluenzae
1kb flanking regions of the target gene were amplified via PCR using Q5 High-fidelity 2X Mastermix and primers indicated in Table S9. For allelic exchange, these fragments were assembled
to flank a kanamycin resistance cassette via isothermal assembly using the NEBuilder HiFi
DNA Assembly MasterMix (New England Biolabs) and cloned into pMRKO. This resulting
reaction was then transformed into NEB5α competent cells using the manufacturer's instructions
(New England Biolabs). Plasmid constructs were verified via restriction digests and Sanger sequencing. After screening, plasmids were transformed into the donor strain MFD-pir, using the
TSS transformation method (6).

These strains were then used to conjugate into H. parainfluenzae. Briefly, washed cells of H.
parainfluenzae overnight cultures were subjected to heat-shock (46°C for 6 minutes) and combined with the donor strain by spread plating on a BHI-YE HP agar plate supplemented with
0.3 mM di-amino pimelate (DAP). Plates were then incubated overnight at 37°C in 5% CO .
2

Cells were then harvested, and dilutions were plated on BHI-YE HP with 40 µg/ml of kanamycin and incubated for 24-48 hours at 37°C in 5% CO . Mutants were then screened by testing
2

for sensitivity to spectinomycin (spectinomycin resistance cassette on pMRKO backbone), PCR
and Sanger sequencing.

The markerless deletion of genes in H. parainfluenzae involved modifications to the above protocol. 1kb flanking regions were amplified and cloned into a pMRKO derivative containing a
sacB gene (pEAKO - Table S8). Plasmids were then transformed into H. parainfluenzae via
conjugation as described above. After transformation, cells were subjected to counterselection
by plating on BHI-YE HP containing 10% sucrose for 4-5 days. Mutants were then screened
via PCR and Sanger sequencing.
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Image Analysis
To allow quantitative analysis of the spatial distribution of the taxa of interest, we used FIJI to
create binarized S. mitis, H. parainfluenzae, and bacterial mass images. A slight misalignment
of the Smit651 channel was brought into closer alignment with the other channels by shifting it
up by 2 pixels, cropping 3 pixels off each edge, and re-scaling the channel image to regain the
original 2,048 by 2,048 resolution. The noise in each channel was reduced by applying a median
filter with a radius of 3 pixels. To create a bacterial biomass mask, the Eub338 channel was
automatically segmented by thresholding with the global Otsu method (7) and dilating the segmented area by 3 pixels. The S. mitis channel was created by segmenting the Str405 and Smit651
channels with the local Bernsen and global RenyiEntropy automatic thresholding methods, respectively (8,9). Both segmented images were combined using the Boolean "AND" operator to
retain the pixels appearing in both images. The H. parainfluenzae channel was created by segmenting the Pas111 and Hpar441 channels with the local Bernsen and global RenyiEntropy
automatic thresholding methods, respectively. Both segmented images were combined using
the Boolean "AND" operator. To ensure that there was a sufficiently large area of H. parainfluenzae in the images for reliable analysis, only the 41 fields of view in which at least 1% of the
bacteria mass was covered by H. parainfluenzae in the associated binary image were used for
the following analyses.
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Abstract

The abundant commensal bacterium, Haemophilus parainfluenzae has been shown to
be closely associated with hydrogen peroxide producing Streptococcus sp. in vivo. The
response of H. parainfluenzae to streptococci-produced hydrogen peroxide revealed a
redundant OxyR-controlled mechanism of dealing with this antimicrobial. Little is
known about the mechanism of how H. parainfluenzae achieves this redundancy and
why it evolved in this manner. Through transcriptome analyses we discovered that there
appears to be a reduced preference for catalase, suggesting a mechanism for its redundancy which is currently under further investigation. The overall effects of being exposed to H2O2 on a consistent basis is not known. However, studies in other species
have shown that H2O2 can induce the SOS response, which has been shown to be a
mechanism of generating genetic diversity as a means of surviving stress. Interestingly,
H. parainfluenzae has been shown to possess a high degree of strain variation within
the human oral cavity. We observed that H. parainfluenzae appears to elicit an SOSlike response to H2O2 based on transcriptome analyses, suggesting a potential mechanism for genetic diversity seen within this species.
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Introduction
Haemophilus parainfluenzae is a Gram-negative facultative anaerobe and commensal
of the human nasopharynx and oral cavity (1,2). It has previously been shown to be
found in close proximity to Mitis group Streptococci in supragingival plaque and are
found to overlap in other sites of the oral cavity and nasopharynx (2,3). Mitis group
Streptococci are known to rapidly consume high-energy carbohydrates and produce
the inhibitory anti-microbial, hydrogen peroxide (H2O2) and use it as a competitive advantage against other species. Therefore, in order to constantly co-exist alongside Mitis group Streptococci, H. parainfluenzae would need to tolerate H2O2. We have previously shown that H. parainfluenzae can tolerate S. mitis produced H2O2 except at
high S. mitis inoculums and that H. parainfluenzae’s response to H2O2 involves a redundant system involving multiple genes that aid in detoxification of H2O2, which is
in contrast to other closely related species (2). The mechanism by which H. parainfluenzae achieves this redundancy and what benefit this type of system bestows is currently unknown and warrants investigation.
To examine the overall response to H2O2, we carried out transcriptome analyses to determine the genes that are affected following the deletion of oxyR, the transcriptional
regulator that controls response to H2O2. These data indicated that catalase is not the
gene most affected by loss of oxyR, which is in contrast to close relatives like H. influenzae where loss of oxyR results in a 334-fold loss in catalase expression (4), compared to a 35-fold decline in H. parainfluenzae. This is consistent with our previous
findings where catalase is redundant in this species (2). We also demonstrated that
overexpression of catalase (katA), in an oxyR deletion mutant (DoxyR) generated a
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strain more resistant to H2O2 than wildtype, suggesting that the regulation of catalase
could explain its redundancy. Therefore, we sought to examine the OxyR regulon by
carrying out Chromatin Immunoprecipitation sequencing (ChIPSeq); however, we
found that C-terminal tagging of OxyR resulted in either the tag being inaccessible or
affected the function of the protein, preventing binding of the tagged protein to DNA,
preventing us from further investigation. Further work is currently being done to evaluate this hypothesis and new tag types need to be tested.

A key feature about H. parainfluenzae in vivo is that there is a high degree of genome
variability within this species that has resulted in strain specific niche associations
(5,6). Given that H. parainfluenzae is found in close association with Mitis group
Streptococci and is found in the same host body sites, it would be interesting to determine whether Streptococcus sp. produced H2O2 could play a role in the genetic diversity seen in strains of H. parainfluenzae. Apart from its anti-microbial activity, H2O2
can have other effects on a cell. It has been shown to result in DNA damage, including
the formation of double and single-strand breaks (7,8). The addition of H2O2 has been
shown to induce the SOS response in Escherichia coli which can result in mutagenesis
(9). In fact, the induction of the SOS system in E. coli has been implicated in the generation of a transient genome-wide state of hypermutation that can be induced as a
mechanism of generating genetic variability in times of stress (10). The overall effects
of H2O2 on H. parainfluenzae are currently unknown despite H2O2 likely being a frequent feature of H. parainfluenzae’s microenvironment due to its proximity to Streptococcus sp.
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To investigate this, we re-examined previous transcriptome analyses (2) that suggested
that when H. parainfluenzae is cocultured with S. mitis aerobically there appears to be
induction of an SOS-like response involving DNA polymerase IV (DNA pol IV)
among other genes. DNA pol IV is a low fidelity polymerase that lacks proof reading
activity and has thus been shown to be an important component of the SOS response(11). This response is similar to mechanisms of induced mutagenesis seen with
E. coli in response to H2O2 (12,13); however, the lack of induction of key genes including recA suggested only partial induction of this system. This was corroborated by
our assays involving experimentally evolved strains of H. parainfluenzae that suggested that there were only minor changes in the genome following a coculture period
of 30 days (this paper). Further transcriptome analyses showed induction of a more
complete SOS-like response following addition of H2O2, suggesting that the concentration of S. mitis used in the previous assays may have been insufficient to induce a
complete response.

Results
H. parainfluenzae redundant H2O2 response is influenced by OxyR
To determine which genes are controlled either directly or indirectly by OxyR, we carried out transcriptome comparisons via RNASeq following addition of a sublethal
dose of H2O2 in wildtype H. parainfluenzae vs a strain lacking the regulator OxyR
(DoxyR). We observed the induction of 23 genes and repression of 46 genes when
comparing DoxyR to wildtype (Table S1-S2). The gene most affected by loss of OxyR
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is oxyR itself (63-fold), suggesting a mechanism of autoregulation, which is a consistent property of many LysM- type regulators (14). The expression of DNA protection during starvation (dps) is increased 37-fold in wildtype compared to DoxyR while
catalase (katA) is increased 20-fold. Other enzymes capable of reacting with H2O2 are
also significantly induced more that 3-fold, including peroxiredoxin (prx) and cytochrome C peroxidase (ccp). This response appears to contrast that of H. influenzae
where catalase is the gene most affected (334-fold) following loss of OxyR (4), suggesting a reduced preference for catalase in H. parainfluenzae. Genes involved in the
pentose phosphate pathway are also significantly induced greater than 2-fold including
glucose-6-phosphate dehydrogenase (g6pD), 6-phosphogluconolactonase, transketolase, transaldolase. This is consistent with autoregulation of OxyR as NADPH produced by the pentose phosphate is important for the activity of glutathione reductase
(4-fold increased in wildtype), which along with glutaredoxin (4-fold increase) and
thioredoxin (2.5-fold increase) are involved in the reduction of OxyR, which is important for recycling OxyR (15). The gene with the greatest repression in wildtype
compared to DoxyR is an iron transport system permease (fecD), repressed 3.8-fold,
while a few other transporters involved in lipid and fatty acid metabolism are also repressed (Table S2).

Regulation of genes by OxyR enables redundant response to H2O2

To rule out the possibility of a malfunctioning catalase being responsible for catalase
redundancy in H. parainfluenzae, we expressed katA in trans, under the control of a
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strong constitutively active promoter in theDoxyR strain background. This generated a
strain four-times more tolerant to H2O2 than the wildtype (Fig. 1), demonstrating that
the catalase protein is functional, and that it is likely the mechanism of catalase regulation that is responsible for its reduced importance in this species.

As previous data indicated that deletion of oxyR was essential for survival of H.
parainfluenzae following exposure to S. mitis produced H2O2, but deletion of katA and
multiple other genes showed no effects(2), it is important to determine whether these
genes are under the control of OxyR. To determine whether catalase and other genes
involved in H2O2 detoxification are likely directly controlled by the same regulator, we
carried out a motif prediction analysis using the tool MEME (16). This suggested that
genes including katA, prx and ccp contained a putative protein binding site with similarities to that of an OxyR binding site in other species (Fig. 3), however there also appears to be some redundancy in this potential consensus site. As expected OxyR itself
contains a domain that is predicted to bind to DNA in a helix-turn-helix conformation,
based on computational prediction (data not shown).

In order to confirm the identity of the genes that are directly controlled by OxyR and
to quantify the relative occupancies of OxyR at different location we attempted to
carry out ChIPSeq (chromatin immunoprecipitation sequencing). This initially involved generating a strain of H. parainfluenzae with the chromosomal copy of oxyR
modified to encode OxyR with a vesicular stomatitis virus-glycoprotein (VSV-G)
epitope tag fused to the C-terminal end of the protein. The construction of this strain
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was confirmed by sequencing. Chromatin Immunoprecipitation quantitative-polymerase chain reaction (ChIP-qPCR) was then carried out to look for enrichment of known
OxyR controlled genes. However, after several attempts we failed to observe enrichment of katA, dps or oxyR following ChIP (Table 1), suggesting that either OxyR does
not control these genes or that the OxyR VSV-G tag cannot be accessed. To rule out
the latter, we constructed a strain where oxyR was modified to encode OxyR with a
tandem affinity purification (TAP) epitope tag. However, this resulted in a phenotype
similar to that of DoxyR (Fig. 2), indicating that the function of OxyR is severely affected by the presence of the TAP tag. Due to time constrains we decided to find alternative methods of testing our hypotheses.

The addition of H2O2 elicits an SOS response in H. parainfluenzae

Apart from resulting in the induction of the OxyR regulon, H2O2 can have other effects
on the cell. To determine the effects of H2O2 on H. parainfluenzae we compared the
transcriptomes of H. parainfluenzae grown aerobically with the addition of H2O2 to a
strain grown aerobically without addition of H2O2 (Table S3-S4). This showed the significant induction of 313 genes greater than 2-fold (Table S3). Unsurprisingly, this included genes typically induced by H2O2 including dps and g6pD, prx and iron transporters, notably katA was not induced, suggesting maximal induction of catalase without addition of exogenous H2O2. Interestingly, we observed induction of genes that
suggest initiation of an SOS-like response. This included induction of genes like DNA
polymerase IV (4.3-fold), inner membrane protein impA (4.5-fold), regulatory protein
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recX (4.2-fold), DNA repair proteins recN (3.2-fold) and recA (2-fold) as well as
genes involved in competence, including type IV pilin pilA (9.1-fold), type IV biogenesis protein pilM (3.4-fold), regulator of competence tfox (2.6-fold), competence protein comEC (4.5-fold). Induction of competence is a mechanism of DNA uptake and a
key component of horizontal gene transfer (17). Competence has also been shown to
be a mechanism of inducing the SOS-response in Vibrio cholerae (18), while H2O2 itself can trigger the SOS response in E.coli (19). DNA pol IV and RecA play key roles
in the SOS response (11,20) and its induction has been shown to be an important
mechanism of adaptation and diversification (21).

Coculture with S. mitis results in partial expression of genes involved in SOS response
due to H2O2 and only minor changes in protein coding sequences

We examined previously generated RNASeq data (2), that looked at gene expression
in H. parainfluenzae in coculture with S. mitis, compared to monoculture. This analysis indicated the induction of some of the genes implicated in the SOS response. This
includes pilA (10.9-fold), pilM (5.2-fold), tfox (4.0-fold), impA (2.2-fold), DNA pol IV
(2.0-fold) and competence protein comEA (2.9-fold). The expression of other key
genes including comEC and recA appear to be modestly higher in coculture; however,
this difference is not significant, suggesting variability between the coculture replicates or scant induction of the SOS system at the time of collection.
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H. parainfluenzae genome shows only minor changes following coculture with S. mitis

To determine whether H. parainfluenzae shows evidence of some level of diversification following coculture with S. mitis we analyzed reads generated from RNASeq experiments involving H. parainfluenzae in monoculture and coculture with S. mitis.
This analysis was carried out using the GATK pipeline (22) and involved detection of
single nucleotide polymorphisms (SNPs) and insertion-deletion (INDELs) in the reads
compared to the reference genome. This analysis detected only minor, insignificant
differences between the mono and coculture reads (Table 2).

Since the analysis of RNASeq reads involved only coding sequences and was carried
out following a single 24 hour mono or coculture incubation, we hypothesized that
there would be greater observable differences if the conditions involved multiple exposures to S. mitis and utilized whole genome sequencing and these differences were
due to S. mitis produced H2O2. We therefore subcultured H. parainfluenzae over a
course of 10 consecutive 24-hour periods of either mono or coculture with either
wildtype or S. mitis DspxB and examined whole genome sequences for sequentially
passaged strains vs the initial inoculum. This analysis showed no detectable SNPs in
monoculture or coculture with DspxB S. mitis. However, we detected 1 SNP in both
the replicates involving coculture with wildtype S. mitis (Table 3). We hypothesize
that more significant differences may be observed following a longer duration and this
is the subject of further investigation.
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Discussion

H. parainfluenzae is a commensal of the human oral cavity and is associated with beneficial immunomodulatory effects (23). Since H. parainfluenzae was previously shown
to coexist alongside the H2O2 producing Mitis group Streptococci (2), it is important
to understand the overall effects of H2O2 on H. parainfluenzae. Our findings reveal a
complex, redundant OxyR- controlled response to H2O2, that suggest a reduced affinity for catalase. We also observed what appears to be induction of an SOS response in
the presence of H2O2, however this appears to be attenuated in our coculture experimental design.

The transcriptional regulator, OxyR is responsible for the overall response to H2O2 in
many species including E. coli, Salmonella typhimurium and H. influenzae (24,25).
We therefore looked at the effects of the deletion of OxyR on H. parainfluenzae. We
previously showed that OxyR was essential for survival of H. parainfluenzae in coculture with S. mitis (2). In this study we looked at the genes affected by deletion of
OxyR, through transcriptome analysis. This suggested the autoregulation of OxyR as
the expression of oxyR was among the genes that were affected, which is consistent
with other OxyR systems (15,25). Genes involved in the reduction of oxidized OxyR
were also affected, suggesting that OxyR is involved in both activating and inactivat-
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ing its own response. The observation of oxyR being the gene most affected in this dataset is also interesting, as similar datasets in close relatives including H. influenzae
show catalase as being the gene most affected with over 300-fold effect in that species(4), while in H. parainfluenzae catalase is the 3rd most affected gene with a 20-fold
effect. This suggests that gene regulation by OxyR may be responsible for the redundant H2O2 response seen in H. parainfluenzae. This is further corroborated by the observation that the overexpression of catalase in the DoxyR strain resulted in a strain
that is more tolerant to H2O2 than wildtype, suggesting that catalase is sufficiently
functional, and that regulation may play a role in redundancy; however, plasmid copy
number and effects of being under a strong promoter may be factors that could limit
our inferences. To further evaluate this, we are currently working on generating a
strain of H. parainfluenzae, where the catalase gene has been replaced by catalase
from H. influenzae, which could absolve the limitations of the previous construct. To
evaluate whether regulation of catalase alone plays a role in redundancy we are currently working on replacing the catalase promoter region of H. parainfluenzae with the
catalase promoter region of H. influenzae to determine whether this increases the affinity of OxyR for the catalase promoter, and therefore, increase the relative expression of catalase.

Since H. parainfluenzae has been shown to possess a high degree of strain variation
(5,6) and is associated with the H2O2 producing Mitis group Streptococci we hypothesized that constant exposure to H2O2 might be a potential mechanism of genome diversification. We observed through transcriptome analyses that the addition of H2O2 to H.
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parainfluenzae induced the expression of genes implicated in the SOS response. This
response in other species has been shown to be a mechanism of generating genome diversity in response to stress (21). However, transcriptome analyses involving H.
parainfluenzae in mono or coculture with S. mitis showed only a handful of these
genes being expressed in coculture. Subsequently we didn’t observe any significant
differences in number of nucleotide changes between mono and coculture. We hypothesized that coculturing H. parainfluenzae with S. mitis over multiple passages would
enable us to see a greater number of nucleotide differences between mono and coculture. However, after 10 rounds of coculture with S. mitis we only observed 1 SNP in
each replicate. It is interesting to note that there were no SNPs in either monoculture
or coculture with DspxB. A potential flaw in this experimental design is that this involved a single colony being passaged overtime in either mono or coculture. We hypothesize that greater changes maybe observed if this assay involved a pool of colonies rather than a single colony as this would enable the detection of greater variation.

In this study, we investigated the effects of H2O2 on H. parainfluenzae and observed
differences in the OxyR regulon of H. parainfluenzae compared to closely related species suggesting that gene regulation by OxyR is responsible for the redundant response
to H2O2 we observed previously(2). We observed evidence of induction of the SOS response in H. parainfluenzae following the addition of H2O2 however, this was attenuated in coculture with S. mitis suggesting insufficient H2O2 production or exposure in
our experimental conditions, which was mirrored by our findings that failed to detect
any significant genome variability following coculture with S. mitis. We attempted an
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increased inoculum of S. mitis; however, we observed poor survival of H. parainfluenzae. Therefore, balancing survival and induction should be a key consideration in future experimental design.

Materials and Methods
Strains and Media
Strains and plasmids used in this study are listed in table 4. Unless indicated S. mitis
was cultured using Brain Heart Infusion BHI broth or solid agar supplemented with
Yeast extract (BHIYE). H. parainfluenzae was cultured using BHIYE, supplemented
with 14µg/ml Nicotinamide Adenine Dinucleotide (Sigma-Aldrich) and 14µg/ml Hemin (Sigma-Aldrich) - (BHIYE-HP). H. parainfluenzae and S. mitis were grown at
37℃ and 5% CO2. E. coli was grown on Luria broth (LB) at 37℃ in standard atmospheric conditions with liquid cultures shaken at 200 RPM. Antibiotics were used at the
following concentrations: Kanamycin 40µg/ml, and Spectinomycin 50µg/ml for E.
coli, 200µg/ml for H. parainfluenzae.

OxyR transcriptome sample preparation
RNASeq analyses were carried out on strains using a colony biofilm model (2,26).
Briefly, equal numbers of either wildtype or DoxyR H. parainfluenzae were spotted on
sterile 25mm 0.2µm polycarbonate membranes that were placed on BHIYE HP agar
plates. The plates were then incubated for 20 hours at 37℃ and 5% CO2, then transferred to fresh pre-warmed plates that were incubated for a further 4 hours. Thereafter,
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membranes were transferred to pre-warmed plates containing 50µM H2O2 and incubated for an additional 20 minutes. Membranes were then immediately placed in
RNAlater solution (AmbionTM). Experiments were carried out in biological duplicates.

RNA extraction and sequencing
RNA was extracted using the Direct-zolTM RNA MiniPrep Plus kit (Zymo Research)
according to manufacturer’s instructions. Ribsomal RNA was then depleted using the
Ribo-zero rRNA removal kit (Illumina) according to the manufacturer’s instructions.
The resulting products were then purified using the RNease MinElute cleanup kit (Qiagen). Library prep and sequencing were carried out as part of an Illumina RNA-Seq
library preparation workshop.

Transcriptome analyses
Genome data for H. parainfluenzae ATCC 33392 was obtained from NCBI and genome annotations were generated using RAST as previously described (2).
RNASeq reads were aligned, mapped and differentially expressed genes analyzed using our previously built pipeline, the RNASeq-analysis-toolkit (2).

Effects of catalase overexpression
The catalase gene of H. parainfluenzae was amplified and ligated into pJAK16
(ATCC) using gibson assembly, where it was placed under the control of a tac promoter which we had verified to be constitutively active in H. parainfluenzae. The re-
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sulting plasmid was then transformed into DoxyR H. parainfluenzae via electroporation as described previously (27). The Minimum inhibitory concentration for
H2O2 was then calculated via 2-fold serial dilutions.

OxyR VSV-G and TAP-tag strain construction
To determine the genes directly controlled by OxyR and quantify the relative occupancy of OxyR at different promoter regions, we sort to carry out ChIPSeq. To carry
out these experiments we sort to generate a strain of H. parainfluenzae containing a
VSV-G-tagged OxyR. A VSV-G-tagged OxyR was generated using a well-established
method of tagging proteins (28). Briefly, the last 381bp of oxyR and a DNA sequence
for the VSV-G protein were cloned into a non-replicating plasmid (pMRKO) using
Gibson assembly. To ensure accurate translation of the VSV-G tag, the DNA sequence
was generated after accounting for codon bias using the Kazusa tool (29). An alanine
linker separating the oxyR fragment and VSV-G epitope tag was also generated to ensure that the tag would be generated in frame. Cells in which a single homologous recombination event occurred were selected on Spectinomycin and sequenced to confirm the generation of OxyR-VSV-G genotypically. To ensure that the generation of
OxyR-VSV-G did not affect the function of OxyR we carried zone of inhibition assays
for H2O2 to confirm that the strain had similar sensitivity to wildtype H. parainfluenzae. The same process was carried out to generate OxyR-TAP tag.
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ChIP-qPCR of OxyR
To evaluate whether the OxyR tag is accessible and functioning as expected we sort to
carry out ChIP-qPCR. ChIP was carried out as outlined previously (30). Briefly, midlog cells of wildtype H. parainfluenzae and OxyR-VSV-G H. parainfluenzae treated
with 50mM H2O2 and OxyR-VSV-G H. parainfluenzae grown anaerobically were harvested and then crosslinked using 1% formaldehyde. Crosslinking was abated using
250mM Glycine. Cells were then washed with PBS and stored at -80°C. The resulting
pellets were then washed in sonication buffer (20mM KHEPES, 50mM Kcl, 0.5mM
DTT, 10% Glycerol and protease inhibitor). Cells were then sonicated at an amplitude
of 40% with a pulse setting of 6 seconds on, 2 seconds off using the Sonic Dismembrator Model 500 (Fisher). ChIP was then carried out in biological triplicate using
anti-VSV-G agarose beads (Sigma). Prior to ChIP, aliquots were obtained as input
controls. qPCR was then carried out to determine whether there was enrichment of
known OxyR controlled promoter sites following ChIP. We tested for the enrichment
of the promoter regions of katA, dps, oxyR vs enrichment for the control gene DNA
gyrase gyrA.

OxyR Motif prediction
To predict which genes are most likely to be directly controlled by OxyR we sort to
detect conserved motifs in the promoter region of genes that had the potential to be
controlled by OxyR. To determine these motifs we used regions 150bp upstream of
the starting site of all genes that had 3x greater expression in wildtype compared to
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DoxyR. These were then submitted to MEME (31) for the detection of conserved binding motifs.

Detection of SNPs and INDELs from coculture RNASeq reads
To evaluate the possibility of genomic variation following coculture we examined nucleotide differences following mono and coculture using reads generated from previous RNASeq experiments (2). This analysis was carried out using the best practices
principles and GATK analysis for the detection of RNASeq short variant discovery
(32). Briefly, this involved reads generated from biological duplicates of H. parainfluenzae in monoculture and coculture with S. mitis. These reads were then mapped to
the reference using Burrows-Wheeler Aligner (BWA) (33), duplicated reads condensed, quality recalibrated and variants called using the recommended tools within
the GATK best practices pipeline and package (32).

Detection of SNPs and INDELs in genome following multiple rounds of coculture
As the analysis of RNASeq reads failed to show significant differences between mono
and coculture we reasoned that this may have been due to the post hoc nature of our
experimental design, as we were examining nucleotide differences only in protein coding sequences following a single round of coculture. We hypothesized that we would
see greater differences if we were to examine whole genome sequences following
multiple rounds of coculture. In order to do this biological duplicates originating from

175

two colonies of H. parainfluenzae were cultured and passaged either through monoculture, coculture with S. mitis or coculture with DspxB S.mitis for 10 rounds of culture
using a colony biofilm model (2,34). The latter was carried out to determine whether
S. mitis produced H2O2 plays a role in any differences. Following the last round of culture, genomic DNA was isolated from the initial day 0 strains as well as the final day
strains generated from mono and coculture using the MasterPure Complete DNA kit
(Lucigen). The purified DNA was then submitted for Illumina sequencing at the Microbial Genome Sequencing Center, Pittsburgh, PA. The detection of SNPs and indels
were carried out using samtools and bcftools (35). Briefly, reads were aligned using
BWA (33), genomes indexed and likelihood scores calculated using samtools and variants called using bcftools.
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Figure 1: Effect of catalase overexpression on sensitivity to H2O2. Minimum inhibitory concentration assays for H2O2 were carried out on wildtype H. parainfluenzae

176

(WT), H. parainfluenzae lacking catalase (DkatA), OxyR (DoxyR) and overexpression
of catalase in DoxyR (katA+ DoxyR).

Table 1: qPCR for enrichment of different putative OxyR controlled promoter
regions

gyrA input
gyrA ChIP
katA input
katA ChIP
dps input
dps ChIP
oxyR input
oxyR ChIP

17.04
26.26
16.5
25.72
16.24
25.6
16.77
26.04

Cp Values
17.01
26.18
16.48
25.68
16.19
25.47
16.76
26

17
26.14
16.41
25.67
16.2
25.5
16.77
25.97

Figure 2: Zone of inhibition assays for H2O2. Zone of inhibition assays for H2O2
were carried out on (left to right) wildtype H. parainfluenzae (WT), H. parainfluenzae
lacking OxyR (DoxyR) and H. parainfluenzae OxyR-TAP tag.
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Figure 3: MEME motif prediction analysis of putative OxyR binding sites. Conserved putative OxyR binding sites were computationally predicted to be located
within 150bp of the start sites of katA, ccp, prx. Ambiguous nucleotides in the predicted binding motif are denoted by noncanonical base denominations (R=AG, Y=CT,
K=GT, M=AC, S=CG, W=AT, B=CGT, D=GAT, H=ACT, V=ACG) (16).
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Table 2: Quantification of SNPs in RNASeq reads in H. parainfluenzae following
mono and coculture with S. mitis.

Condition

Number of SNPs

H. parainfluenzae monoculture rep1

10

H. parainfluenzae monoculture rep2

12

H. parainfluenzae coculture with S.mitis rep1

50

H. parainfluenzae coculture with S. mitis rep2

14
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Table 3: Quantification of SNPs in H. parainfluenzae following mono and coculture with wildtype and DspxB S. mitis.
Condition

Number of
SNPs

H. parainfluenzae monoculture rep1

0

H. parainfluenzae monoculture rep2

0

H. parainfluenzae coculture with S.mitis rep1

1

H. parainfluenzae coculture with S. mitis rep2

1

H. parainfluenzae coculture with DspxB S.mitis rep1

0

H. parainfluenzae coculture with DspxB S. mitis rep2

0
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Appendix
Table S1: Genes induced in DoxyR compared to wildtype following addition of
H2O2
Fold
change

ID

fig|6666666.571729.peg.13
71
fig|6666666.571729.peg.84
3.23
7
fig|6666666.571729.peg.63
3.18
5
fig|6666666.571729.peg.18
3.13
40
3.76

3.12 fig|6666666.571729.peg.30
3.04
3.01
2.82
2.74
2.60
2.51
2.43

fig|6666666.571729.peg.15
90
fig|6666666.571729.peg.60
fig|6666666.571729.peg.14
43
fig|6666666.571729.peg.29
5
fig|6666666.571729.peg.17
48
fig|6666666.571729.peg.12
29
fig|6666666.571729.peg.29
6

fig|6666666.571729.peg.10
95
fig|6666666.571729.peg.17
2.30
6
fig|6666666.571729.peg.19
2.29
95
2.31

fig|6666666.571729.peg.12
2.28
14

Description
Iron(III) dicitrate transport system permease protein FecD (TC 3.A.1.14.1)
Long-chain-fatty-acid--CoA ligase (EC
6.2.1.3);Ontology_term
High-affinity choline uptake protein BetT
hypothetical protein
Competence protein C%3B Chromosome
segregation ATPases
Xanthine permease
Glycerol uptake facilitator protein
Cytosine permease
Lipid A export permease/ATP-binding
protein MsbA
Chromosome segregation ATPases
hypothetical protein
COG1132: ABC-type multidrug transport
system%2C ATPase and permease components
hypothetical protein
Sodium-dependent anion transporter family
Uncharacterized ferredoxin-like protein
YfhL
3-hydroxyacyl-[acyl-carrier-protein] dehydratase%2C FabA form (EC 4.2.1.59)
@ Trans-2-decenoyl-[acyl-carrier-protein]
isomerase (EC 5.3.3.14);Ontology_term
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2.18
2.18
2.10
2.05
2.03
2.00
2.00

fig|6666666.571729.peg.20
04
fig|6666666.571729.peg.24
1
fig|6666666.571729.peg.47
4
fig|6666666.571729.peg.12
74
fig|6666666.571729.peg.18
10
fig|6666666.571729.peg.31
3
fig|6666666.571729.peg.31
9

Diaminopimelate decarboxylase and/or diaminopimelate epimerase leader peptide
Cell division protein ZapB
Uncharacterized inner membrane protein
RarD
ABC-type Co2+ transport system%2C
periplasmic component
Transcriptional regulator%2C MerR family
TonB-dependent hemin%2C ferrichrome
receptor
Fluoride ion transporter CrcB

Table S2: Genes repressed in in DoxyR compared to wildtype following addition
of H2O2
Fold
change

ID

Description

-62.81

fig|6666666.571729.peg.33
7

Hydrogen peroxide-inducible genes activator > OxyR

-37.41

fig|6666666.571729.peg.12
32

DNA protection during starvation protein (dps)

-20.38

fig|6666666.571729.peg.14
59

Catalase KatA (EC 1.11.1.6);Ontology_term

-8.87

fig|6666666.571729.peg.40
1

Glucose-6-phosphate 1-dehydrogenase
(EC 1.1.1.49);Ontology_term

fig|6666666.571729.peg.92
9
fig|6666666.571729.peg.93
-7.01
0
-7.09

hypothetical protein
hypothetical protein

-6.31

fig|6666666.571729.peg.15
48

Alkyl hydroperoxide reductase subunit
C-like protein

-5.03

fig|6666666.571729.peg.17
00

Cytochrome c551 peroxidase (EC
1.11.1.5);Ontology_term

185

-4.52

fig|6666666.571729.peg.10
89

Superoxide dismutase [Cu-Zn] precursor (EC 1.15.1.1);Ontology_term

-4.34

fig|6666666.571729.peg.18
98

Glutathione reductase (EC 1.8.1.7);Ontology_term

-3.98

fig|6666666.571729.peg.86
7

Glutaredoxin 1

-3.69

fig|6666666.571729.peg.40
0

6-phosphogluconolactonase (EC
3.1.1.31)%2C eukaryotic type;Ontology_term

-3.59 fig|6666666.571729.peg.84

Aspartate--ammonia ligase (EC
6.3.1.1);Ontology_term

-3.59

fig|6666666.571729.peg.81
3

Manganese ABC transporter%2C ATPbinding protein SitB

-3.55

fig|6666666.571729.peg.11
26

Glucose-6-phosphate isomerase (EC
5.3.1.9);Ontology_term

-3.40

fig|6666666.571729.peg.14
64

GTP cyclohydrolase II (EC
3.5.4.25);Ontology_term

-3.18

fig|6666666.571729.peg.62
9

NADP-specific glutamate dehydrogenase (EC 1.4.1.4);Ontology_term

fig|6666666.571729.peg.93
1
fig|6666666.571729.peg.65
-3.16
5
-3.16

hypothetical protein
Transketolase (EC 2.2.1.1);Ontology_term

-2.95

fig|6666666.571729.peg.81
2

Manganese ABC transporter%2C inner
membrane permease protein SitC

-2.86

fig|6666666.571729.peg.39
9

DUF1176 domain-containing protein

-2.86

fig|6666666.571729.peg.14
30

NAD(P) transhydrogenase N-domain
of subunit alpha (EC 1.6.1.2) / NAD(P)
transhydrogenase C-domain of subunit
alpha (EC 1.6.1.2);Ontology_term

-2.78

fig|6666666.571729.peg.93
4

Pentapeptide repeat family protein

fig|6666666.571729.peg.20
-2.73
03
-2.65

fig|6666666.571729.peg.93
2

186

Frataxin homolog CyaY%2C facilitates
Fe-S cluster assembly%2C interacts
with IscS
hypothetical protein

-2.64

fig|6666666.571729.peg.81
4

fig|6666666.571729.peg.93
3
fig|6666666.571729.peg.77
-2.61
6
-2.62

Manganese ABC transporter%2C
periplasmic-binding protein SitA
hypothetical protein
NrfC protein

-2.57

fig|6666666.571729.peg.14
13

Exodeoxyribonuclease III (EC
3.1.11.2);Ontology_term

-2.50

fig|6666666.571729.peg.13
37

Cell division-associated%2C ATP-dependent zinc metalloprotease FtsH

-2.50

fig|6666666.571729.peg.16
46

Thioredoxin

-2.48

fig|6666666.571729.peg.82
6

-2.42 fig|6666666.571729.peg.16
fig|6666666.571729.peg.77
7
fig|6666666.571729.peg.94
-2.39
9
-2.41

ABC transporter involved in cytochrome c biogenesis%2C CcmB subunit
Transaldolase (EC 2.2.1.2);Ontology_term
Cytochrome c-type protein NrfB precursor
Flavodoxin 1

-2.36

fig|6666666.571729.peg.82
9

Cytochrome c-type biogenesis protein
CcmE%2C heme chaperone

-2.32

fig|6666666.571729.peg.14
29

NAD(P) transhydrogenase subunit beta
(EC 1.6.1.2);Ontology_term

fig|6666666.571729.peg.14
-2.30
12

DNA for glycosyltransferase%2C lytic
transglycosylase%2C dTDP-4-rhamnose reductase

fig|6666666.571729.peg.19
03

Fumarate reductase flavoprotein subunit (EC 1.3.5.4);Ontology_term

-2.29

fig|6666666.571729.peg.39
8
fig|6666666.571729.peg.14
-2.15
03
-2.26

fig|6666666.571729.peg.13
-2.10
92
-2.10

fig|6666666.571729.peg.77
5

187

DUF1176 domain-containing protein
Hydrogenase-4 component A
Formate dehydrogenase H (EC 1.2.1.2)
@ selenocysteine-containing;Ontology_term
NrfD protein

fig|6666666.571729.peg.66
-2.09
1
-2.05 fig|6666666.571729.peg.26
fig|6666666.571729.peg.66
-2.04
2

DEAD-box ATP-dependent RNA helicase DeaD ( CshA) (EC 3.6.4.13);Ontology_term
[4Fe-4S] cluster carrier protein NfuA
Lipoprotein NlpI

Table S3: Genes induced in H. parainfluenzae following addition of H2O2
Fold
change

ID

Description

34.51

fig|6666666.571729.peg.602

hypothetical protein

31.85

fig|6666666.571729.peg.1707

hypothetical protein

24.78

fig|6666666.571729.peg.1635

DNA translocase FtsK

19.94

fig|6666666.571729.peg.816

hypothetical protein

19.80

fig|6666666.571729.peg.1271

hypothetical protein

13.75

fig|6666666.571729.peg.1301

hypothetical protein

12.75

fig|6666666.571729.peg.941

Sulfate and thiosulfate binding protein CysP

11.05

fig|6666666.571729.peg.1232

DNA protection during starvation
protein

9.96

fig|6666666.571729.peg.888

Type II secretory pathway%2C pseudopilin PulG

9.89

fig|6666666.571729.peg.1893

Outer membrane receptor proteins%2C mostly Fe transport

9.80

fig|6666666.571729.peg.30

Competence protein C%3B Chromosome segregation ATPases

9.10

fig|6666666.571729.peg.747

Type IV pilin PilA
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8.98

fig|6666666.571729.peg.93

hypothetical protein

8.19

fig|6666666.571729.peg.1633

Serine/threonine protein phosphatase
(EC 3.1.3.16);Ontology_term

7.98

fig|6666666.571729.peg.159

hypothetical protein

7.75

fig|6666666.571729.peg.890

hypothetical protein

7.74

fig|6666666.571729.peg.842

hypothetical protein

fig|6666666.571729.peg.629

NADP-specific glutamate dehydrogenase (EC 1.4.1.4);Ontology_term

fig|6666666.571729.peg.677

Uncharacterized inner membrane
transporter YhbE

fig|6666666.571729.peg.1182

Bacterial ribosome SSU maturation
protein RimP

6.56

fig|6666666.571729.peg.1986

Cobalt/zinc/cadmium resistance protein CzcD

6.17

fig|6666666.571729.peg.1638

putative 5'(3')-deoxyribonucleotidase

6.12

fig|6666666.571729.peg.889

Type II secretory pathway%2C component PulJ

6.05

fig|6666666.571729.peg.586

Acyl carrier protein

6.02

fig|6666666.571729.peg.1631

AAA ATPase%2C central region

5.92

fig|6666666.571729.peg.1634

NAD-dependent protein deacetylase
of SIR2 family

5.85

fig|6666666.571729.peg.268

5.78

fig|6666666.571729.peg.942

5.60

fig|6666666.571729.peg.945

hypothetical protein
Precorrin-2 oxidase (EC 1.3.1.76) @
Sirohydrochlorin ferrochelatase activity of CysG (EC 4.99.1.4) / Uroporphyrinogen-III
methyltransferase
Sulfate
adenylyltransferase
subunit 1
(EC
2.1.1.107);Ontology_term
(EC 2.7.7.4);Ontology_term

fig|6666666.571729.peg.939

Sulfate transport system permease
protein CysW

7.56
7.50
6.93

5.48
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fig|6666666.571729.peg.41

Hydroxymethylpyrimidine ABC
transporter%2C ATPase component

fig|6666666.571729.peg.1780

Iron compound ABC uptake transporter permease protein

5.23

fig|6666666.571729.peg.1028

Inorganic triphosphatase (EC
3.6.1.25);Ontology_term

5.03

fig|6666666.571729.peg.1736

Iron-sulfur cluster regulator IscR

4.96

fig|6666666.571729.peg.678

Uncharacterized inner membrane
transporter YhbE

4.95

fig|6666666.571729.peg.431

4.93

fig|6666666.571729.peg.1636

4.80

fig|6666666.571729.peg.943

IroE protein
Putative DNA-binding protein in
cluster with Type I restriction-modification system
Adenylyl-sulfate reductase [thioredoxin] (EC 1.8.4.10);Ontology_term

4.79

fig|6666666.571729.peg.501

hypothetical protein

4.70

fig|6666666.571729.peg.366

LSU ribosomal protein L24p (L26e)

4.68

fig|6666666.571729.peg.1994

4.65

fig|6666666.571729.peg.2004

4.64

fig|6666666.571729.peg.1942

hypothetical protein
Diaminopimelate decarboxylase
and/or diaminopimelate epimerase
leader peptide
Ferric siderophore transport system%2C biopolymer transport protein ExbB

4.64

fig|6666666.571729.peg.502

4.60

fig|6666666.571729.peg.1288

4.56

fig|6666666.571729.peg.401

4.56

fig|6666666.571729.peg.1894

hypothetical protein
Type III restriction-modification system methylation subunit (EC
2.1.1.72);Ontology_term
Glucose-6-phosphate 1-dehydrogenase (EC 1.1.1.49);Ontology_term
TonB-dependent receptor%3B Outer
membrane receptor for ferrienterochelin and colicins

4.51

fig|6666666.571729.peg.913

ImpA

5.45
5.41

190

4.50

fig|6666666.571729.peg.1530

DNA internalization-related competence protein ComEC/Rec2

4.49

fig|6666666.571729.peg.339

hypothetical protein

4.47

fig|6666666.571729.peg.1302

hypothetical protein

fig|6666666.571729.peg.84

Aspartate--ammonia ligase (EC
6.3.1.1);Ontology_term

fig|6666666.571729.peg.1230

Sel1 domain protein repeat-containing protein

4.32

fig|6666666.571729.peg.1049

DNA polymerase IV (EC
2.7.7.7);Ontology_term

4.30

fig|6666666.571729.peg.1632

hypothetical protein

4.29

fig|6666666.571729.peg.1481

Putative permease

4.26

fig|6666666.571729.peg.940

Sulfate transport system permease
protein CysT

4.21

fig|6666666.571729.peg.320

Regulatory protein RecX

4.14

fig|6666666.571729.peg.1959

L-lactate dehydrogenase

4.12

fig|6666666.571729.peg.587

Acyl carrier protein

4.12

fig|6666666.571729.peg.407

hypothetical protein

4.12

fig|6666666.571729.peg.1408

4.11

fig|6666666.571729.peg.744

hypothetical protein
Leader peptidase (Prepilin peptidase)
(EC 3.4.23.43) / N-methyltransferase
(EC 2.1.1.-);Ontology_term

4.09

fig|6666666.571729.peg.691

hypothetical protein

4.07

fig|6666666.571729.peg.260

hypothetical protein

fig|6666666.571729.peg.601

Dialkylrecorsinol condensing enzyme

4.37
4.34

4.01

191

4.00

fig|6666666.571729.peg.92

hypothetical protein

3.96

fig|6666666.571729.peg.633

Twin-arginine translocation protein
TatA

3.92

fig|6666666.571729.peg.261

hypothetical protein

3.84

fig|6666666.571729.peg.672

hypothetical protein

3.80

fig|6666666.571729.peg.596

Efflux ABC transporter%2C ATPbinding protein

3.80

fig|6666666.571729.peg.208

Protein YihD

3.79

fig|6666666.571729.peg.72

hypothetical protein

3.79

fig|6666666.571729.peg.465

Integrase

3.79

fig|6666666.571729.peg.835

hypothetical protein

3.77

fig|6666666.571729.peg.1417

Na+/H+ antiporter

3.76

fig|6666666.571729.peg.186

Molybdopterin-guanine dinucleotide
biosynthesis protein MobB

3.72

fig|6666666.571729.peg.992

SSU ribosomal protein S15p (S13e)

3.71

fig|6666666.571729.peg.66

hypothetical protein

3.71

fig|6666666.571729.peg.907

hypothetical protein

3.71

fig|6666666.571729.peg.1149

Protein YecM

3.70

fig|6666666.571729.peg.464

3.69

fig|6666666.571729.peg.376

3.68

fig|6666666.571729.peg.1570

Integrase
LSU ribosomal protein L36p @ LSU
ribosomal protein L36p%2C zinc-dependent
PTS IIA-like nitrogen-regulatory
protein PtsN

192

fig|6666666.571729.peg.1852

Periplasmic nitrate reductase component NapD

3.68

fig|6666666.571729.peg.1985

Transcriptional regulator%2C MerR
family

3.68

fig|6666666.571729.peg.2011

16S rRNA processing protein RimM

3.67

fig|6666666.571729.peg.160

hypothetical protein

3.66

fig|6666666.571729.peg.162

hypothetical protein

3.64

fig|6666666.571729.peg.313

TonB-dependent hemin%2C ferrichrome receptor

3.62

fig|6666666.571729.peg.1482

hypothetical protein

3.60

fig|6666666.571729.peg.814

Manganese ABC transporter%2C
periplasmic-binding protein SitA

3.60

fig|6666666.571729.peg.597

hypothetical protein

3.60

fig|6666666.571729.peg.252

hypothetical protein

3.58

fig|6666666.571729.peg.1220

Anticodon nuclease

3.57

fig|6666666.571729.peg.1841

SAM-dependent methyltransferase

3.52

fig|6666666.571729.peg.254

hypothetical protein

3.68

3.52

fig|6666666.571729.peg.1743

3.51

fig|6666666.571729.peg.1412

Tol-Pal system-associated acyl-CoA
thioesterase
DNA for glycosyltransferase%2C
lytic transglycosylase%2C dTDP-4rhamnose reductase

3.50

fig|6666666.571729.peg.1238

RNA:NAD 2'-phosphotransferase

3.50

fig|6666666.571729.peg.1952

Carbonic anhydrase (EC 4.2.1.1);Ontology_term

3.49

fig|6666666.571729.peg.298

hypothetical protein
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3.49

fig|6666666.571729.peg.949

Flavodoxin 1

3.48

fig|6666666.571729.peg.256

hypothetical protein

3.47

fig|6666666.571729.peg.560

hypothetical protein

3.47

fig|6666666.571729.peg.1576

hypothetical protein

3.45

fig|6666666.571729.peg.269

3.44

fig|6666666.571729.peg.39

hypothetical protein
Hydroxymethylpyrimidine ABC
transporter%2C substrate-binding
component

3.42

fig|6666666.571729.peg.1601

FIG035246: DoxX family protein

fig|6666666.571729.peg.32

Type IV pilus biogenesis protein
PilM

fig|6666666.571729.peg.435

Biofilm PGA synthesis deacetylase
PgaB (EC 3.-)

3.39

fig|6666666.571729.peg.1779

Iron compound ABC uptake transporter permease protein

3.38

fig|6666666.571729.peg.879

LemA family protein

3.34

fig|6666666.571729.peg.1794

Intracellular septation protein IspA

3.32

fig|6666666.571729.peg.262

hypothetical protein

3.32

fig|6666666.571729.peg.1122

Phage integrase

3.29

fig|6666666.571729.peg.1656

hypothetical protein

3.29

fig|6666666.571729.peg.1943

Biopolymer transport protein
ExbD/TolR

3.28

fig|6666666.571729.peg.67

hypothetical protein

3.28

fig|6666666.571729.peg.1010

CRISPR-associated protein Cas1

3.40
3.40

194

3.25

fig|6666666.571729.peg.1806

Copper-sensing two-component system response regulator CpxR

3.23

fig|6666666.571729.peg.1438

hypothetical protein

3.23

fig|6666666.571729.peg.1445

Lactam utilization protein LamB

fig|6666666.571729.peg.1846

Transcriptional regulator%2C AcrR
family

3.21

fig|6666666.571729.peg.916

Putative molybdenum transport
ATP-binding protein modF

3.20

fig|6666666.571729.peg.470

hypothetical protein

3.20

fig|6666666.571729.peg.1231

Sel1-like repeat

3.19

fig|6666666.571729.peg.22

Membrane protein LAPB

3.19

fig|6666666.571729.peg.1584

DNA repair protein RecN

3.16

fig|6666666.571729.peg.592

3.12

fig|6666666.571729.peg.379

hypothetical protein
SSU ribosomal protein S4p (S9e) @
SSU ribosomal protein S4p
(S9e)%2C zinc-independent

3.11

fig|6666666.571729.peg.1579

Protein SprT

3.11

fig|6666666.571729.peg.253

hypothetical protein

3.09

fig|6666666.571729.peg.161

hypothetical protein

3.08

fig|6666666.571729.peg.1443

3.07

fig|6666666.571729.peg.1

3.07

fig|6666666.571729.peg.812

Cytosine permease
D-glycero-beta-D-manno-heptose1%2C7-bisphosphate 7-phosphatase
(EC 3.1.3.82);Ontology_term
Manganese ABC transporter%2C inner membrane permease protein SitC

3.05

fig|6666666.571729.peg.1185

Ribosome-binding factor A

3.22

195

3.03

fig|6666666.571729.peg.1460

3.02

fig|6666666.571729.peg.40

Na+/alanine symporter
Hydroxymethylpyrimidine ABC
transporter%2C transmembrane
component

3.02

fig|6666666.571729.peg.1654

hypothetical protein

fig|6666666.571729.peg.1291

Molybdopterin synthase sulfur carrier subunit

2.96

fig|6666666.571729.peg.1987

Dihydroneopterin aldolase (EC
4.1.2.25);Ontology_term

2.96

fig|6666666.571729.peg.503

hypothetical protein

2.96

fig|6666666.571729.peg.538

Glycosyltransferase

2.95

fig|6666666.571729.peg.877

Uncharacterized protein YdiJ

2.94

fig|6666666.571729.peg.535

hypothetical protein

2.93

fig|6666666.571729.peg.64

hypothetical protein

2.93

fig|6666666.571729.peg.369

SSU ribosomal protein S8p (S15Ae)

2.92

fig|6666666.571729.peg.248

hypothetical protein

2.89

fig|6666666.571729.peg.500

hypothetical protein

2.88

fig|6666666.571729.peg.1655

hypothetical protein

2.87

fig|6666666.571729.peg.476

Na+/H+ antiporter NhaA type

2.86

fig|6666666.571729.peg.1428

hypothetical protein

2.82

fig|6666666.571729.peg.1272

Fumarate and nitrate reduction regulatory protein

2.82

fig|6666666.571729.peg.649

hypothetical protein

3.00

196

2.81

fig|6666666.571729.peg.118

SSU ribosomal protein S12p (S23e)

2.81

fig|6666666.571729.peg.1765

hypothetical protein

2.81

fig|6666666.571729.peg.1645

DNA ligase

2.79

fig|6666666.571729.peg.10

hypothetical protein

2.78

fig|6666666.571729.peg.455

Transcriptional regulator%2C MarR
family

2.78

fig|6666666.571729.peg.1969

Tyrosine-specific transport protein

2.77

fig|6666666.571729.peg.1277

Mobile element protein

2.74

fig|6666666.571729.peg.914

ImpA

2.74

fig|6666666.571729.peg.322

2.73

fig|6666666.571729.peg.380

2.72

fig|6666666.571729.peg.235

Patatin-like phospholipase
DNA-directed RNA polymerase alpha subunit (EC 2.7.7.6);Ontology_term
Permease of the drug/metabolite
transporter (DMT) superfamily

2.71

fig|6666666.571729.peg.896

5'-deoxynucleotidase YfbR (EC
3.1.3.89);Ontology_term

2.71

fig|6666666.571729.peg.403

hypothetical protein

2.71

fig|6666666.571729.peg.1237

FIG00847315: hypothetical protein

2.70

fig|6666666.571729.peg.606

hypothetical protein

2.69

fig|6666666.571729.peg.1544

Putative Ton-B dependent hemine
receptor

2.69

fig|6666666.571729.peg.662

Lipoprotein NlpI

2.68

fig|6666666.571729.peg.593

hypothetical protein

197

2.67

fig|6666666.571729.peg.929

hypothetical protein

2.65

fig|6666666.571729.peg.265

Vitamin B12 ABC transporter%2C
ATP-binding protein BtuD

2.63

fig|6666666.571729.peg.5

hypothetical protein

2.63

fig|6666666.571729.peg.533

2.62

fig|6666666.571729.peg.42

2.60

fig|6666666.571729.peg.745

2.60

fig|6666666.571729.peg.1737

2.59

fig|6666666.571729.peg.1011

hypothetical protein
23S rRNA (adenine(2030)-N(6))methyltransferase (EC
2.1.1.266);Ontology_term
Type II secretory pathway%2C component PulF%3B Type IV fimbrial
assembly protein PilC
tRNA (cytidine(32)/uridine(32)-2'O)-methyltransferase (EC
2.1.1.200);Ontology_term
CRISPR-associated endonuclease
Cas9

2.59

fig|6666666.571729.peg.263

hypothetical protein

2.58

fig|6666666.571729.peg.1681

hypothetical protein

2.58

fig|6666666.571729.peg.590

hypothetical protein

2.58

fig|6666666.571729.peg.402

3'(2')%2C5'-bisphosphate nucleotidase (EC 3.1.3.7);Ontology_term

2.57

fig|6666666.571729.peg.370

2.56

fig|6666666.571729.peg.184

2.56

fig|6666666.571729.peg.946

LSU ribosomal protein L6p (L9e)
Dipeptide ABC transporter%2C substrate-binding protein DppA (TC
3.A.1.5.2)
Sulfite reductase [NADPH] flavoprotein alpha-component (EC
1.8.1.2);Ontology_term

2.56

fig|6666666.571729.peg.323

DNA transformation protein TfoX

2.55

fig|6666666.571729.peg.1974

Transcriptional regulator of glmS
gene%2C DeoR family

2.54

fig|6666666.571729.peg.645

hypothetical protein

198

2.54

fig|6666666.571729.peg.368

2.54

fig|6666666.571729.peg.837

SSU ribosomal protein S14p (S29e)
@ SSU ribosomal protein S14p
(S29e)%2C zinc-independent
DnaA inactivator Hda (shorter homolog of DnaA)

2.53

fig|6666666.571729.peg.1868

hypothetical protein

fig|6666666.571729.peg.1386

Transcriptional regulator%2C MerR
family

fig|6666666.571729.peg.1183

Transcription termination protein
NusA

fig|6666666.571729.peg.964

Permease of the drug/metabolite
transporter (DMT) superfamily

fig|6666666.571729.peg.986

ABC transporter%2C ATP-binding
protein

fig|6666666.571729.peg.746

Type IV fimbrial assembly%2C
ATPase PilB

fig|6666666.571729.peg.423

deoxyribose-phosphate aldolase( EC:4.1.2.4 );Ontology_term

2.53
2.52
2.52
2.50
2.50
2.48
2.48

fig|6666666.571729.peg.1463

2.47

fig|6666666.571729.peg.1750

Phosphatidylglycerophosphatase B
(EC 3.1.3.27);Ontology_term
Holliday junction ATP-dependent
DNA helicase RuvA (EC
3.6.4.12);Ontology_term

2.47

fig|6666666.571729.peg.679

GTP-binding protein Obg

2.46

fig|6666666.571729.peg.1100

2.46

fig|6666666.571729.peg.1287

TonB-dependent receptor
Type III restriction-modification system restriction subunit (EC
3.1.21.5);Ontology_term

2.46

fig|6666666.571729.peg.285

2.44

fig|6666666.571729.peg.1164

hypothetical protein
Limit dextrin alpha-1%2C6-maltotetraose-hydrolase (EC
3.2.1.196);Ontology_term

2.44

fig|6666666.571729.peg.60

Glycerol uptake facilitator protein

fig|6666666.571729.peg.635

High-affinity choline uptake protein
BetT

2.43

199

2.42

fig|6666666.571729.peg.1172

L-lysine permease

2.42

fig|6666666.571729.peg.1523

Ferric iron ABC transporter%2C
ATP-binding protein

2.41

fig|6666666.571729.peg.65

hypothetical protein

fig|6666666.571729.peg.999

Glycine cleavage system transcriptional activator GcvA

2.40

fig|6666666.571729.peg.1865

Dihydrofolate reductase (EC
1.5.1.3);Ontology_term

2.40

fig|6666666.571729.peg.325

hypothetical protein

2.39

fig|6666666.571729.peg.1603

2.38

fig|6666666.571729.peg.1581

2.38

fig|6666666.571729.peg.1187

2.38

fig|6666666.571729.peg.1328

FIG023677: hypothetical protein
Para-aminobenzoate synthase%2C
amidotransferase component (EC
2.6.1.85);Ontology_term
Chorismate mutase I (EC 5.4.99.5) /
Cyclohexadienyl dehydrogenase (EC
1.3.1.12)(EC 1.3.1.43);Ontology_termprotease sohB (EC
Possible
3.4.21.-);Ontology_term

2.37

fig|6666666.571729.peg.7

hypothetical protein

2.37

fig|6666666.571729.peg.1658

hypothetical protein

2.36

fig|6666666.571729.peg.540

UDP-glucose 4-epimerase (EC
5.1.3.2);Ontology_term

2.35

fig|6666666.571729.peg.1905

Fumarate reductase subunit C

2.34

fig|6666666.571729.peg.1916

Glycosyl transferase

2.41

2.33

fig|6666666.571729.peg.441

2.33

fig|6666666.571729.peg.236

2.33

fig|6666666.571729.peg.1478
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Permease of the drug/metabolite
transporter (DMT) superfamily
16S rRNA (guanine(527)-N(7))-methyltransferase (EC 2.1.1.170);Ontology_term
Biotin operon repressor / Biotin-protein ligase (EC 6.3.4.9)(EC
6.3.4.10)(EC 6.3.4.11)(EC
6.3.4.15);Ontology_term

2.33

fig|6666666.571729.peg.1413

Exodeoxyribonuclease III (EC
3.1.11.2);Ontology_term

2.33

fig|6666666.571729.peg.1756

hypothetical protein

2.33

fig|6666666.571729.peg.1694

2.32

fig|6666666.571729.peg.155

2.32

fig|6666666.571729.peg.100

2.32

fig|6666666.571729.peg.1759

T6SS component TssB (ImpB/VipA)
ABC transporter%2C permease protein (cluster 3%2C basic aa/glutamine/opines)
5'-nucleotidase (EC 3.1.3.5)%3B
2'%2C3'-cyclic-nucleotide 2'-phosphodiesterase (EC 3.1.4.16)%3B Putative UDP-sugar hydrolase (EC
3.6.1.45);Ontology_term
hypothetical protein

2.31

fig|6666666.571729.peg.1547

Cystathionine beta-lyase (EC
4.4.1.8);Ontology_term

2.31

fig|6666666.571729.peg.373

2.31

fig|6666666.571729.peg.154

LSU ribosomal protein L30p (L7e)
ABC transporter%2C permease protein (cluster 3%2C basic aa/glutamine/opines)

2.30

fig|6666666.571729.peg.1128

Protein tyrosine/serine phosphatase

2.30

fig|6666666.571729.peg.55

Sulfate transporter%2C CysZ-type

2.29

fig|6666666.571729.peg.1691

T6SS component TssF (ImpG/VasA)

fig|6666666.571729.peg.971

Glycogen phosphorylase (EC
2.4.1.1);Ontology_term

fig|6666666.571729.peg.1637

NAD-dependent protein deacetylase
of SIR2 family

fig|6666666.571729.peg.57

L-cystine ABC transporter%2C substrate-binding protein TcyA

2.25

fig|6666666.571729.peg.49

Thymidine kinase (EC 2.7.1.21);Ontology_term

2.25

fig|6666666.571729.peg.404

Predicted membrane protein

2.24

fig|6666666.571729.peg.1879

hypothetical protein

2.27
2.27
2.26

201

2.24

fig|6666666.571729.peg.1909

Primosomal replication protein N

2.23

fig|6666666.571729.peg.875

COG2315: Uncharacterized protein
conserved in bacteria

2.23

fig|6666666.571729.peg.377

SSU ribosomal protein S13p (S18e)

fig|6666666.571729.peg.1711

Phospholipid ABC transporter-binding protein MlaB

2.22

fig|6666666.571729.peg.813

Manganese ABC transporter%2C
ATP-binding protein SitB

2.22

fig|6666666.571729.peg.994

Hypothetical protein DUF454

2.21

fig|6666666.571729.peg.1647

Cystathionine gamma-synthase (EC
2.5.1.48);Ontology_term

2.20

fig|6666666.571729.peg.2013

2.20

fig|6666666.571729.peg.539

2.20

fig|6666666.571729.peg.1876

2.20

fig|6666666.571729.peg.1712

2.23

hypothetical protein
Lipid carrier : UDP-N-acetylgalactosaminyltransferase (EC 2.4.1.-) /
Alpha-1%2C3-N-acetylgalactosamine transferase PglA (EC
2.4.1.-)%3B
glycosyltransPutative innerPutative
membrane
protein
ferase;Ontology_term
Phospholipid ABC transporter shuttle protein MlaC

2.18

fig|6666666.571729.peg.781

2.18

fig|6666666.571729.peg.1933

Formamidopyrimidine-DNA glycosylase (EC 3.2.2.23);Ontology_term
1%2C4-dihydroxy-2-naphthoate polyprenyltransferase (EC 2.5.1.74);Ontology_term

2.18

fig|6666666.571729.peg.463

hypothetical protein

2.18

fig|6666666.571729.peg.1317

Stringent starvation protein A

2.17

fig|6666666.571729.peg.1684

T6SS component TssA (ImpA)

2.17

fig|6666666.571729.peg.1477

Uncharacterized protein
MSMEG_6412

2.16

fig|6666666.571729.peg.1668

hypothetical protein

202

2.16

fig|6666666.571729.peg.1085

2.16

fig|6666666.571729.peg.965

ABC transporter%2C permease protein 2 (cluster 5%2C nickel/peptides/opines)
Permease of the drug/metabolite
transporter (DMT) superfamily

2.15

fig|6666666.571729.peg.1221

Type I restriction-modification system%2C specificity subunit S

2.15

fig|6666666.571729.peg.584

FIG017861: hypothetical protein

2.15

fig|6666666.571729.peg.1610

2.15

fig|6666666.571729.peg.1827

2.15

fig|6666666.571729.peg.944

Protein PhnA
3-hydroxyacyl-[acyl-carrier-protein]
dehydratase%2C FabZ form (EC
4.2.1.59);Ontology_term
Sulfate adenylyltransferase subunit 2
(EC 2.7.7.4);Ontology_term

fig|6666666.571729.peg.187

Sigma factor RpoE negative regulatory protein RseB precursor

fig|6666666.571729.peg.416

tRNA pseudouridine(13) synthase
(EC 5.4.99.27);Ontology_term

2.14
2.14
2.13

fig|6666666.571729.peg.660

2.13

fig|6666666.571729.peg.87

2.13

fig|6666666.571729.peg.1690

Membrane-bound lytic murein
transglycosylase F (EC 4.2.2.n1)
Anaerobic glycerol-3-phosphate dehydrogenase subunit B (EC
1.1.5.3);Ontology_term
T6SS component TssG
(ImpH/VasB)

2.13

fig|6666666.571729.peg.1652

hypothetical protein

2.13

fig|6666666.571729.peg.62

hypothetical protein

2.13

fig|6666666.571729.peg.1006

Riboflavin synthase eubacterial/eukaryotic (EC 2.5.1.9);Ontology_term

2.12

fig|6666666.571729.peg.224

hypothetical protein

2.11

fig|6666666.571729.peg.389

hypothetical protein

2.11

fig|6666666.571729.peg.869

hypothetical protein

203

2.11

fig|6666666.571729.peg.107

Nucleoside triphosphate pyrophosphohydrolase MazG (EC
3.6.1.8);Ontology_term

2.11

fig|6666666.571729.peg.1452

hypothetical protein

2.10

fig|6666666.571729.peg.595

FIG00847847: hypothetical protein

fig|6666666.571729.peg.316

Pantothenate kinase (EC
2.7.1.33);Ontology_term

fig|6666666.571729.peg.506

Lipoprotein signal peptidase (EC
3.4.23.36);Ontology_term

2.10
2.10
2.09

fig|6666666.571729.peg.1456

2.09

fig|6666666.571729.peg.1222

2.09

fig|6666666.571729.peg.735

2.09

fig|6666666.571729.peg.536

2.09

fig|6666666.571729.peg.1825

Exopolysaccharide biosynthesis protein
Type I restriction-modification system%2C DNA-methyltransferase
subunit M (EC 2.1.1.72);Ontology_term
Efflux
ABC transporter%2C permease/ATP-binding protein
Alpha-1%2C4-N-acetylgalactosamine transferase PglH (EC
2.4.1.-);Ontology_term
Lipid-A-disaccharide synthase (EC
2.4.1.182);Ontology_term

2.08

fig|6666666.571729.peg.375

Protein translocase subunit SecY

2.08

fig|6666666.571729.peg.1176

2.08

fig|6666666.571729.peg.1393

2.08

fig|6666666.571729.peg.1262

Protein ygiW precursor
Formate hydrogenlyase maturation
protease (EC 3.4.23.51);Ontology_term
tRNA-(cytosine32)-2-thiocytidine
synthetase TtcA

2.08

fig|6666666.571729.peg.292

converved hypothetical protein

2.07

fig|6666666.571729.peg.1807

Copper sensory histidine kinase
CpxA

2.07

fig|6666666.571729.peg.321

2.06

fig|6666666.571729.peg.95
204

RecA protein
Phosphoribosylformylglycinamidine
synthase%2C synthetase subunit (EC
6.3.5.3) / Phosphoribosylformylglycinamidine synthase%2C glutamine amidotransferase subunit (EC
6.3.5.3);Ontology_term

fig|6666666.571729.peg.237

Redox-sensing transcriptional regulator QorR

fig|6666666.571729.peg.1280

Transcriptional regulator%2C LysR
family

2.04

fig|6666666.571729.peg.1686

T6SS outer membrane component
TssL (ImpK/VasF)

2.04

fig|6666666.571729.peg.648

Mobile element protein

fig|6666666.571729.peg.1378

LPS-core synthesis glycosyltransferase PM0509

2.03

fig|6666666.571729.peg.1336

Dihydropteroate synthase (EC
2.5.1.15);Ontology_term

2.03

fig|6666666.571729.peg.1913

LOS biosynthesis enzyme LBGB

2.05
2.05

2.03

2.02

fig|6666666.571729.peg.750

2.02

fig|6666666.571729.peg.271

2.02

fig|6666666.571729.peg.1088

Uncharacterized UPF0721 integral
membrane protein
S-ribosylhomocysteine lyase (EC
4.4.1.21) @ Autoinducer-2 production protein LuxS;Ontology_term
Conserved protein YcjX with nucleoside triphosphate hydrolase domain

fig|6666666.571729.peg.1082

Signal peptide peptidase SppA (protease 4)

fig|6666666.571729.peg.763

Phosphatidate cytidylyltransferase
(EC 2.7.7.41);Ontology_term

fig|6666666.571729.peg.1548

Alkyl hydroperoxide reductase subunit C-like protein

2.02
2.01
2.00

Table S4: Genes repressed in H. parainfluenzae following addition of H2O2 compared to no added H2O2

Fold
change

ID

Description
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-4683.91

fig|6666666.571729.peg.756

FIG00697202: hypothetical protein

-90.59

fig|6666666.571729.peg.537

-68.30

fig|6666666.571729.peg.458

-37.22

fig|6666666.571729.peg.646

hypothetical protein
Putative Dihydrolipoamide dehydrogenase (EC 1.8.1.4)%3B Mercuric ion
reductase (EC 1.16.1.1)%3B PF00070
family%2C FAD-dependent NAD(P)disulphide oxidoreductase;Ontology_term protein
hypothetical

-32.75

fig|6666666.571729.peg.1745

Cytochrome d ubiquinol oxidase subunit X (EC 1.10.3.-);Ontology_term

-29.18

fig|6666666.571729.peg.388

Osmotically-inducible lipoprotein
OsmB

-28.32

fig|6666666.571729.peg.1020

hypothetical protein

-25.31

fig|6666666.571729.peg.742

DNA gyrase inhibitor YacG

-17.45

fig|6666666.571729.peg.607

hypothetical protein

-16.26

fig|6666666.571729.peg.347

hypothetical protein

-13.98

fig|6666666.571729.peg.704

5-formyltetrahydrofolate cyclo-ligase
(EC 6.3.3.2);Ontology_term

-11.51

fig|6666666.571729.peg.1289

hypothetical protein

-11.44

fig|6666666.571729.peg.1275

hypothetical protein

-11.25

fig|6666666.571729.peg.1389

Substrate-specific component NikM
of nickel ECF transporter

-11.19

fig|6666666.571729.peg.1796

YciL protein

-10.86

fig|6666666.571729.peg.461

Inner membrane protein%2C
KefB/KefC family

-10.46

fig|6666666.571729.peg.218

hypothetical protein

206

-9.73

fig|6666666.571729.peg.1884

Nucleoid-associated protein YaaK

-9.51

fig|6666666.571729.peg.1299

-9.25

fig|6666666.571729.peg.566

LSU ribosomal protein L20p
LSU ribosomal protein L32p @ LSU
ribosomal protein L32p%2C zinc-independent

-8.62

fig|6666666.571729.peg.251

hypothetical protein

-8.29

fig|6666666.571729.peg.1473

hypothetical protein

-8.01

fig|6666666.571729.peg.1409

Outer membrane stress sensor protease DegQ%2C serine protease

-7.81

fig|6666666.571729.peg.562

Carboxymuconolactone decarboxylase family protein

-7.48

fig|6666666.571729.peg.676

-7.11

fig|6666666.571729.peg.13

LSU ribosomal protein L27p
2-iminobutanoate/2-iminopropanoate
deaminase RidA/TdcF (EC
3.5.99.10);Ontology_term

fig|6666666.571729.peg.1818

Heat shock protein 60 kDa family
chaperone GroEL

fig|6666666.571729.peg.1982

ABC transporter%2C permease protein (cluster 10%2C nitrate/sulfonate/bicarbonate)

fig|6666666.571729.peg.1360

Periplasmic protein p19 involved in
high-affinity Fe2+ transport

-6.14

fig|6666666.571729.peg.1862

FKBP-type peptidyl-prolyl cis-trans
isomerase FklB (EC 5.2.1.8);Ontology_term

-6.13

fig|6666666.571729.peg.1738

Tol-Pal system peptidoglycan-associated lipoprotein PAL

-6.01

fig|6666666.571729.peg.1908

SSU ribosomal protein S18p @ SSU
ribosomal protein S18p%2C zinc-independent

-6.00

fig|6666666.571729.peg.1586

Heat shock protein GrpE

-6.68

-6.62
-6.59
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-5.96

fig|6666666.571729.peg.433

AagD

-5.96

fig|6666666.571729.peg.1950

Uncharacterized protein YhdT

-5.90

fig|6666666.571729.peg.453

putative phage shock protein E precursor

-5.80

fig|6666666.571729.peg.685

Rhomboid family protein

-5.55

fig|6666666.571729.peg.905

Chaperone protein DnaK

-5.54

fig|6666666.571729.peg.1720

Galactokinase (EC 2.7.1.6);Ontology_term

-5.52

fig|6666666.571729.peg.1013

LSU ribosomal protein L25p

-5.44

fig|6666666.571729.peg.1552

ADP-ribose pyrophosphatase (EC
3.6.1.13);Ontology_term

-5.39

fig|6666666.571729.peg.1768

hypothetical protein

-5.28

fig|6666666.571729.peg.903

O-acetylhomoserine sulfhydrylase
(EC 2.5.1.49) @ O-succinylhomoserine sulfhydrylase (EC 2.5.1.48);Ontology_term

-5.19

fig|6666666.571729.peg.1821

Uncharacterized transporter YfbS

-5.10

fig|6666666.571729.peg.250

2-oxoglutarate/malate translocator

-5.08

fig|6666666.571729.peg.69

hypothetical protein

-5.07

fig|6666666.571729.peg.902

Chaperone protein DnaJ

-5.04

fig|6666666.571729.peg.1395

Hydrogenase-4 component I

-4.98

fig|6666666.571729.peg.1809

Copper(I) chaperone CopZ

fig|6666666.571729.peg.524

Diacylglycerol kinase (EC
2.7.1.107);Ontology_term

-4.96
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-4.82

fig|6666666.571729.peg.508

-4.70

fig|6666666.571729.peg.1284

hypothetical protein
N5-carboxyaminoimidazole ribonucleotide mutase (EC 5.4.99.18);Ontology_term

-4.60

fig|6666666.571729.peg.1040

FIG001587: exported protein

-4.59

fig|6666666.571729.peg.1077

Adenylosuccinate synthetase (EC
6.3.4.4);Ontology_term

-4.55

fig|6666666.571729.peg.1403

Hydrogenase-4 component A

-4.54

fig|6666666.571729.peg.836

hypothetical protein

-4.48

fig|6666666.571729.peg.546

Nucleoside diphosphate kinase (EC
2.7.4.6);Ontology_term

-4.41

fig|6666666.571729.peg.446

PTS system%2C mannose-specific
IID component

-4.41

fig|6666666.571729.peg.306

Hydrogenase maturation protease

fig|6666666.571729.peg.1072

3-oxoacyl-[acyl-carrier-protein] synthase%2C KASI (EC 2.3.1.41);Ontology_term

fig|6666666.571729.peg.183

Pyridoxamine 5'-phosphate oxidase
(EC 1.4.3.5);Ontology_term

-4.39
-4.37
-4.36

fig|6666666.571729.peg.1934

-4.33

fig|6666666.571729.peg.680

-4.33

fig|6666666.571729.peg.977

-4.29

fig|6666666.571729.peg.1819

tRNA (adenine(37)-N6)-methyltransferase
LSU ribosomal protein L36p @ LSU
ribosomal protein L36p%2C zinc-independent
Lipid A biosynthesis lauroyl acyltransferase (EC 2.3.1.241);Ontology_term
Heat shock protein 10 kDa family
chaperone GroES

fig|6666666.571729.peg.447

PTS system%2C mannose-specific
IIC component

fig|6666666.571729.peg.310

Ni/Fe-hydrogenase 2 small subunit
HybO (EC 1.12.99.6);Ontology_term

-4.28
-4.27
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-4.25

fig|6666666.571729.peg.862

Phosphotransferase system%2C phosphocarrier protein HPr

-4.23

fig|6666666.571729.peg.906

hypothetical protein

-4.20

fig|6666666.571729.peg.96

-4.19

fig|6666666.571729.peg.1858

Orf2
Glutathionylspermidine synthase (EC
6.3.1.8) / Glutathionylspermidine amidohydrolase (EC 3.5.1.78);Ontology_term

-4.15

fig|6666666.571729.peg.789

Cyclic AMP receptor protein

-4.13

fig|6666666.571729.peg.1588

Hypothetical protein VC0266 (sugar
utilization related?)

-4.05

fig|6666666.571729.peg.1322

Integration host factor alpha subunit

-4.03

fig|6666666.571729.peg.48

hypothetical protein

-4.00

fig|6666666.571729.peg.1388

Additional component NikL of nickel
ECF transporter

-3.94

fig|6666666.571729.peg.451

Uncharacterized protein YnbE

-3.92

fig|6666666.571729.peg.665

UPF0033 protein YeeD

-3.88

fig|6666666.571729.peg.1021

Ribose-phosphate pyrophosphokinase
(EC 2.7.6.1);Ontology_term

-3.86

fig|6666666.571729.peg.1925

-3.86

fig|6666666.571729.peg.785

-3.81

fig|6666666.571729.peg.1998

-3.81

fig|6666666.571729.peg.550

-3.80

fig|6666666.571729.peg.686
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DnaJ-like protein DjlA
Phosphopantothenoylcysteine decarboxylase (EC 4.1.1.36) / Phosphopantothenoylcysteine synthetase (EC
6.3.2.5);Ontology_term
Fructose-bisphosphate aldolase class
II (EC 4.1.2.13);Ontology_term
TonB-dependent receptor
IMP cyclohydrolase (EC 3.5.4.10) /
Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC
2.1.2.3);Ontology_term

-3.71

fig|6666666.571729.peg.1436

Uncharacterized protein YraP

-3.70

fig|6666666.571729.peg.1089

Superoxide dismutase [Cu-Zn] precursor (EC 1.15.1.1);Ontology_term

-3.65

fig|6666666.571729.peg.1563

hypothetical protein

fig|6666666.571729.peg.496

2-haloalkanoic acid dehalogenase (EC
3.8.1.2);Ontology_term

-3.61

fig|6666666.571729.peg.801

Ribonuclease P protein component
(EC 3.1.26.5);Ontology_term

-3.61

fig|6666666.571729.peg.2016

VgrG protein

fig|6666666.571729.peg.716

Lactoylglutathione lyase (EC
4.4.1.5);Ontology_term

fig|6666666.571729.peg.278

D-aminoacyl-tRNA deacylase (EC
3.1.1.96);Ontology_term

-3.58

fig|6666666.571729.peg.787

Transcriptional regulator SlmA%2C
TetR family

-3.55

fig|6666666.571729.peg.659

hypothetical protein

fig|6666666.571729.peg.270

Formate-dependent phosphoribosylglycinamide formyltransferase

-3.51

fig|6666666.571729.peg.1808

Copper-translocating P-type ATPase
(EC 3.6.3.4);Ontology_term

-3.50

fig|6666666.571729.peg.210

UPF0438 protein YifE

-3.49

fig|6666666.571729.peg.1907

LSU ribosomal protein L9p

-3.49

fig|6666666.571729.peg.1883

Recombination protein RecR

-3.48

fig|6666666.571729.peg.1835

Ribosome recycling factor

fig|6666666.571729.peg.2001

Uncharacterized glycine randical protein HI_0521

-3.63

-3.60
-3.58

-3.54

-3.46
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-3.44

fig|6666666.571729.peg.1961

N-acetylmuramic acid 6-phosphate
etherase (EC 4.2.1.126);Ontology_term

-3.44

fig|6666666.571729.peg.457

hypothetical protein

-3.40

fig|6666666.571729.peg.226

Threonine dehydratase biosynthetic
(EC 4.3.1.19);Ontology_term

-3.38

fig|6666666.571729.peg.1937

Alternative ribosome-rescue factor A

-3.37

fig|6666666.571729.peg.1081

Putative NAD(P)H nitroreductase
YdjA

-3.35

fig|6666666.571729.peg.1512

Phospholipid-binding protein

-3.34

fig|6666666.571729.peg.1722

Galactose-1-phosphate uridylyltransferase (EC 2.7.7.10);Ontology_term

-3.34

fig|6666666.571729.peg.1485

Transcriptional activator MetR

-3.33

fig|6666666.571729.peg.1516

Thiol peroxidase%2C Tpx-type (EC
1.11.1.15);Ontology_term

-3.31

fig|6666666.571729.peg.1542

HesA/MoeB/ThiF family protein >
sulfur transfer pathway protein CsdL

-3.29

fig|6666666.571729.peg.11

LSU ribosomal protein L7p/L12p
(P1/P2)

-3.27

fig|6666666.571729.peg.411

ATP-dependent protease subunit
HslV (EC 3.4.25.2);Ontology_term

-3.27

fig|6666666.571729.peg.1264

Bacterial non-heme ferritin (EC
1.16.3.2);Ontology_term

-3.25

fig|6666666.571729.peg.1261

-3.23

fig|6666666.571729.peg.1168

-3.23

fig|6666666.571729.peg.1169

-3.20

fig|6666666.571729.peg.334
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tRNA 2-thiouridine synthesis protein
TusE
6%2C7-dimethyl-8-ribityllumazine
synthase (EC 2.5.1.78);Ontology_term
Transcription termination protein
NusB
Cell division protein DivIC
(FtsB)%2C stabilizes FtsL against
RasP cleavage

-3.19

fig|6666666.571729.peg.2000

ADP-heptose--lipooligosaccharide
heptosyltransferase II

-3.17

fig|6666666.571729.peg.1660

VgrG protein

fig|6666666.571729.peg.1143

LSU rRNA pseudouridine(2605) synthase (EC 5.4.99.22);Ontology_term

fig|6666666.571729.peg.1074

Acetolactate synthase small subunit
(EC 2.2.1.6);Ontology_term

fig|6666666.571729.peg.700

Putative pre-16S rRNA nuclease
YqgF

-3.13

fig|6666666.571729.peg.336

Unsaturated fatty acid biosythesis repressor FabR%2C TetR family

-3.09

fig|6666666.571729.peg.180

Uncharacterized oxidoreductase YjhC

-3.07

fig|6666666.571729.peg.495

Large exoproteins involved in heme
utilization or adhesion

-3.05

fig|6666666.571729.peg.68

hypothetical protein

-3.05

fig|6666666.571729.peg.1954

Biotin carboxyl carrier protein of acetyl-CoA carboxylase

-3.03

fig|6666666.571729.peg.1427

UPF0033 protein YedF

-3.16
-3.14
-3.14

-2.97

fig|6666666.571729.peg.73

-2.96

fig|6666666.571729.peg.1875

-2.96

fig|6666666.571729.peg.1873

Purine nucleoside phosphorylase (EC
2.4.2.1);Ontology_term
5-methyltetrahydrofolate--homocysteine methyltransferase (EC
2.1.1.13);Ontology_term
3-isopropylmalate dehydratase large
subunit (EC 4.2.1.33);Ontology_term

-2.96

fig|6666666.571729.peg.1509

-2.95

fig|6666666.571729.peg.820

DNA polymerase III psi subunit (EC
2.7.7.7);Ontology_term
(E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase (flavodoxin) (EC
1.17.7.3);Ontology_term

-2.94

fig|6666666.571729.peg.1453

Repair of Iron Centers di-iron protein
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-2.90

fig|6666666.571729.peg.179

probable oxidoreductase protein

fig|6666666.571729.peg.705

Chaperone protein ClpB (ATP-dependent unfoldase)

-2.87

fig|6666666.571729.peg.841

Nitric-oxide reductase (EC
1.7.99.7)%2C quinol-dependent;Ontology_term

-2.86

fig|6666666.571729.peg.608

Protein translocase subunit SecA

-2.83

fig|6666666.571729.peg.1067

probable membrane protein YPO3565

-2.83

fig|6666666.571729.peg.1404

[NiFe] hydrogenase metallocenter assembly protein HypC

-2.82

fig|6666666.571729.peg.699

-2.82

fig|6666666.571729.peg.1211

UPF0301 protein YqgE
Cold shock protein of CSP family >
CspD (naming convention as in
E.coli)

-2.80

fig|6666666.571729.peg.430

33 kDa chaperonin HslO

-2.78

fig|6666666.571729.peg.422

-2.78

fig|6666666.571729.peg.1240

Deoxyribose-phosphate aldolase (EC
4.1.2.4);Ontology_term
5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (EC 2.1.1.14);Ontology_term

-2.77

fig|6666666.571729.peg.497

hypothetical protein

fig|6666666.571729.peg.1382

[NiFe] hydrogenase metallocenter assembly protein HypE

fig|6666666.571729.peg.1993

Uncharacterized MFS-type transporter

fig|6666666.571729.peg.1135

Putative TEGT family carrier/transport protein

fig|6666666.571729.peg.1310

Anthranilate phosphoribosyltransferase (EC 2.4.2.18);Ontology_term

fig|6666666.571729.peg.1867

6-phosphofructokinase (EC
2.7.1.11);Ontology_term

-2.89

-2.77
-2.77
-2.77
-2.76
-2.76

214

-2.76

fig|6666666.571729.peg.290

L-asparaginase (EC 3.5.1.1);Ontology_term

-2.76

fig|6666666.571729.peg.687

-2.74

fig|6666666.571729.peg.413

-2.74

fig|6666666.571729.peg.439

Phosphoribosylamine--glycine ligase
(EC 6.3.4.13);Ontology_term
FKBP-type peptidyl-prolyl cis-trans
isomerase SlyD (EC 5.2.1.8);Ontology_term
Iron(III) dicitrate transport system
permease protein FecC (TC
3.A.1.14.1)

-2.74

fig|6666666.571729.peg.717

Uncharacterized protease YegQ

fig|6666666.571729.peg.1506

Formate dehydrogenase O gamma
subunit (EC 1.2.1.2);Ontology_term

fig|6666666.571729.peg.526

Glycerate kinase (EC 2.7.1.31);Ontology_term

fig|6666666.571729.peg.1387

Additional periplasmic component
NikK of nickel ECF transporter

fig|6666666.571729.peg.701

FIG00003370: Multicopper polyphenol oxidase

fig|6666666.571729.peg.894

Diaminohydroxyphosphoribosylaminopyrimidine deaminase (EC
3.5.4.26) / 5-amino-6-(5-phosphoribosylamino)uracil reductase (EC
1.1.1.193);Ontology_term

fig|6666666.571729.peg.529

Pyrroline-5-carboxylate reductase
(EC 1.5.1.2);Ontology_term

fig|6666666.571729.peg.521

DNA recombination and repair protein RecO

fig|6666666.571729.peg.61

Glycerol kinase (EC 2.7.1.30);Ontology_term

fig|6666666.571729.peg.2005

Diaminopimelate decarboxylase (EC
4.1.1.20);Ontology_term

-2.68

fig|6666666.571729.peg.1306

FMN-dependent NADH-azoreductase
(EC 1.7.1.6);Ontology_term

-2.67

fig|6666666.571729.peg.1857

Cytochrome c-type protein NapC

-2.72
-2.71
-2.70
-2.70

-2.69
-2.68
-2.68
-2.68
-2.68
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-2.67

fig|6666666.571729.peg.1076

Protein of unknown function DUF484

-2.66

fig|6666666.571729.peg.129

Triosephosphate isomerase (EC
5.3.1.1);Ontology_term

-2.65

fig|6666666.571729.peg.1316

Stringent starvation protein B

fig|6666666.571729.peg.301

ATP-dependent protease La (EC
3.4.21.53) Type I;Ontology_term

fig|6666666.571729.peg.1903

Fumarate reductase flavoprotein subunit (EC 1.3.5.4);Ontology_term

-2.62

fig|6666666.571729.peg.821

Histidyl-tRNA synthetase (EC
6.1.1.21);Ontology_term

-2.61

fig|6666666.571729.peg.1365

Putative thioredoxin precursor

-2.61

fig|6666666.571729.peg.1206

UPF0319 protein YccT precursor

-2.60

fig|6666666.571729.peg.206

Protease HtpX

fig|6666666.571729.peg.1139

Predicted hydroxymethylpyrimidine
transporter CytX

fig|6666666.571729.peg.609

Mutator MutT protein (7%2C8-dihydro-8-oxoguanine-triphosphatase)
(EC 3.6.1.-);Ontology_term

fig|6666666.571729.peg.766

2-succinyl-5-enolpyruvyl-6-hydroxy3-cyclohexene-1-carboxylic-acid synthase (EC 2.2.1.9);Ontology_term

fig|6666666.571729.peg.412

ATP-dependent hsl protease ATPbinding subunit HslU

fig|6666666.571729.peg.417

5'-nucleotidase SurE (EC 3.1.3.5);Ontology_term

-2.52

fig|6666666.571729.peg.135

Threonylcarbamoyl-AMP synthase
(EC 2.7.7.87);Ontology_term

-2.52

fig|6666666.571729.peg.682

tmRNA-binding protein SmpB

-2.50

fig|6666666.571729.peg.353

hypothetical protein

-2.63
-2.63

-2.60

-2.58

-2.57
-2.54
-2.54
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fig|6666666.571729.peg.139

Thiosulfate sulfurtransferase GlpE
(EC 2.8.1.1);Ontology_term

-2.48

fig|6666666.571729.peg.1850

FIG002060: uncharacterized protein
YggL

-2.48

fig|6666666.571729.peg.1402

Hydrogenase-4 component B

-2.49

-2.47

fig|6666666.571729.peg.1782

-2.46

fig|6666666.571729.peg.1751

Zinc ABC transporter%2C ATP-binding protein ZnuC
Crossover junction endodeoxyribonuclease RuvC (EC 3.1.22.4);Ontology_term

-2.46

fig|6666666.571729.peg.1144

Cys regulon transcriptional activator
CysB

-2.46

fig|6666666.571729.peg.1541

Zinc ABC transporter%2C substratebinding protein ZnuA

-2.46

fig|6666666.571729.peg.667

UPF0597 protein YhaM

-2.45

fig|6666666.571729.peg.472

Multidrug efflux system EmrABOMF%2C inner-membrane proton/drug antiporter EmrB (MFS type)

-2.44

fig|6666666.571729.peg.1968

UPF0701 protein YicC

fig|6666666.571729.peg.1405

[NiFe] hydrogenase metallocenter assembly protein HypF

fig|6666666.571729.peg.838

Uracil permease @ Uracil:proton
symporter UraA

fig|6666666.571729.peg.893

Ribonucleotide reductase transcriptional regulator NrdR

-2.44
-2.44
-2.43
-2.43

fig|6666666.571729.peg.886

-2.42

fig|6666666.571729.peg.217

-2.42

fig|6666666.571729.peg.1227
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Biotin synthase (EC 2.8.1.6);Ontology_term
2'%2C3'-cyclic-nucleotide 2'-phosphodiesterase (EC 3.1.4.16) / 3'-nucleotidase (EC 3.1.3.6);Ontology_term
FIG023911: putative membrane protein

-2.42

fig|6666666.571729.peg.734

Putative transport protein YidE

fig|6666666.571729.peg.532

Glutamine synthetase type I (EC
6.3.1.2);Ontology_term

-2.42

fig|6666666.571729.peg.527

Site-specific tyrosine recombinase
XerD

-2.40

fig|6666666.571729.peg.966

hypothetical protein

fig|6666666.571729.peg.1708

Pyridoxal phosphate-containing protein YggS

fig|6666666.571729.peg.1836

Uridylate kinase (EC 2.7.4.22);Ontology_term

-2.38

fig|6666666.571729.peg.1073

Acetolactate synthase large subunit
(EC 2.2.1.6);Ontology_term

-2.38

fig|6666666.571729.peg.1919

-2.38

fig|6666666.571729.peg.1346

FIG00696423: hypothetical protein
BioD-like N-terminal domain / Phosphate acetyltransferase (EC
2.3.1.8);Ontology_term

-2.36

fig|6666666.571729.peg.692

Serine hydroxymethyltransferase (EC
2.1.2.1);Ontology_term

-2.35

fig|6666666.571729.peg.493

NADH-dependent butanol dehydrogenase A (EC 1.1.1.-);Ontology_term

-2.35

fig|6666666.571729.peg.466

Single-stranded DNA-binding protein

-2.33

fig|6666666.571729.peg.1286

Aspartate aminotransferase (EC
2.6.1.1);Ontology_term

fig|6666666.571729.peg.1046

3-deoxy-D-manno-octulosonate 8phosphate phosphatase (EC
3.1.3.45);Ontology_term

fig|6666666.571729.peg.1101

Cytidylate kinase (EC 2.7.4.25);Ontology_term

fig|6666666.571729.peg.1719

Aldose 1-epimerase (EC 5.1.3.3);Ontology_term

-2.42

-2.39
-2.39

-2.33
-2.32
-2.31
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-2.31

fig|6666666.571729.peg.280

UPF0225 protein YchJ

-2.30

fig|6666666.571729.peg.1304

Aldose 1-epimerase

fig|6666666.571729.peg.752

Thymidylate synthase (EC
2.1.1.45);Ontology_term

fig|6666666.571729.peg.1775

Ribosome LSU-associated GTP-binding protein HflX

-2.29

fig|6666666.571729.peg.142

Ketol-acid reductoisomerase
(NADP(+)) (EC 1.1.1.86);Ontology_term

-2.29

fig|6666666.571729.peg.721

UDP-glucose 4-epimerase (EC
5.1.3.2);Ontology_term

-2.28

fig|6666666.571729.peg.492

LSU ribosomal protein L1p (L10Ae)

-2.28

fig|6666666.571729.peg.1695

-2.27

fig|6666666.571729.peg.193

T6SS PAAR-repeat protein
PTS system%2C fructose-specific IIA
component (EC 2.7.1.202) / Fructosespecific phosphocarrier protein
HPr;Ontology_term

-2.27

fig|6666666.571729.peg.548

-2.27

fig|6666666.571729.peg.1353

FIG00782388: hypothetical protein
Glutamate-1-semialdehyde 2%2C1aminomutase (EC 5.4.3.8);Ontology_term

fig|6666666.571729.peg.848

NAD-dependent glyceraldehyde-3phosphate dehydrogenase (EC
1.2.1.12);Ontology_term

-2.26

fig|6666666.571729.peg.1787

DNA mismatch repair endonuclease
MutH

-2.24

fig|6666666.571729.peg.1151

Outer membrane lipoprotein

fig|6666666.571729.peg.1810

Transcriptional regulator%2C MerR
family

fig|6666666.571729.peg.1783

Zinc ABC transporter%2C permease
protein ZnuB

-2.30
-2.29

-2.27

-2.24
-2.23
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-2.22

fig|6666666.571729.peg.825

-2.22

fig|6666666.571729.peg.478

ABC transporter involved in cytochrome c biogenesis%2C ATPase
component CcmA
23S rRNA (guanosine(2251)-2'-O)methyltransferase (EC 2.1.1.185);Ontology_term

-2.22

fig|6666666.571729.peg.1005

Multidrug efflux transporter
MdtK/NorM (MATE family)

-2.22

fig|6666666.571729.peg.1104

probable membrane protein YPO2224

-2.21

fig|6666666.571729.peg.138

Flavin-utilizing monoxygenase

fig|6666666.571729.peg.1777

ABC transporter%2C substrate-binding protein (cluster 8%2C B12/iron
complex)

fig|6666666.571729.peg.1642

Arginine ABC transporter%2C substrate-binding protein ArtI

fig|6666666.571729.peg.1800

Glutamyl-tRNA synthetase (EC
6.1.1.17);Ontology_term

-2.21
-2.21
-2.21
-2.20

fig|6666666.571729.peg.975

-2.20

fig|6666666.571729.peg.783

-2.20

fig|6666666.571729.peg.1320

Enoyl-[acyl-carrier-protein] reductase
[NADH] (EC 1.3.1.9);Ontology_term
LSU ribosomal protein L28p @ LSU
ribosomal protein L28p%2C zinc-independent
5%2C10-methylenetetrahydrofolate
reductase (EC 1.5.1.20);Ontology_term

-2.19

fig|6666666.571729.peg.706

Molybdopterin adenylyltransferase
(EC 2.7.7.75);Ontology_term

-2.19

fig|6666666.571729.peg.1880

PTS system%2C sucrose-specific IIB
component (EC 2.7.1.211) / PTS system%2C sucrose-specific IIC component;Ontology_term

-2.19

fig|6666666.571729.peg.674

Octaprenyl diphosphate synthase (EC
2.5.1.90);Ontology_term

fig|6666666.571729.peg.574

3-oxoacyl-[ACP] reductase (EC
1.1.1.100) FadG2%2C NOT involved
in fatty acid synthesis;Ontology_term
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Transcription elongation factor GreB

fig|6666666.571729.peg.1314

Tryptophan synthase alpha chain (EC
4.2.1.20);Ontology_term
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Frataxin homolog CyaY%2C facilitates Fe-S cluster assembly%2C interacts with IscS

-2.18

fig|6666666.571729.peg.822

UPF0070 protein YfgM
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hypothetical protein
UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase (EC
6.3.2.10);Ontology_term
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Oligopeptide ABC transporter%2C
ATP-binding protein OppF (TC
3.A.1.5.1)
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Glycerol-3-phosphate transporter
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Thymidylate kinase (EC 2.7.4.9);Ontology_term
ABC transporter%2C substrate-binding protein (cluster 5%2C nickel/peptides/opines)
Galactose/methyl galactoside ABC
transporter%2C permease protein
MglC (EC 3.6.3.17);Ontology_term
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thiamine-phosphate pyrophosphorylase( EC:2.5.1.3 );Ontology_term
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Electron transport complex protein
RnfE
Uncharacterized protein EC-HemY in
Proteobacteria (unrelated to HemYtype PPO in GramPositives)
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Hydrogenase-2 operon protein HybA
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Cytochrome c-type heme lyase subunit nrfE%2C nitrite reductase complex assembly
Spermidine/putrescine import ABC
transporter substrate-binding protein
PotD (TC 3.A.1.11.1)
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Phosphoglycerate kinase (EC
2.7.2.3);Ontology_term
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Fluoride ion transporter CrcB

fig|6666666.571729.peg.27

Competence protein F homolog%2C
phosphoribosyltransferase domain%3B protein YhgH required for
utilization of DNA as sole source of
carbon and energy
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FIG005121: SAM-dependent methyltransferase (EC 2.1.1.-);Ontology_term
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D-alanine--D-alanine ligase (EC
6.3.2.4);Ontology_term
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Ribonuclease E (EC 3.1.26.12);Ontology_term
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Transcription accessory protein (S1
RNA-binding domain)
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Cytidine deaminase (EC 3.5.4.5);Ontology_term
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Histidine permease YuiF
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Selenocysteine-specific translation
elongation factor
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Methionine ABC transporter substrate-binding protein
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Ribosome-associated inhibitor A
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Uncharacterized integral membrane
protein GSU2901
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fig|6666666.571729.peg.1305

Threonyl-tRNA synthetase (EC
6.1.1.3);Ontology_term
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Acetolactate synthase large subunit
(EC 2.2.1.6);Ontology_term
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Murein hydrolase activator NlpD
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Glutaredoxin 2
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ATP synthase epsilon chain (EC
3.6.3.14);Ontology_term
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Argininosuccinate synthase (EC
6.3.4.5);Ontology_term
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hypothetical protein
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Ribonuclease PH (EC 2.7.7.56);Ontology_term
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Deoxycytidine triphosphate deaminase (EC 3.5.4.13);Ontology_term
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Phosphoglycerate mutase (EC
5.4.2.11);Ontology_term
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Excinuclease ABC subunit A
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Arginine ABC transporter%2C permease protein ArtM
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Phosphatidylglycerol--membrane-oligosaccharide glycerophosphotransferase (EC 2.7.8.20);Ontology_term
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UPF0381 protein HI_0636
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Hydrogenase-4 component G
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Cell division protein FtsZ
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Purine nucleotide synthesis repressor
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6-phosphogluconate dehydrogenase%2C decarboxylating (EC
1.1.1.44);Ontology_term
Biotin carboxylase of acetyl-CoA carboxylase (EC 6.3.4.14);Ontology_term

